data_2gdt_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gdt _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.351 0.596 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 40' ' ' CYS . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CG2' ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.449 ' H ' ' CG2' ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.401 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 100' ' ' VAL . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.1 m80 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 121.583 0.706 . . . . 0.0 111.382 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.456 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.458 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 42.9 m80 . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 121.695 0.759 . . . . 0.0 110.837 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.307 1.051 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.287 0.565 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.479 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 m80 . . . . . 0 CA--C 1.552 1.036 0 CA-C-O 121.124 0.488 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 22.1 tp60 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t . . . . . 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.545 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.274 0.559 . . . . 0.0 111.705 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.482 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 C--O 1.238 0.447 0 CA-C-O 122.456 1.122 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 . . . . . 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 103' ' ' THR . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 101' ' ' GLY . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.487 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.347 0.594 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.409 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.6 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.422 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.45 HD21 ' HG ' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.442 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.568 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.436 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 122.002 0.906 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 . . . . . 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.468 ' CD2' ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 29.6 tp60 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HE2' ' CE1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 . . . . . 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.672 0.748 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.429 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' HG1' ' A' ' 103' ' ' THR . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 102' ' ' GLU . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.403 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.562 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.6 m80 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.481 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.564 HH22 ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . 0.564 ' CG2' HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.43 ' CD1' HG21 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.51 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 86' ' ' TYR . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.43 HG21 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 75' ' ' VAL . 29.5 p . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.425 ' HA ' ' H ' ' A' ' 63' ' ' SER . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 52' ' ' GLN . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 49' ' ' VAL . 30.8 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . 0.41 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.429 ' CD1' ' HG ' ' A' ' 40' ' ' CYS . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.429 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.436 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.9 m80 . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 120.886 0.374 . . . . 0.0 111.706 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.546 ' HE ' HD12 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 64.8 162.14 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.642 1.977 . . . . 0.0 110.424 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.531 ' CD1' ' HG ' ' A' ' 40' ' ' CYS . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.531 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p 43.01 78.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.53 84.13 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.42 18.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.286 1.434 . . . . 0.0 111.107 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt -147.91 166.72 26.81 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.264 1.426 . . . . 0.0 108.383 -163.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t -150.71 82.02 1.34 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -162.43 162.8 27.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -120.24 -6.7 9.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -112.54 88.51 2.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -156.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.28 171.52 43.9 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.85 -0.532 . . . . 0.0 111.866 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -62.53 170.13 2.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.465 1.506 . . . . 0.0 110.045 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.11 93.34 1.41 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . 0.449 ' CG2' ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.449 ' H ' ' CG2' ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.401 ' H ' ' CD ' ' A' ' 102' ' ' GLU . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.401 ' CD ' ' H ' ' A' ' 100' ' ' VAL . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -49.05 125.46 10.61 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -142.39 105.28 4.55 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 171.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -64.15 -50.04 69.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.034 -1.981 . . . . 0.0 108.155 173.82 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.1 m80 62.21 165.59 0.1 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.37 1.868 . . . . 0.0 111.382 -167.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.404 ' CD1' HG21 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.458 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t 52.15 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -133.65 2.94 3.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.613 -1.304 . . . . 0.0 110.905 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.86 53.55 1.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.694 1.197 . . . . 0.0 110.108 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 mt -149.03 164.58 34.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 130.195 3.398 . . . . 0.0 106.548 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -165.46 76.33 0.25 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -135.55 176.19 8.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.6 -0.687 . . . . 0.0 111.076 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -120.3 9.18 10.96 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.149 0.98 . . . . 0.0 111.569 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.24 177.84 0.45 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.752 0.821 . . . . 0.0 112.803 -171.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.36 -9.01 7.56 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.629 -1.095 . . . . 0.0 115.262 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -136.74 -171.48 2.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.428 1.614 . . . . 0.0 108.33 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -134.51 4.34 3.38 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 121.28 -0.887 . . . . 0.0 112.318 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.456 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.458 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.404 HG21 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -50.66 112.56 0.72 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -103.12 174.28 5.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 155.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -92.55 -88.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 153.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.934 -3.267 . . . . 0.0 104.934 151.506 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 42.9 m80 67.79 166.41 0.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.216 2.207 . . . . 0.0 110.837 -167.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . 0.4 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.462 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.462 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t 45.29 -149.61 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -91.49 55.11 2.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.29 20.08 12.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.29 2.636 . . . . 0.0 114.006 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.1 8.63 3.07 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.321 1.448 . . . . 0.0 113.715 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -67.67 -18.48 64.95 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t 43.04 -147.73 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.345 1.458 . . . . 0.0 112.474 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -88.48 -69.16 0.72 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.631 1.572 . . . . 0.0 110.081 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.83 159.9 32.76 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.022 0.439 . . . . 0.0 111.873 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.31 132.02 1.04 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -59.2 163.21 3.9 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.691 -0.888 . . . . 0.0 110.432 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -49.39 96.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.431 1.893 . . . . 0.0 111.644 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -57.28 154.29 10.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -157.46 130.53 7.67 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.922 2.089 . . . . 0.0 106.753 159.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -76.34 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 -175.32 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.652 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 66.74 158.23 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.897 2.079 . . . . 0.0 109.893 -161.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.479 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.95 144.68 1.74 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.86 28.93 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.241 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.76 27.08 4.66 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.301 1.441 . . . . 0.0 111.97 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -128.73 106.11 8.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -159.8 118.21 2.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 109.174 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -157.36 -59.62 0.09 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.278 1.431 . . . . 0.0 109.326 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.36 -12.38 8.62 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -147.87 139.6 23.91 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.559 0.744 . . . . 0.0 109.237 -167.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.71 -113.58 3.23 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 160.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.6 m80 61.73 150.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.862 2.065 . . . . 0.0 109.318 -146.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -71.74 96.82 1.66 Allowed 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.609 -1.307 . . . . 0.0 108.092 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.479 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -59.52 151.44 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -135.27 152.59 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 161.433 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -72.23 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 159.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 104.606 -3.398 . . . . 0.0 104.606 161.78 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 m80 58.64 174.88 0.07 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.89 1.276 . . . . 0.0 109.89 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.401 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 22.1 tp60 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.401 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.545 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.7 t 23.93 84.62 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.07 -46.2 82.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.969 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.48 100.72 1.13 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 153.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 108.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.073 0.949 . . . . 0.0 109.042 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 p -83.44 -80.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.139 1.375 . . . . 0.0 110.627 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 m -62.71 157.16 21.66 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 109.915 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.83 -59.84 4.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.875 0.47 . . . . 0.0 110.13 167.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -147.36 -75.59 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 164.186 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.87 -89.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 C-N-CA 127.47 2.462 . . . . 0.0 114.156 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -128.85 131.53 47.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.485 1.514 . . . . 0.0 107.327 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -70.61 94.24 0.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.545 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.416 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -65.73 159.72 24.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -124.1 -177.16 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.606 1.963 . . . . 0.0 109.108 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -88.57 -88.57 0.15 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.071 176.29 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.98 169.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.543 1.937 . . . . 0.0 111.705 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.482 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.482 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.422 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.4 -131.82 0.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -132.58 162.55 30.99 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 146.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.13 76.71 0.17 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 114.205 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -134.84 77.99 1.72 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.862 1.265 . . . . 0.0 111.016 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -91.92 -43.82 9.26 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.0 m -73.7 159.87 32.37 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.123 0.874 . . . . 0.0 112.49 -160.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -51.99 -33.38 37.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.459 1.903 . . . . 0.0 114.544 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -69.94 138.32 52.24 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 89.58 0.2 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -67.45 87.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.972 1.709 . . . . 0.0 111.621 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp 40.39 74.94 0.09 Allowed 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.442 1.897 . . . . 0.0 111.253 -168.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.422 HG21 ' HE2' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -76.77 68.05 2.94 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt 28.53 95.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 130.893 3.677 . . . . 0.0 113.06 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.7 -0.96 16.92 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -174.163 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.609 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -141.13 164.95 28.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.541 1.936 . . . . 0.0 107.123 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.2 tp60 -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.423 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t 66.81 153.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -82.77 -0.06 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.395 -0.816 . . . . 0.0 111.865 -169.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.21 7.39 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.646 1.178 . . . . 0.0 112.592 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 24.33 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.953 2.901 . . . . 0.0 116.462 161.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m 48.1 52.06 13.74 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.723 1.209 . . . . 0.0 111.924 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -45.04 -58.73 3.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.716 1.606 . . . . 0.0 110.334 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -120.76 49.93 1.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.513 1.125 . . . . 0.0 108.647 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 45.01 72.13 0.22 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.547 1.939 . . . . 0.0 114.346 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.23 72.65 0.42 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.796 1.189 . . . . 0.0 110.629 171.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.4 m80 58.4 170.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.239 2.615 . . . . 0.0 115.245 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 83.76 0.42 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.506 1.122 . . . . 0.0 109.05 167.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 103' ' ' THR . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.419 ' H ' ' C ' ' A' ' 101' ' ' GLY . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.57 42.08 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 52.2 -160.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.368 . . . . 0.0 110.498 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.73 -90.73 0.57 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 142.237 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.359 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -66.54 169.24 7.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.721 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.442 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.512 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.487 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.487 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.442 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t 56.67 -95.94 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.62 42.85 27.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.855 2.062 . . . . 0.0 110.518 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.26 6.38 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.552 1.941 . . . . 0.0 111.545 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -131.29 174.88 9.61 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.499 -1.376 . . . . 0.0 109.877 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 p -73.66 103.52 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.134 1.374 . . . . 0.0 111.207 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.281 6.3 t 36.47 88.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.756 3.222 . . . . 0.0 113.23 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -45.35 88.22 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.272 -0.893 . . . . 0.0 111.592 -170.263 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 25.18 89.07 0.01 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 129.819 3.247 . . . . 0.0 114.395 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.47 -150.82 8.43 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-O 121.592 0.551 . . . . 0.0 112.511 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.48 174.14 0.23 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -68.05 94.13 0.47 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.039 -1.038 . . . . 0.0 109.909 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.442 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.512 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -48.27 129.57 15.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -133.1 151.0 52.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -76.83 -34.88 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 165.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -163.029 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 59.82 174.07 0.08 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.016 1.326 . . . . 0.0 110.544 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.6 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t 65.13 -55.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 57.64 14.19 2.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.202 2.201 . . . . 0.0 112.18 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.09 33.7 4.13 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.244 1.418 . . . . 0.0 113.169 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 mt -144.22 -38.5 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.933 1.293 . . . . 0.0 111.07 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.0 57.03 2.65 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.858 1.263 . . . . 0.0 110.642 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p -60.74 -18.08 52.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 114.067 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 35.07 62.26 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.703 2.001 . . . . 0.0 115.055 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 93.75 113.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.643 2.777 . . . . 0.0 109.336 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.07 -96.62 0.17 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -125.38 168.1 14.02 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.68 1.192 . . . . 0.0 109.361 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -132.81 78.92 1.82 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.409 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.6 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -69.19 145.08 53.54 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -121.49 128.34 51.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.567 1.147 . . . . 0.0 108.125 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -70.34 -62.31 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.5 -2.278 . . . . 0.0 110.428 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.767 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.422 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 0.4 OUTLIER 62.55 174.51 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.93 1.692 . . . . 0.0 109.768 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.425 ' CD1' HG23 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.96 -62.43 0.2 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t0 91.73 156.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 1 C-N-CA 131.964 4.106 . . . . 0.0 107.605 -173.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 82.62 14.09 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.64 2.376 . . . . 0.0 114.814 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 46.34 0.72 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.487 1.115 . . . . 0.0 111.861 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 p -54.96 102.97 0.08 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.918 1.287 . . . . 0.0 110.171 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.1 m -158.17 131.41 7.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -88.26 -24.7 23.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.209 1.004 . . . . 0.0 112.114 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -59.93 161.96 6.04 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.824 0.738 . . . . 0.0 110.849 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 -170.77 49.81 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.479 0.561 . . . . 0.0 113.19 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -82.55 161.95 22.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.2 1.0 . . . . 0.0 110.023 165.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -79.81 90.46 5.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.195 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.425 HG23 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.422 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -56.09 156.12 5.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -149.06 150.75 33.29 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 173.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -120.83 -95.04 0.49 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 157.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.523 0 N-CA-C 106.024 -2.83 . . . . 0.0 106.024 169.231 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.66 149.65 50.11 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 155.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . 0.579 ' CE1' ' CZ ' ' A' ' 20' ' ' PHE . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.45 HD21 ' HG ' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.55 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.568 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t 54.63 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -144.15 15.35 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.792 1.637 . . . . 0.0 109.346 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.67 67.48 1.06 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.688 1.195 . . . . 0.0 109.247 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.0 mt -142.4 -53.0 0.41 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.968 1.707 . . . . 0.0 108.288 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.82 -60.43 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.455 2.302 . . . . 0.0 115.028 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.1 p -141.44 -179.7 6.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.598 1.545 . . . . 0.0 109.522 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.7 t30 42.2 61.44 1.97 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 113.8 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.97 165.7 15.59 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.65 0.78 . . . . 0.0 110.811 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.81 -144.27 7.49 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -64.21 170.71 3.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.806 0.803 . . . . 0.0 109.832 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 94.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.568 1.547 . . . . 0.0 110.094 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.568 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -58.56 138.62 56.71 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -143.76 154.5 43.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -60.48 -42.85 97.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.085 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 103.452 -3.859 . . . . 0.0 103.452 -172.041 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.439 ' CD2' ' HG1' ' A' ' 68' ' ' THR . 1.3 m-70 -122.92 165.17 17.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.436 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.443 ' CD ' ' H ' ' A' ' 54' ' ' GLU . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HE2' HG22 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m -40.07 124.38 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -78.61 51.16 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.117 2.167 . . . . 0.0 110.704 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 36.87 79.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 C-N-CA 129.811 3.244 . . . . 0.0 113.692 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 mp -94.65 -128.01 0.13 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.22 -1.809 . . . . 0.0 106.588 -170.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -69.61 79.55 0.42 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.404 1.002 . . . . 0.0 110.979 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' THR . . . . . 0.439 ' HG1' ' CD2' ' A' ' 2' ' ' HIS . 5.3 t -132.81 179.19 6.31 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.959 -179.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.57 -57.1 1.93 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.07 168.54 26.81 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 168.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.49 141.73 3.21 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 167.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -63.59 92.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.887 2.075 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 35.35 75.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.275 2.23 . . . . 0.0 111.789 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.47 HG22 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.451 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -58.41 120.31 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -74.41 173.02 10.88 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.461 0.704 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -110.7 0.28 17.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 111.143 168.605 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 129.277 3.322 . . . . 0.0 106.043 -177.801 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 61.18 -177.07 0.12 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 112.142 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.438 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.468 ' CD2' ' H ' ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . 0.406 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 29.6 tp60 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . 0.406 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.452 ' CE1' HG23 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.607 ' HE2' ' CE1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p 43.81 -131.21 0.75 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.32 -48.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.51 85.71 4.57 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.323 1.049 . . . . 0.0 111.401 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.79 162.45 35.44 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.647 1.579 . . . . 0.0 112.759 173.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.5 p -166.66 178.69 5.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.237 1.815 . . . . 0.0 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.313 6.0 t 29.51 -84.7 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.34 3.456 . . . . 0.0 114.38 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -61.27 -31.85 71.67 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.312 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 26.71 68.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.897 2.479 . . . . 0.0 111.49 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.96 95.66 0.28 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.707 1.146 . . . . 0.0 111.385 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 175.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.459 1.903 . . . . 0.0 113.05 -171.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -77.35 88.11 3.75 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 159.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.44 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.607 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.452 HG23 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -66.94 124.76 23.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -95.78 95.88 8.59 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.38 -53.13 48.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.62 0.768 . . . . 0.0 110.893 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 N-CA-C 105.034 -3.226 . . . . 0.0 105.034 -158.938 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.403 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 -59.5 152.11 22.59 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 167.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.409 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.447 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.443 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.443 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p 55.63 174.27 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.09 -9.89 49.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.003 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.7 -17.26 1.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.286 0.2 OUTLIER 42.98 -90.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.031 2.532 . . . . 0.0 114.861 177.376 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t 60.68 178.54 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.34 1.856 . . . . 0.0 113.629 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.273 10.5 t 46.62 178.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.068 3.747 . . . . 0.0 114.755 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.48 60.92 2.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 107.868 165.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 158.57 6.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.116 1.366 . . . . 0.0 110.975 -171.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.5 -138.79 1.77 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 112.201 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.93 146.27 42.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.859 -0.789 . . . . 0.0 110.246 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? -52.12 100.02 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 O-C-N 125.712 1.883 . . . . 0.0 112.2 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.429 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.428 ' C ' ' HG1' ' A' ' 103' ' ' THR . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' THR . . . . . 0.428 ' HG1' ' C ' ' A' ' 102' ' ' GLU . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -54.71 117.85 3.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.9 169.29 18.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 105.418 168.298 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -99.65 -100.41 0.23 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 105.093 -3.203 . . . . 0.0 105.093 155.045 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.02 145.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.554 3.142 . . . . 0.0 109.593 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.529 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.402 ' CD1' HG21 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.562 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t 49.35 -116.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.15 -39.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.642 1.977 . . . . 0.0 107.125 152.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.56 30.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.872 0.844 . . . . 0.0 111.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.5 174.11 10.28 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.37 3.868 . . . . 0.0 106.936 -173.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t -142.94 145.12 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.446 1.098 . . . . 0.0 108.059 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -89.73 68.53 7.56 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 167.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -121.23 -100.64 0.42 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 153.456 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -100.26 64.93 1.2 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.18 162.07 30.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.13 177.0 5.06 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.168 0.508 . . . . 0.0 111.771 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -70.69 91.92 0.84 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 159.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . 0.529 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.562 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.402 HG21 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 93.07 0.07 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -108.8 112.21 24.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 163.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -65.88 -38.92 90.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 117.486 -1.73 . . . . 0.0 110.765 176.451 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -103.49 154.03 19.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 158.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.481 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.564 HH22 ' CG2' ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . 0.564 ' CG2' HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.43 ' CD1' HG21 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.51 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t 64.75 169.93 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -138.05 -17.21 1.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.754 -145.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.37 44.06 1.04 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.762 1.625 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.3 mt -146.64 -67.8 0.27 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.749 1.22 . . . . 0.0 109.118 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t 46.89 78.67 0.07 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.624 1.569 . . . . 0.0 111.109 -158.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.316 9.1 t 51.09 41.88 28.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 0.0 112.253 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . 0.476 HD21 ' CD2' ' A' ' 70' ' ' HIS . 27.5 t30 -74.48 -67.32 0.64 Allowed 'General case' 0 C--N 1.344 0.332 0 O-C-N 121.354 -0.841 . . . . 0.0 111.015 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . 0.476 ' CD2' HD21 ' A' ' 69' ' ' ASN . 0.6 OUTLIER -165.7 179.75 5.82 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.011 1.725 . . . . 0.0 109.725 178.231 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.06 179.91 32.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.036 1.303 . . . . 0.0 113.602 168.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -62.45 165.55 6.04 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.379 1.071 . . . . 0.0 110.144 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -80.04 69.37 6.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.51 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.431 ' HG1' ' C ' ' A' ' 86' ' ' TYR . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.43 HG21 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -62.94 151.66 38.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -146.34 169.85 17.99 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.624 0.769 . . . . 0.0 111.381 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -121.35 -17.95 7.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 CA-C-O 117.364 -1.798 . . . . 0.0 109.268 -177.166 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -96.5 168.68 10.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 166.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.425 ' H ' ' HA ' ' A' ' 75' ' ' VAL . 29.5 p -48.39 -68.17 0.21 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.1 t0 53.02 23.27 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.431 2.692 . . . . 0.0 112.625 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.18 21.11 1.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -158.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -126.51 115.23 19.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -70.29 72.32 0.46 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.818 2.047 . . . . 0.0 111.722 -169.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.4 m -134.51 -43.8 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.6 1.16 . . . . 0.0 111.842 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.82 -32.01 5.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.592 1.542 . . . . 0.0 113.129 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 24.15 69.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 128.976 2.91 . . . . 0.0 112.347 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.2 -28.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.864 -0.965 . . . . 0.0 113.516 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -124.09 145.23 49.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.916 1.358 . . . . 0.0 108.007 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 75.14 2.08 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.469 0.707 . . . . 0.0 109.816 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.425 ' HA ' ' H ' ' A' ' 63' ' ' SER . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -56.61 142.18 40.58 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -133.57 70.54 1.46 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.46 -45.68 88.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.981 -3.648 . . . . 0.0 103.981 -144.615 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -78.49 159.12 28.39 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' HB3' ' CG2' ' A' ' 58' ' ' VAL . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.41 ' HA ' HE21 ' A' ' 52' ' ' GLN . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . 0.41 HE21 ' HA ' ' A' ' 49' ' ' VAL . 30.8 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.426 ' CG2' ' HB3' ' A' ' 27' ' ' ALA . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . 0.41 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t 46.23 -116.34 0.63 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.66 -58.89 0.18 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.011 1.724 . . . . 0.0 106.373 166.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.7 112.72 21.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.761 0.824 . . . . 0.0 111.096 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.01 172.88 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.681 1.592 . . . . 0.0 107.233 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 t -132.2 160.69 35.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.6 4.44 28.31 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.082 0.855 . . . . 0.0 111.318 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.51 60.98 0.22 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.585 2.354 . . . . 0.0 112.536 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 42.5 73.24 0.14 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 129.013 2.925 . . . . 0.0 110.515 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.02 161.28 24.11 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.592 1.568 . . . . 0.0 110.575 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -87.72 156.97 19.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.254 0.622 . . . . 0.0 111.234 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -73.21 95.94 2.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 161.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.41 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.406 ' C ' ' H ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -66.49 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' H ' ' C ' ' A' ' 112' ' ' LEU . 12.4 ttmt 60.93 -139.65 0.55 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.229 1.412 . . . . 0.0 107.291 -176.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -93.79 -80.83 0.38 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 104.76 -3.336 . . . . 0.0 104.76 -157.478 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 60.47 171.95 0.09 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.676 1.99 . . . . 0.0 110.753 -162.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.423 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.429 ' CD1' ' HG ' ' A' ' 40' ' ' CYS . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.429 ' HG ' ' CD1' ' A' ' 35' ' ' LEU . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 24.9 tp60 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t 35.64 88.93 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -75.96 68.91 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.367 0.667 . . . . 0.0 112.032 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.26 19.02 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 112.452 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 mt -124.46 160.99 27.01 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.342 -0.849 . . . . 0.0 111.114 -162.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -114.23 -15.01 12.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.611 1.165 . . . . 0.0 112.301 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 146.22 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -99.24 55.57 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.23 155.95 38.63 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.109 -0.994 . . . . 0.0 108.705 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -173.91 55.27 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.98 156.24 31.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.947 0.899 . . . . 0.0 110.822 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -71.96 91.94 1.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.428 HG21 ' HE2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.436 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -51.69 129.53 26.29 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -157.81 98.73 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 130.089 3.356 . . . . 0.0 106.284 161.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -53.95 -38.98 65.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 148.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.401 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 166.035 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 33.9 m80 58.05 -176.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.529 0.732 . . . . 0.0 111.706 -173.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.448 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.546 ' HE ' HD12 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.546 HD12 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.43 ' HE2' ' CG2' ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.18 -48.13 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 66' ' ' LEU . 24.3 t0 68.3 -62.58 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.912 2.485 . . . . 0.0 109.888 -168.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.6 30.17 0.06 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.952 1.701 . . . . 0.0 112.91 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 64' ' ' ASP 0.34 0.6 OUTLIER 26.77 60.59 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 130.088 3.355 . . . . 0.0 116.042 164.476 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -24.83 -61.67 0.06 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 130.43 3.492 . . . . 0.0 114.09 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.8 p -140.62 169.7 17.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -31.97 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.404 2.282 . . . . 0.0 113.556 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -166.33 151.83 8.42 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.45 1.9 . . . . 0.0 106.517 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.29 69.33 0.17 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' HIS . . . . . 0.416 ' HB3' ' H ' ' A' ' 73' ' ' LYS . 25.5 m-70 54.21 -160.8 0.14 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.137 0.97 . . . . 0.0 110.664 -164.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.416 ' H ' ' HB3' ' A' ' 72' ' ' HIS . 7.4 tppt? -66.43 73.38 0.08 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.158 2.183 . . . . 0.0 110.592 173.202 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . 0.43 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASN . . . . . 0.448 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 138.76 58.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 30.5 mttt -141.19 133.85 28.66 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 146.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -120.3 -52.36 2.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.989 0 N-CA-C 105.589 -3.004 . . . . 0.0 105.589 170.705 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.351 0.596 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.458 ' HB2' HD12 ' A' ' 111' ' ' LEU . 22.1 m80 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 121.583 0.706 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 111' ' ' LEU . 2.0 tt0 -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 46' ' ' GLU . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.643 ' CD1' HG22 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 2' ' ' HIS . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 121.695 0.759 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 49' ' ' VAL . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.614 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.307 1.051 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.287 0.565 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' HD12 ' A' ' 53' ' ' LEU . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' GLU . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.401 ' C ' HG23 ' A' ' 95' ' ' VAL . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 93' ' ' LEU . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 75' ' ' VAL . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 57' ' ' TYR . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 . . . . . 0 CA--C 1.552 1.036 0 CA-C-O 121.124 0.488 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HD3' HD22 ' A' ' 53' ' ' LEU . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' VAL . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 57' ' ' TYR . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.502 HD22 ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 4.1 tp-100 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' HD22 ' A' ' 50' ' ' LEU . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.7 t . . . . . 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 63' ' ' SER . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 59' ' ' PHE . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.274 0.559 . . . . 0.0 111.705 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 42' ' ' LEU . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' GLN . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 39' ' ' THR . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 9' ' ' VAL . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 31' ' ' ALA . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.598 ' CD1' HG22 ' A' ' 95' ' ' VAL . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 C--O 1.238 0.447 0 CA-C-O 122.456 1.122 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.598 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 . . . . . 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 104' ' ' PRO . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB3' HD13 ' A' ' 53' ' ' LEU . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 49' ' ' VAL . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 53' ' ' LEU . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 11' ' ' GLN 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.347 0.594 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 61' ' ' LYS . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.427 HD12 HG11 ' A' ' 75' ' ' VAL . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.651 ' CD1' HD11 ' A' ' 77' ' ' LEU . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' A' ' 95' ' ' VAL . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.504 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 59' ' ' PHE . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.1 m170 . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' SG ' ' A' ' 40' ' ' CYS . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 53' ' ' LEU . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 40' ' ' CYS . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.639 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD2' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 35' ' ' LEU . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.426 ' HG2' HG13 ' A' ' 24' ' ' VAL . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 75' ' ' VAL . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' VAL . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.627 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 75' ' ' VAL . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.442 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' HG2' ' A' ' 61' ' ' LYS . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 24' ' ' VAL . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.627 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.491 HD12 HG11 ' A' ' 75' ' ' VAL . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLN . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' CA ' ' HG2' ' A' ' 54' ' ' GLU . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.604 HD23 ' SG ' ' A' ' 40' ' ' CYS . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' VAL . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HG2' ' CA ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' A' ' 75' ' ' VAL 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 122.002 0.906 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 111' ' ' LEU . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 62' ' ' ARG . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 35' ' ' LEU . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.433 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.512 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 91' ' ' ILE . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 89' ' ' SER . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 75' ' ' VAL . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 59' ' ' PHE . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 . . . . . 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' A' ' 16' ' ' LEU . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' HD13 ' A' ' 53' ' ' LEU . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 49' ' ' VAL . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 46' ' ' GLU . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 5.4 tp-100 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.69 ' HE3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.69 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 59' ' ' PHE . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.631 HG22 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 . . . . . 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.405 HD12 ' HA3' ' A' ' 41' ' ' GLY . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' GLN . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 79' ' ' ALA . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 95' ' ' VAL . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.64 HG12 HD23 ' A' ' 96' ' ' LEU . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 95' ' ' VAL . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG23 HD21 ' A' ' 96' ' ' LEU . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HG2' HG11 ' A' ' 78' ' ' VAL . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.672 0.748 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' ARG . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.432 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.65 HG22 ' CD1' ' A' ' 59' ' ' PHE . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 58' ' ' VAL . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 53' ' ' LEU . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB3' HD13 ' A' ' 53' ' ' LEU . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 59' ' ' PHE . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.69 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 111' ' ' LEU . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 62' ' ' ARG . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.604 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 75' ' ' VAL . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' LEU . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 74' ' ' VAL . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.52 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.644 HH22 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 18' ' ' ARG . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 74' ' ' VAL . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 11' ' ' GLN . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 15' ' ' VAL . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 95' ' ' VAL . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.609 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 91' ' ' ILE . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 89' ' ' SER . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 59' ' ' PHE . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 43' ' ' VAL . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.502 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD13 ' H ' ' A' ' 88' ' ' ARG . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 50' ' ' LEU . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 103' ' ' THR . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 11' ' ' GLN . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 5.5 tp-100 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 95' ' ' VAL . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' HG21 ' A' ' 78' ' ' VAL . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 91' ' ' ILE . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 89' ' ' SER . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.623 HG22 ' CD1' ' A' ' 59' ' ' PHE . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CB ' HD12 ' A' ' 111' ' ' LEU . 33.9 m80 . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 120.886 0.374 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.549 ' HG3' HD22 ' A' ' 111' ' ' LEU . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.645 ' HE ' HD13 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 95' ' ' VAL . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.645 HD13 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' A' ' 50' ' ' LEU . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 95' ' ' VAL . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' HG22 ' A' ' 91' ' ' ILE . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ILE . . . . . 0.414 HG22 ' CB ' ' A' ' 89' ' ' SER . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 59' ' ' PHE . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 4' ' ' GLN . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 64.8 162.14 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.642 1.977 . . . . 0.0 110.424 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p 43.01 78.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.53 84.13 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.42 18.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.286 1.434 . . . . 0.0 111.107 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt -147.91 166.72 26.81 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.264 1.426 . . . . 0.0 108.383 -163.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t -150.71 82.02 1.34 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -162.43 162.8 27.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -120.24 -6.7 9.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -112.54 88.51 2.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -156.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.28 171.52 43.9 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.85 -0.532 . . . . 0.0 111.866 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -62.53 170.13 2.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.465 1.506 . . . . 0.0 110.045 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.11 93.34 1.41 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -49.05 125.46 10.61 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -142.39 105.28 4.55 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 171.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -64.15 -50.04 69.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.034 -1.981 . . . . 0.0 108.155 173.82 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' HB2' HD12 ' A' ' 111' ' ' LEU . 22.1 m80 62.21 165.59 0.1 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.37 1.868 . . . . 0.0 111.382 -167.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 111' ' ' LEU . 2.0 tt0 -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 46' ' ' GLU . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.643 ' CD1' HG22 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t 52.15 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -133.65 2.94 3.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.613 -1.304 . . . . 0.0 110.905 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.86 53.55 1.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.694 1.197 . . . . 0.0 110.108 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 mt -149.03 164.58 34.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 130.195 3.398 . . . . 0.0 106.548 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -165.46 76.33 0.25 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -135.55 176.19 8.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.6 -0.687 . . . . 0.0 111.076 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -120.3 9.18 10.96 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.149 0.98 . . . . 0.0 111.569 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.24 177.84 0.45 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.752 0.821 . . . . 0.0 112.803 -171.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.36 -9.01 7.56 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.629 -1.095 . . . . 0.0 115.262 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -136.74 -171.48 2.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.428 1.614 . . . . 0.0 108.33 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -134.51 4.34 3.38 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 121.28 -0.887 . . . . 0.0 112.318 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 2' ' ' HIS . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -50.66 112.56 0.72 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -103.12 174.28 5.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 155.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -92.55 -88.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 153.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.934 -3.267 . . . . 0.0 104.934 151.506 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 26.0 m-70 67.79 166.41 0.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.216 2.207 . . . . 0.0 110.837 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 49' ' ' VAL . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.614 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t 45.29 -149.61 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -91.49 55.11 2.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.29 20.08 12.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.29 2.636 . . . . 0.0 114.006 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.1 8.63 3.07 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.321 1.448 . . . . 0.0 113.715 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -67.67 -18.48 64.95 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t 43.04 -147.73 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.345 1.458 . . . . 0.0 112.474 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -88.48 -69.16 0.72 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.631 1.572 . . . . 0.0 110.081 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.83 159.9 32.76 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.022 0.439 . . . . 0.0 111.873 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.31 132.02 1.04 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -59.2 163.21 3.9 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.691 -0.888 . . . . 0.0 110.432 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -49.39 96.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.431 1.893 . . . . 0.0 111.644 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 154.29 10.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -157.46 130.53 7.67 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.922 2.089 . . . . 0.0 106.753 159.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -76.34 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 -175.32 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.652 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 66.74 158.23 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.897 2.079 . . . . 0.0 109.893 -161.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' HD12 ' A' ' 53' ' ' LEU . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' GLU . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.401 ' C ' HG23 ' A' ' 95' ' ' VAL . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.95 144.68 1.74 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.86 28.93 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.241 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.76 27.08 4.66 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.301 1.441 . . . . 0.0 111.97 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -128.73 106.11 8.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -159.8 118.21 2.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 109.174 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -157.36 -59.62 0.09 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.278 1.431 . . . . 0.0 109.326 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.9 t-20 -121.36 -12.38 8.62 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 26.5 m80 -147.87 139.6 23.91 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.559 0.744 . . . . 0.0 109.237 -167.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.71 -113.58 3.23 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 160.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.6 m80 61.73 150.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.862 2.065 . . . . 0.0 109.318 -146.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -71.74 96.82 1.66 Allowed 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.609 -1.307 . . . . 0.0 108.092 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 93' ' ' LEU . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 75' ' ' VAL . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 57' ' ' TYR . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.2 t60 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -59.52 151.44 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -135.27 152.59 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 161.433 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -72.23 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 159.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 104.606 -3.398 . . . . 0.0 104.606 161.78 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 m80 58.64 174.88 0.07 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.89 1.276 . . . . 0.0 109.89 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HD3' HD22 ' A' ' 53' ' ' LEU . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' VAL . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 57' ' ' TYR . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.502 HD22 ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 4.1 tp-100 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' HD22 ' A' ' 50' ' ' LEU . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.7 t 23.93 84.62 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.07 -46.2 82.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.969 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.48 100.72 1.13 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 153.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 108.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.073 0.949 . . . . 0.0 109.042 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 p -83.44 -80.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.139 1.375 . . . . 0.0 110.627 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 m -62.71 157.16 21.66 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 109.915 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.83 -59.84 4.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.875 0.47 . . . . 0.0 110.13 167.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -147.36 -75.59 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 164.186 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.87 -89.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 C-N-CA 127.47 2.462 . . . . 0.0 114.156 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -128.85 131.53 47.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.485 1.514 . . . . 0.0 107.327 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -70.61 94.24 0.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 63' ' ' SER . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 59' ' ' PHE . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.4 t60 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -65.73 159.72 24.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -124.1 -177.16 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.606 1.963 . . . . 0.0 109.108 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -88.57 -88.57 0.15 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.071 176.29 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.98 169.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.543 1.937 . . . . 0.0 111.705 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 42' ' ' LEU . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' GLN . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 39' ' ' THR . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 9' ' ' VAL . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 31' ' ' ALA . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.598 ' CD1' HG22 ' A' ' 95' ' ' VAL . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.4 -131.82 0.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -132.58 162.55 30.99 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 146.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.13 76.71 0.17 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 114.205 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -134.84 77.99 1.72 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.862 1.265 . . . . 0.0 111.016 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -91.92 -43.82 9.26 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.0 m -73.7 159.87 32.37 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.123 0.874 . . . . 0.0 112.49 -160.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -51.99 -33.38 37.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.459 1.903 . . . . 0.0 114.544 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -69.94 138.32 52.24 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 89.58 0.2 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -67.45 87.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.972 1.709 . . . . 0.0 111.621 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp 40.39 74.94 0.09 Allowed 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.442 1.897 . . . . 0.0 111.253 -168.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.598 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -76.77 68.05 2.94 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt 28.53 95.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 130.893 3.677 . . . . 0.0 113.06 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.7 -0.96 16.92 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -174.163 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.609 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -141.13 164.95 28.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.541 1.936 . . . . 0.0 107.123 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 104' ' ' PRO . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB3' HD13 ' A' ' 53' ' ' LEU . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 49' ' ' VAL . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 0.6 OUTLIER -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t 66.81 153.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -82.77 -0.06 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.395 -0.816 . . . . 0.0 111.865 -169.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.21 7.39 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.646 1.178 . . . . 0.0 112.592 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 24.33 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.953 2.901 . . . . 0.0 116.462 161.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m 48.1 52.06 13.74 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.723 1.209 . . . . 0.0 111.924 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -45.04 -58.73 3.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.716 1.606 . . . . 0.0 110.334 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -120.76 49.93 1.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.513 1.125 . . . . 0.0 108.647 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 45.01 72.13 0.22 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.547 1.939 . . . . 0.0 114.346 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.23 72.65 0.42 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.796 1.189 . . . . 0.0 110.629 171.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.4 m80 58.4 170.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.239 2.615 . . . . 0.0 115.245 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 83.76 0.42 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.506 1.122 . . . . 0.0 109.05 167.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.57 42.08 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 52.2 -160.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.368 . . . . 0.0 110.498 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.73 -90.73 0.57 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 142.237 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.359 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -66.54 169.24 7.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.721 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 53' ' ' LEU . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 11' ' ' GLN 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t 56.67 -95.94 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.62 42.85 27.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.855 2.062 . . . . 0.0 110.518 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.26 6.38 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.552 1.941 . . . . 0.0 111.545 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -131.29 174.88 9.61 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.499 -1.376 . . . . 0.0 109.877 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 p -73.66 103.52 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.134 1.374 . . . . 0.0 111.207 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.281 6.3 t 36.47 88.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.756 3.222 . . . . 0.0 113.23 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -45.35 88.22 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.272 -0.893 . . . . 0.0 111.592 -170.263 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 25.18 89.07 0.01 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 129.819 3.247 . . . . 0.0 114.395 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.47 -150.82 8.43 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-O 121.592 0.551 . . . . 0.0 112.511 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.48 174.14 0.23 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -68.05 94.13 0.47 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.039 -1.038 . . . . 0.0 109.909 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 61' ' ' LYS . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD12 HG11 ' A' ' 75' ' ' VAL . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -48.27 129.57 15.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -133.1 151.0 52.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -76.83 -34.88 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 165.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -163.029 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 59.82 174.07 0.08 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.016 1.326 . . . . 0.0 110.544 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.651 ' CD1' HD11 ' A' ' 77' ' ' LEU . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' A' ' 95' ' ' VAL . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t 65.13 -55.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 57.64 14.19 2.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.202 2.201 . . . . 0.0 112.18 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.09 33.7 4.13 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.244 1.418 . . . . 0.0 113.169 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 mt -144.22 -38.5 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.933 1.293 . . . . 0.0 111.07 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.0 57.03 2.65 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.858 1.263 . . . . 0.0 110.642 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p -60.74 -18.08 52.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 114.067 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 35.07 62.26 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.703 2.001 . . . . 0.0 115.055 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 93.75 113.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.643 2.777 . . . . 0.0 109.336 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.07 -96.62 0.17 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -125.38 168.1 14.02 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.68 1.192 . . . . 0.0 109.361 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -132.81 78.92 1.82 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.504 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 59' ' ' PHE . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -69.19 145.08 53.54 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -121.49 128.34 51.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.567 1.147 . . . . 0.0 108.125 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -70.34 -62.31 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.5 -2.278 . . . . 0.0 110.428 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.767 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 20.1 m170 62.55 174.51 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.93 1.692 . . . . 0.0 109.768 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG22 ' HE3' ' A' ' 114' ' ' LYS . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' SG ' ' A' ' 40' ' ' CYS . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 53' ' ' LEU . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 40' ' ' CYS . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.639 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD2' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.96 -62.43 0.2 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t0 91.73 156.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 1 C-N-CA 131.964 4.106 . . . . 0.0 107.605 -173.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 82.62 14.09 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.64 2.376 . . . . 0.0 114.814 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 46.34 0.72 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.487 1.115 . . . . 0.0 111.861 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 p -54.96 102.97 0.08 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.918 1.287 . . . . 0.0 110.171 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.1 m -158.17 131.41 7.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -88.26 -24.7 23.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.209 1.004 . . . . 0.0 112.114 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -59.93 161.96 6.04 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.824 0.738 . . . . 0.0 110.849 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 -170.77 49.81 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.479 0.561 . . . . 0.0 113.19 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -82.55 161.95 22.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.2 1.0 . . . . 0.0 110.023 165.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -79.81 90.46 5.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.195 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 35' ' ' LEU . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.426 ' HG2' HG13 ' A' ' 24' ' ' VAL . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 75' ' ' VAL . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.09 156.12 5.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.591 ' HE3' HG22 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.06 150.75 33.29 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 173.456 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -120.83 -95.04 0.49 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 157.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.523 0 N-CA-C 106.024 -2.83 . . . . 0.0 106.024 169.231 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.66 149.65 50.11 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 155.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' VAL . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.627 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 75' ' ' VAL . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t 54.63 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -144.15 15.35 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.792 1.637 . . . . 0.0 109.346 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.67 67.48 1.06 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.688 1.195 . . . . 0.0 109.247 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.0 mt -142.4 -53.0 0.41 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.968 1.707 . . . . 0.0 108.288 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.82 -60.43 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.455 2.302 . . . . 0.0 115.028 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.1 p -141.44 -179.7 6.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.598 1.545 . . . . 0.0 109.522 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.7 t30 42.2 61.44 1.97 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 113.8 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.97 165.7 15.59 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.65 0.78 . . . . 0.0 110.811 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.81 -144.27 7.49 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -64.21 170.71 3.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.806 0.803 . . . . 0.0 109.832 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 94.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.568 1.547 . . . . 0.0 110.094 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' HG2' ' A' ' 61' ' ' LYS . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 24' ' ' VAL . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.627 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.491 HD12 HG11 ' A' ' 75' ' ' VAL . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -58.56 138.62 56.71 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -143.76 154.5 43.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -60.48 -42.85 97.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.085 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 103.452 -3.859 . . . . 0.0 103.452 -172.041 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -122.92 165.17 17.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLN . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' CA ' ' HG2' ' A' ' 54' ' ' GLU . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.604 HD23 ' SG ' ' A' ' 40' ' ' CYS . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' VAL . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HG2' ' CA ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' A' ' 75' ' ' VAL 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m -40.07 124.38 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -78.61 51.16 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.117 2.167 . . . . 0.0 110.704 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 36.87 79.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 C-N-CA 129.811 3.244 . . . . 0.0 113.692 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 mp -94.65 -128.01 0.13 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.22 -1.809 . . . . 0.0 106.588 -170.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -69.61 79.55 0.42 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.404 1.002 . . . . 0.0 110.979 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -132.81 179.19 6.31 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.959 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.57 -57.1 1.93 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.07 168.54 26.81 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 168.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.49 141.73 3.21 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 167.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -63.59 92.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.887 2.075 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 35.35 75.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.275 2.23 . . . . 0.0 111.789 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 111' ' ' LEU . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 62' ' ' ARG . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 35' ' ' LEU . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.433 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.512 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 91' ' ' ILE . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 89' ' ' SER . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 75' ' ' VAL . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 59' ' ' PHE . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -58.41 120.31 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -74.41 173.02 10.88 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.461 0.704 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -110.7 0.28 17.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 111.143 168.605 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 129.277 3.322 . . . . 0.0 106.043 -177.801 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 61.18 -177.07 0.12 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 112.142 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' A' ' 16' ' ' LEU . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' HD13 ' A' ' 53' ' ' LEU . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 49' ' ' VAL . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 46' ' ' GLU . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 5.4 tp-100 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.69 ' HE3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p 43.81 -131.21 0.75 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.32 -48.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.51 85.71 4.57 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.323 1.049 . . . . 0.0 111.401 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.79 162.45 35.44 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.647 1.579 . . . . 0.0 112.759 173.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.5 p -166.66 178.69 5.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.237 1.815 . . . . 0.0 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.313 6.0 t 29.51 -84.7 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.34 3.456 . . . . 0.0 114.38 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -61.27 -31.85 71.67 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.312 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 26.71 68.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.897 2.479 . . . . 0.0 111.49 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.96 95.66 0.28 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.707 1.146 . . . . 0.0 111.385 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 175.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.459 1.903 . . . . 0.0 113.05 -171.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -77.35 88.11 3.75 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 159.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.69 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 59' ' ' PHE . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.631 HG22 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -66.94 124.76 23.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -95.78 95.88 8.59 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.38 -53.13 48.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.62 0.768 . . . . 0.0 110.893 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 N-CA-C 105.034 -3.226 . . . . 0.0 105.034 -158.938 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 -59.5 152.11 22.59 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 167.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.405 HD12 ' HA3' ' A' ' 41' ' ' GLY . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' GLN . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 79' ' ' ALA . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 95' ' ' VAL . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.64 HG12 HD23 ' A' ' 96' ' ' LEU . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 95' ' ' VAL . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG23 HD21 ' A' ' 96' ' ' LEU . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HG2' HG11 ' A' ' 78' ' ' VAL . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p 55.63 174.27 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.09 -9.89 49.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.003 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.7 -17.26 1.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.286 0.2 OUTLIER 42.98 -90.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.031 2.532 . . . . 0.0 114.861 177.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t 60.68 178.54 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.34 1.856 . . . . 0.0 113.629 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.273 10.5 t 46.62 178.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.068 3.747 . . . . 0.0 114.755 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.48 60.92 2.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 107.868 165.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 158.57 6.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.116 1.366 . . . . 0.0 110.975 -171.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.5 -138.79 1.77 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 112.201 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.93 146.27 42.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.859 -0.789 . . . . 0.0 110.246 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? -52.12 100.02 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 O-C-N 125.712 1.883 . . . . 0.0 112.2 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' ARG . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.432 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG22 ' CD1' ' A' ' 59' ' ' PHE . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 58' ' ' VAL . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t60 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -54.71 117.85 3.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -138.9 169.29 18.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 105.418 168.298 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -99.65 -100.41 0.23 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 105.093 -3.203 . . . . 0.0 105.093 155.045 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.02 145.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.554 3.142 . . . . 0.0 109.593 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 53' ' ' LEU . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB3' HD13 ' A' ' 53' ' ' LEU . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 59' ' ' PHE . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mm-40 -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.69 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t 49.35 -116.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.15 -39.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.642 1.977 . . . . 0.0 107.125 152.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.56 30.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.872 0.844 . . . . 0.0 111.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.5 174.11 10.28 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.37 3.868 . . . . 0.0 106.936 -173.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t -142.94 145.12 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.446 1.098 . . . . 0.0 108.059 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -89.73 68.53 7.56 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 167.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -121.23 -100.64 0.42 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 153.456 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -100.26 64.93 1.2 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.18 162.07 30.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.13 177.0 5.06 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.168 0.508 . . . . 0.0 111.771 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -70.69 91.92 0.84 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 159.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 111' ' ' LEU . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 62' ' ' ARG . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.604 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 75' ' ' VAL . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' LEU . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 74' ' ' VAL . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 93.07 0.07 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -108.8 112.21 24.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 163.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -65.88 -38.92 90.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 117.486 -1.73 . . . . 0.0 110.765 176.451 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -103.49 154.03 19.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 158.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.52 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.644 HH22 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 18' ' ' ARG . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t 64.75 169.93 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -138.05 -17.21 1.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.754 -145.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.37 44.06 1.04 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.762 1.625 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.3 mt -146.64 -67.8 0.27 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.749 1.22 . . . . 0.0 109.118 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t 46.89 78.67 0.07 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.624 1.569 . . . . 0.0 111.109 -158.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.316 9.1 t 51.09 41.88 28.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 0.0 112.253 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.0 t-20 -74.48 -67.32 0.64 Allowed 'General case' 0 C--N 1.344 0.332 0 O-C-N 121.354 -0.841 . . . . 0.0 111.015 178.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -165.7 179.75 5.82 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.011 1.725 . . . . 0.0 109.725 178.231 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.06 179.91 32.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.036 1.303 . . . . 0.0 113.602 168.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -62.45 165.55 6.04 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.379 1.071 . . . . 0.0 110.144 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -80.04 69.37 6.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 74' ' ' VAL . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -62.94 151.66 38.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -146.34 169.85 17.99 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.624 0.769 . . . . 0.0 111.381 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -121.35 -17.95 7.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 CA-C-O 117.364 -1.798 . . . . 0.0 109.268 -177.166 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -96.5 168.68 10.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 166.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 11' ' ' GLN . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 15' ' ' VAL . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 95' ' ' VAL . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.609 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 p -48.39 -68.17 0.21 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.1 t0 53.02 23.27 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.431 2.692 . . . . 0.0 112.625 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.18 21.11 1.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -158.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -126.51 115.23 19.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -70.29 72.32 0.46 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.818 2.047 . . . . 0.0 111.722 -169.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.4 m -134.51 -43.8 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.6 1.16 . . . . 0.0 111.842 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.82 -32.01 5.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.592 1.542 . . . . 0.0 113.129 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 24.15 69.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 128.976 2.91 . . . . 0.0 112.347 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.2 -28.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.864 -0.965 . . . . 0.0 113.516 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -124.09 145.23 49.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.916 1.358 . . . . 0.0 108.007 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 75.14 2.08 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.469 0.707 . . . . 0.0 109.816 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 91' ' ' ILE . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 89' ' ' SER . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 59' ' ' PHE . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 43' ' ' VAL . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.502 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -56.61 142.18 40.58 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -133.57 70.54 1.46 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.46 -45.68 88.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.981 -3.648 . . . . 0.0 103.981 -144.615 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -78.49 159.12 28.39 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD13 ' H ' ' A' ' 88' ' ' ARG . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 50' ' ' LEU . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 5.8 mm-40 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t 46.23 -116.34 0.63 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.66 -58.89 0.18 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.011 1.724 . . . . 0.0 106.373 166.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.7 112.72 21.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.761 0.824 . . . . 0.0 111.096 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.01 172.88 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.681 1.592 . . . . 0.0 107.233 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 t -132.2 160.69 35.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.6 4.44 28.31 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.082 0.855 . . . . 0.0 111.318 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.51 60.98 0.22 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.585 2.354 . . . . 0.0 112.536 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 42.5 73.24 0.14 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 129.013 2.925 . . . . 0.0 110.515 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.02 161.28 24.11 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.592 1.568 . . . . 0.0 110.575 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -87.72 156.97 19.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.254 0.622 . . . . 0.0 111.234 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -73.21 95.94 2.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 161.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 103' ' ' THR . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -66.49 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt 60.93 -139.65 0.55 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.229 1.412 . . . . 0.0 107.291 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -93.79 -80.83 0.38 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 104.76 -3.336 . . . . 0.0 104.76 -157.478 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 60.47 171.95 0.09 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.676 1.99 . . . . 0.0 110.753 -162.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 11' ' ' GLN . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 5.5 tp-100 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 95' ' ' VAL . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' HG21 ' A' ' 78' ' ' VAL . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t 35.64 88.93 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -75.96 68.91 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.367 0.667 . . . . 0.0 112.032 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.26 19.02 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 112.452 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 mt -124.46 160.99 27.01 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.342 -0.849 . . . . 0.0 111.114 -162.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -114.23 -15.01 12.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.611 1.165 . . . . 0.0 112.301 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 146.22 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -99.24 55.57 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.23 155.95 38.63 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.109 -0.994 . . . . 0.0 108.705 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -173.91 55.27 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.98 156.24 31.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.947 0.899 . . . . 0.0 110.822 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -71.96 91.94 1.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 91' ' ' ILE . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 89' ' ' SER . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.623 HG22 ' CD1' ' A' ' 59' ' ' PHE . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -51.69 129.53 26.29 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -157.81 98.73 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 130.089 3.356 . . . . 0.0 106.284 161.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -53.95 -38.98 65.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 148.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.401 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 166.035 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CB ' HD12 ' A' ' 111' ' ' LEU . 33.9 m80 58.05 -176.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.529 0.732 . . . . 0.0 111.706 -173.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.549 ' HG3' HD22 ' A' ' 111' ' ' LEU . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.645 ' HE ' HD13 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 95' ' ' VAL . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.645 HD13 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' A' ' 50' ' ' LEU . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 95' ' ' VAL . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.18 -48.13 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.3 t0 68.3 -62.58 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.912 2.485 . . . . 0.0 109.888 -168.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.6 30.17 0.06 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.952 1.701 . . . . 0.0 112.91 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.34 0.6 OUTLIER 26.77 60.59 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 130.088 3.355 . . . . 0.0 116.042 164.476 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -24.83 -61.67 0.06 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 130.43 3.492 . . . . 0.0 114.09 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.8 p -140.62 169.7 17.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -31.97 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.404 2.282 . . . . 0.0 113.556 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -166.33 151.83 8.42 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.45 1.9 . . . . 0.0 106.517 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.29 69.33 0.17 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 54.21 -160.8 0.14 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.137 0.97 . . . . 0.0 110.664 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -66.43 73.38 0.08 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.158 2.183 . . . . 0.0 110.592 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' HG22 ' A' ' 91' ' ' ILE . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ILE . . . . . 0.414 HG22 ' CB ' ' A' ' 89' ' ' SER . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 59' ' ' PHE . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 4' ' ' GLN . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 138.76 58.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.408 ' H ' ' HA ' ' A' ' 2' ' ' HIS . 30.5 mttt -141.19 133.85 28.66 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 146.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -120.3 -52.36 2.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.989 0 N-CA-C 105.589 -3.004 . . . . 0.0 105.589 170.705 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 . . . . . 0 N--CA 1.47 0.571 0 CA-C-O 121.351 0.596 . . . . 0.0 110.424 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p . . . . . 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt . . . . . 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 . . . . . 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.458 ' HB2' HD12 ' A' ' 111' ' ' LEU . 22.1 m80 . . . . . 0 CA--C 1.553 1.088 0 CA-C-O 121.583 0.706 . . . . 0.0 111.382 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 46' ' ' GLU . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.643 ' CD1' HG22 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t . . . . . 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt . . . . . 0 C--O 1.224 -0.253 0 N-CA-C 112.318 0.488 . . . . 0.0 112.318 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 2' ' ' HIS . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 . . . . . 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.9 m80 . . . . . 0 CA--C 1.547 0.834 0 CA-C-O 121.695 0.759 . . . . 0.0 110.837 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 49' ' ' VAL . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.614 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t . . . . . 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? . . . . . 0 C--O 1.235 0.313 0 CA-C-O 122.307 1.051 . . . . 0.0 111.644 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 . . . . . 0 CA--C 1.542 0.645 0 CA-C-O 121.287 0.565 . . . . 0.0 109.893 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' HD12 ' A' ' 53' ' ' LEU . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' GLU . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.405 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.401 ' C ' HG23 ' A' ' 95' ' ' VAL . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm . . . . . 0 C--O 1.242 0.708 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 93' ' ' LEU . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 75' ' ' VAL . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 57' ' ' TYR . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 . . . . . 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 m80 . . . . . 0 CA--C 1.552 1.036 0 CA-C-O 121.124 0.488 . . . . 0.0 109.89 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HD3' HD22 ' A' ' 53' ' ' LEU . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' VAL . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 57' ' ' TYR . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.502 HD22 ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 22.1 tp60 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' HD22 ' A' ' 50' ' ' LEU . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.7 t . . . . . 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt . . . . . 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 63' ' ' SER . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 59' ' ' PHE . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? . . . . . 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.474 0.771 0 CA-C-O 121.274 0.559 . . . . 0.0 111.705 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 42' ' ' LEU . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' GLN . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 39' ' ' THR . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 9' ' ' VAL . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 31' ' ' ALA . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.598 ' CD1' HG22 ' A' ' 95' ' ' VAL . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.444 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp . . . . . 0 C--O 1.238 0.447 0 CA-C-O 122.456 1.122 . . . . 0.0 111.253 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.598 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 . . . . . 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 104' ' ' PRO . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB3' HD13 ' A' ' 53' ' ' LEU . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 49' ' ' VAL . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 2.2 tp60 -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t . . . . . 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.406 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 . . . . . 0 CA--C 1.542 0.658 0 CA-C-O 121.0 0.429 . . . . 0.0 110.721 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 53' ' ' LEU . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 11' ' ' GLN 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.509 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t . . . . . 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm . . . . . 0 C--O 1.235 0.34 0 CA-C-O 121.347 0.594 . . . . 0.0 109.909 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 61' ' ' LYS . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.427 HD12 HG11 ' A' ' 75' ' ' VAL . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 . . . . . 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 . . . . . 0 CA--C 1.554 1.134 0 N-CA-C 110.544 -0.169 . . . . 0.0 110.544 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.651 ' CD1' HD11 ' A' ' 77' ' ' LEU . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' A' ' 95' ' ' VAL . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.504 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 59' ' ' PHE . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 . . . . . 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 0.4 OUTLIER . . . . . 0 CA--C 1.55 0.948 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' SG ' ' A' ' 40' ' ' CYS . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 53' ' ' LEU . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 40' ' ' CYS . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.639 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD2' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt . . . . . 0 N--CA 1.446 -0.628 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 35' ' ' LEU . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.426 ' HG2' HG13 ' A' ' 24' ' ' VAL . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 75' ' ' VAL . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 . . . . . 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' VAL . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.627 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 75' ' ' VAL . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.442 0 N-CA-C 110.094 -0.336 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' HG2' ' A' ' 61' ' ' LYS . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 24' ' ' VAL . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.627 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.491 HD12 HG11 ' A' ' 75' ' ' VAL . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 . . . . . 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 . . . . . 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLN . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.441 ' CA ' ' HG2' ' A' ' 54' ' ' GLU . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.604 HD23 ' SG ' ' A' ' 40' ' ' CYS . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' VAL . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HG2' ' CA ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' A' ' 75' ' ' VAL 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m . . . . . 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 122.002 0.906 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 111' ' ' LEU . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 62' ' ' ARG . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 35' ' ' LEU . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.433 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.512 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 91' ' ' ILE . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 89' ' ' SER . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 75' ' ' VAL . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 59' ' ' PHE . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 . . . . . 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' A' ' 16' ' ' LEU . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' HD13 ' A' ' 53' ' ' LEU . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 49' ' ' VAL . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 46' ' ' GLU . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 29.6 tp60 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.69 ' HE3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p . . . . . 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm . . . . . 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.69 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 59' ' ' PHE . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.631 HG22 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 . . . . . 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.405 HD12 ' HA3' ' A' ' 41' ' ' GLY . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' GLN . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.512 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 79' ' ' ALA . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.621 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 95' ' ' VAL . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.64 HG12 HD23 ' A' ' 96' ' ' LEU . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 95' ' ' VAL . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.51 HG23 HD21 ' A' ' 96' ' ' LEU . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HG2' HG11 ' A' ' 78' ' ' VAL . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p . . . . . 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? . . . . . 0 C--O 1.237 0.425 0 CA-C-O 121.672 0.748 . . . . 0.0 112.2 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' ARG . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.432 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.65 HG22 ' CD1' ' A' ' 59' ' ' PHE . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 58' ' ' VAL . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.537 0.466 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 53' ' ' LEU . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB3' HD13 ' A' ' 53' ' ' LEU . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 59' ' ' PHE . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.69 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t . . . . . 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt . . . . . 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 111' ' ' LEU . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 62' ' ' ARG . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.604 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 75' ' ' VAL . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' LEU . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 74' ' ' VAL . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.6 m80 . . . . . 0 CA--C 1.531 0.216 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.52 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.644 HH22 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 18' ' ' ARG . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t . . . . . 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt . . . . . 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 74' ' ' VAL . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 . . . . . 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 11' ' ' GLN . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 15' ' ' VAL . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 95' ' ' VAL . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.609 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 p . . . . . 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.518 -0.275 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 91' ' ' ILE . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 89' ' ' SER . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 59' ' ' PHE . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 43' ' ' VAL . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.502 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? . . . . . 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 . . . . . 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 HD13 ' H ' ' A' ' 88' ' ' ARG . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.464 ' HA ' HE21 ' A' ' 52' ' ' GLN . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . 0.464 HE21 ' HA ' ' A' ' 49' ' ' VAL . 30.8 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 50' ' ' LEU . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t . . . . . 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm . . . . . 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 103' ' ' THR . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 . . . . . 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 . . . . . 0 CA--C 1.551 0.999 0 N-CA-C 110.753 -0.091 . . . . 0.0 110.753 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 11' ' ' GLN . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 24.9 tp60 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 95' ' ' VAL . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' HG21 ' A' ' 78' ' ' VAL . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? . . . . . 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 91' ' ' ILE . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 89' ' ' SER . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.623 HG22 ' CD1' ' A' ' 59' ' ' PHE . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 . . . . . 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CB ' HD12 ' A' ' 111' ' ' LEU . 33.9 m80 . . . . . 0 CA--C 1.545 0.782 0 CA-C-O 120.886 0.374 . . . . 0.0 111.706 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.549 ' HG3' HD22 ' A' ' 111' ' ' LEU . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.645 ' HE ' HD13 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 95' ' ' VAL . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.645 HD13 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' A' ' 50' ' ' LEU . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 95' ' ' VAL . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? . . . . . 0 CA--C 1.538 0.493 0 N-CA-C 110.592 -0.151 . . . . 0.0 110.592 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' HG22 ' A' ' 91' ' ' ILE . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ILE . . . . . 0.414 HG22 ' CB ' ' A' ' 89' ' ' SER . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 59' ' ' PHE . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 4' ' ' GLN . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.608 0 N-CA-C 110.105 -1.198 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.7 m-70 64.8 162.14 0.13 Allowed 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 126.642 1.977 . . . . 0.0 110.424 -171.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 85.1 t -79.71 146.81 7.21 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.281 0 N-CA-C 106.548 -1.649 . . . . 0.0 106.548 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -94.74 135.81 35.79 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-N 119.407 1.003 . . . . 0.0 108.773 169.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 40.1 mt -143.21 151.69 40.9 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-O 120.809 0.338 . . . . 0.0 110.847 177.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.404 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.1 OUTLIER -117.21 157.84 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.112 1.365 . . . . 0.0 109.599 178.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.3 mt -141.25 157.38 66.51 Favored Pre-proline 0 N--CA 1.468 0.429 0 C-N-CA 125.125 1.37 . . . . 0.0 108.294 169.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -71.9 166.39 29.68 Favored 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.065 2.51 . . . . 0.0 109.35 164.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.7 t -124.87 124.41 67.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 175.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.53 157.49 28.24 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 125.855 1.662 . . . . 0.0 106.587 -170.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 38.8 mt-30 -84.47 136.55 33.79 Favored 'General case' 0 C--N 1.333 -0.127 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.6 p -60.98 -18.93 18.71 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 O-C-N 121.325 -0.859 . . . . 0.0 110.949 178.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -85.38 -6.24 59.24 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 113.832 1.049 . . . . 0.0 113.832 178.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -106.46 -36.25 6.85 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 124.46 1.104 . . . . 0.0 109.91 176.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.8 t -65.36 65.02 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 C-N-CA 129.377 3.071 . . . . 0.0 112.25 173.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 74.6 mt -34.49 -43.51 0.17 Allowed 'General case' 0 CA--C 1.534 0.354 0 O-C-N 120.474 -1.391 . . . . 0.0 113.395 170.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.5 t -115.66 106.99 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-N 119.495 1.043 . . . . 0.0 110.151 -178.077 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -106.1 0.33 25.38 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 123.334 0.653 . . . . 0.0 112.614 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -94.55 130.39 10.28 Favored Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 107.099 -2.4 . . . . 0.0 107.099 175.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.1 m-85 -82.8 -14.13 54.96 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.77 0.785 . . . . 0.0 111.454 160.475 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 175.69 -177.24 47.51 Favored Glycine 0 CA--C 1.524 0.634 0 C-N-CA 126.212 1.863 . . . . 0.0 108.616 -173.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -129.99 41.39 3.43 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.564 1.545 . . . . 0.0 110.426 -177.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.7 m -147.17 162.93 37.88 Favored 'General case' 0 C--O 1.234 0.272 0 O-C-N 120.923 -1.111 . . . . 0.0 108.375 146.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 23.4 t -54.79 -60.73 1.33 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.416 0 C-N-CA 124.913 1.285 . . . . 0.0 109.428 -177.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.4 mt-10 -66.29 -29.66 69.92 Favored 'General case' 0 N--CA 1.446 -0.63 0 O-C-N 123.696 0.622 . . . . 0.0 111.503 -170.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -60.13 -63.16 1.4 Allowed 'General case' 0 CA--C 1.516 -0.364 0 C-N-CA 124.282 1.033 . . . . 0.0 109.136 173.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.43 -39.46 83.6 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.246 -174.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -43.0 82.51 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.809 0.843 . . . . 0.0 111.417 176.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 50.8 m -70.98 -49.74 42.0 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 124.541 1.136 . . . . 0.0 110.661 -176.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 50.8 mm-40 -61.98 -42.22 98.9 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 125.145 1.378 . . . . 0.0 110.342 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -53.86 -60.81 2.83 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 124.637 1.175 . . . . 0.0 108.395 172.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.1 ttt-85 -45.3 -36.14 3.9 Favored 'General case' 0 N--CA 1.466 0.365 0 C-N-CA 123.61 0.764 . . . . 0.0 111.817 174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -83.67 -34.87 24.9 Favored 'General case' 0 N--CA 1.434 -1.245 0 C-N-CA 124.168 0.987 . . . . 0.0 112.01 -178.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.6 m80 -70.66 -29.28 65.58 Favored 'General case' 0 C--O 1.22 -0.474 0 CA-C-N 120.913 1.688 . . . . 0.0 107.777 175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 mp -65.04 -46.98 79.03 Favored 'General case' 0 N--CA 1.446 -0.631 0 O-C-N 121.33 -0.856 . . . . 0.0 110.701 166.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.8 ttpt -62.2 -34.12 75.86 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 124.897 1.279 . . . . 0.0 111.587 -178.704 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 93.1 m-20 -74.97 -47.77 27.68 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 126.318 1.847 . . . . 0.0 109.223 171.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 105.21 8.92 35.07 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 128.272 2.844 . . . . 0.0 112.311 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 34.0 p -94.41 38.89 1.09 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 127.36 2.264 . . . . 0.0 110.376 179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 16.1 t -114.14 155.63 25.69 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 172.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -138.13 174.86 21.71 Favored Glycine 0 CA--C 1.529 0.932 0 C-N-CA 125.137 1.351 . . . . 0.0 109.765 167.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.6 tp -112.57 148.95 33.45 Favored 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.85 1.26 . . . . 0.0 109.637 -176.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 23.9 t -125.38 127.8 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 C-N-CA 127.256 2.222 . . . . 0.0 106.216 170.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -71.29 140.14 50.21 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 177.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.6 mt -80.46 108.33 14.0 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 124.148 0.979 . . . . 0.0 108.656 176.631 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -123.4 173.72 7.81 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 124.527 1.131 . . . . 0.0 108.497 173.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 76.7 tttt -64.61 -35.35 80.71 Favored 'General case' 0 C--O 1.234 0.248 0 O-C-N 121.269 -0.894 . . . . 0.0 112.728 -163.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -95.44 17.91 58.4 Favored Glycine 0 CA--C 1.523 0.582 0 CA-C-N 119.323 0.965 . . . . 0.0 113.825 -175.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 71.8 t -90.61 -48.41 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.217 0 CA-C-N 119.362 1.581 . . . . 0.0 112.598 -163.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.3 mt -48.72 -51.07 56.53 Favored Pre-proline 0 CA--C 1.541 0.617 0 CA-C-O 116.854 -1.546 . . . . 0.0 112.471 -178.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 29.2 Cg_endo -84.37 43.86 1.42 Allowed 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.628 2.219 . . . . 0.0 110.811 -174.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 30.1 mt-30 -142.28 -17.49 0.73 Allowed 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 127.398 2.279 . . . . 0.0 111.056 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 72.9 mt -79.57 -175.2 4.67 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.724 2.01 . . . . 0.0 107.538 175.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -82.49 -88.37 0.09 Allowed 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 107.101 -1.444 . . . . 0.0 107.101 176.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.9 tp60 -156.39 -59.65 0.02 OUTLIER Pre-proline 0 N--CA 1.429 -1.514 0 CA-C-O 116.613 -1.66 . . . . 0.0 110.759 -177.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -79.29 85.63 1.82 Allowed 'Trans proline' 0 N--CA 1.441 -1.608 0 N-CA-C 107.138 -1.908 . . . . 0.0 107.138 -174.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 15.1 m-85 -78.4 104.42 8.98 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 104.83 -2.285 . . . . 0.0 104.83 -173.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 10.6 t -75.19 95.34 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -79.7 164.96 23.32 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 123.291 1.52 . . . . 0.0 112.146 -178.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 92' ' ' THR . 47.3 pt -124.82 126.06 70.8 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.018 0 CA-C-N 112.345 -2.207 . . . . 0.0 106.856 167.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.462 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.7 OUTLIER -124.96 152.3 44.34 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 119.105 0.866 . . . . 0.0 109.319 173.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.43 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 0.0 OUTLIER -78.6 57.94 2.12 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.118 0.967 . . . . 0.0 113.169 -168.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.3 p 43.01 78.89 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 128.349 2.66 . . . . 0.0 112.167 171.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 25.1 t0 -79.53 84.13 5.44 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -163.42 18.65 0.07 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.286 1.434 . . . . 0.0 111.107 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 69.2 mt -147.91 166.72 26.81 Favored 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.264 1.426 . . . . 0.0 108.383 -163.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t -150.71 82.02 1.34 Allowed 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 174.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 15.1 t -162.43 162.8 27.81 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 105.784 -1.932 . . . . 0.0 105.784 -179.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -120.24 -6.7 9.87 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 -170.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -112.54 88.51 2.84 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -156.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -178.28 171.52 43.9 Favored Glycine 0 CA--C 1.521 0.467 0 O-C-N 121.85 -0.532 . . . . 0.0 111.866 -177.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -62.53 170.13 2.63 Favored 'General case' 0 C--O 1.233 0.214 0 C-N-CA 125.465 1.506 . . . . 0.0 110.045 165.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 91.6 mttt -72.11 93.34 1.41 Allowed 'General case' 0 C--O 1.233 0.198 0 N-CA-C 107.98 -1.119 . . . . 0.0 107.98 167.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 44.7 t -71.09 149.22 10.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 106.938 -1.505 . . . . 0.0 106.938 165.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.43 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 1.9 m -140.87 173.92 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.273 0 CA-C-N 118.978 0.808 . . . . 0.0 110.13 169.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -141.51 152.11 43.87 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.478 1.111 . . . . 0.0 108.728 173.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.9 mt -79.51 126.32 30.71 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 129.024 2.93 . . . . 0.0 109.92 -177.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.462 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.1 OUTLIER -146.03 166.64 8.66 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 127.321 2.248 . . . . 0.0 106.63 -174.106 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -154.52 146.28 23.36 Favored 'General case' 0 N--CA 1.472 0.645 0 O-C-N 120.122 -1.611 . . . . 0.0 109.589 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 -142.26 149.11 39.14 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 126.845 2.058 . . . . 0.0 108.337 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.6 ttm -78.48 -72.2 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.137 1.375 . . . . 0.0 110.167 175.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 77.1 m-20 -78.33 -5.73 53.03 Favored 'General case' 0 N--CA 1.476 0.864 0 O-C-N 119.475 -2.015 . . . . 0.0 110.16 -177.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 64.85 30.11 77.11 Favored Glycine 0 CA--C 1.532 1.117 0 O-C-N 121.352 -0.842 . . . . 0.0 111.213 -164.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 2.1 mp -33.66 -56.83 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 126.799 2.039 . . . . 0.0 111.206 171.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -114.52 175.02 5.66 Favored 'General case' 0 N--CA 1.438 -1.058 0 C-N-CA 126.065 1.746 . . . . 0.0 108.211 179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 65.38 -70.71 0.09 Allowed 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 126.897 2.079 . . . . 0.0 112.597 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.9 -51.07 41.76 Favored Glycine 0 C--N 1.334 0.425 0 CA-C-N 120.386 1.448 . . . . 0.0 110.189 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -79.34 72.29 5.93 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 165.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 50.7 m -161.03 171.21 19.04 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 127.731 2.412 . . . . 0.0 109.211 166.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -97.44 0.53 59.88 Favored Glycine 0 CA--C 1.527 0.782 0 CA-C-O 118.374 -1.237 . . . . 0.0 112.332 174.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.556 HG23 ' H ' ' A' ' 92' ' ' THR . 17.2 tt -65.69 -93.25 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.344 0.334 0 CA-C-N 119.444 1.622 . . . . 0.0 108.369 173.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.556 ' H ' HG23 ' A' ' 91' ' ' ILE 0.399 0.2 OUTLIER 21.61 116.45 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 131.209 3.803 . . . . 0.0 118.273 148.278 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.415 ' N ' HD22 ' A' ' 93' ' ' LEU . 0.2 OUTLIER -112.62 -13.08 13.33 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 123.954 0.901 . . . . 0.0 112.715 -168.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 168.27 -168.57 40.97 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 126.242 1.877 . . . . 0.0 109.767 168.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.17 141.36 42.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 125.757 1.623 . . . . 0.0 106.788 169.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.4 mm? -80.2 159.86 25.82 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.225 0.61 . . . . 0.0 110.24 175.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.7 m -147.44 155.23 45.88 Favored Pre-proline 0 C--O 1.24 0.579 0 C-N-CA 126.499 1.92 . . . . 0.0 109.413 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 32.9 Cg_endo -71.03 117.79 5.35 Favored 'Trans proline' 0 N--CA 1.454 -0.853 0 C-N-CA 121.784 1.656 . . . . 0.0 107.999 171.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -71.14 116.07 11.02 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 97.4 t -126.96 67.38 0.34 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 127.764 2.425 . . . . 0.0 106.918 170.912 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 68.13 19.19 71.82 Favored Glycine 0 C--N 1.338 0.641 0 N-CA-C 116.284 1.274 . . . . 0.0 116.284 160.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -74.49 0.91 13.2 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 116.198 1.925 . . . . 0.0 116.198 -162.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.7 m 69.17 101.99 0.04 OUTLIER Pre-proline 0 C--N 1.32 -0.69 0 C-N-CA 130.559 3.543 . . . . 0.0 110.65 -178.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -65.52 158.61 52.07 Favored 'Trans proline' 0 N--CA 1.445 -1.382 0 C-N-CA 121.605 1.536 . . . . 0.0 112.87 175.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -109.25 -17.1 8.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 113.133 -1.848 . . . . 0.0 110.274 171.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -166.46 173.95 9.4 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 126.168 1.787 . . . . 0.0 108.543 -170.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -131.56 151.34 51.67 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 126.812 2.045 . . . . 0.0 107.902 173.392 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 5.8 mmt85 -134.65 107.04 7.26 Favored 'General case' 0 CA--C 1.512 -0.496 0 C-N-CA 125.413 1.485 . . . . 0.0 109.238 -175.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 10.1 p30 -78.69 154.69 29.91 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.02 171.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 25.2 m -148.6 178.65 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 127.864 2.466 . . . . 0.0 107.674 172.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -103.87 168.82 8.88 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 156.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.48 115.0 10.51 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 129.1 2.96 . . . . 0.0 108.204 -174.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.2 mtt180 -49.05 125.46 10.61 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 126.418 1.887 . . . . 0.0 110.969 174.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -142.39 105.28 4.55 Favored 'General case' 0 CA--C 1.512 -0.485 0 N-CA-C 106.515 -1.661 . . . . 0.0 106.515 171.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 24.5 m-20 -64.15 -50.04 69.75 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 108.277 -1.009 . . . . 0.0 108.277 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 117.034 -1.981 . . . . 0.0 108.155 173.82 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.673 0 N-CA-C 109.142 -1.583 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.458 ' HB2' HD12 ' A' ' 111' ' ' LEU . 22.1 m80 62.21 165.59 0.1 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.37 1.868 . . . . 0.0 111.382 -167.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -107.79 121.8 61.23 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.571 0 C-N-CA 126.711 2.005 . . . . 0.0 107.397 178.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' N ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -71.37 118.65 14.44 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 120.036 1.289 . . . . 0.0 107.894 172.915 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 70.1 mt -112.2 142.12 45.06 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 123.903 0.881 . . . . 0.0 108.625 175.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -129.98 129.0 43.2 Favored 'General case' 0 C--O 1.234 0.282 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 -174.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 69.5 mt -127.99 149.3 70.51 Favored Pre-proline 0 C--N 1.328 -0.353 0 C-N-CA 124.356 1.063 . . . . 0.0 108.938 -171.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -71.23 159.44 51.95 Favored 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.128 1.885 . . . . 0.0 108.463 164.715 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.5 t -118.71 120.45 64.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 N-CA-C 105.897 -1.89 . . . . 0.0 105.897 177.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.8 mt -110.97 147.11 35.4 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 125.358 1.463 . . . . 0.0 107.548 -173.385 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 -67.59 146.45 53.87 Favored 'General case' 0 CA--C 1.515 -0.376 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.0 p -61.0 -27.92 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-O 118.279 -0.867 . . . . 0.0 110.346 179.1 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 35.6 ptt180 -66.75 -37.73 85.21 Favored 'General case' 0 C--N 1.345 0.389 0 CA-C-N 119.572 1.078 . . . . 0.0 110.276 179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -78.3 -21.89 48.99 Favored 'General case' 0 CA--C 1.52 -0.199 0 CA-C-O 122.214 1.007 . . . . 0.0 111.015 -165.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 85.4 t -76.41 61.77 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 C-N-CA 127.588 2.355 . . . . 0.0 108.851 -174.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.0 mt -42.94 -31.21 0.48 Allowed 'General case' 0 C--N 1.322 -0.606 0 C-N-CA 128.138 2.575 . . . . 0.0 114.331 -168.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.5 m -124.1 115.25 44.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.443 0 N-CA-C 106.461 -1.681 . . . . 0.0 106.461 167.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.33 38.97 2.72 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.457 1.503 . . . . 0.0 108.942 -171.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.49 88.8 0.12 Allowed Glycine 0 N--CA 1.447 -0.574 0 N-CA-C 108.261 -1.936 . . . . 0.0 108.261 -178.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -43.83 -36.46 2.34 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.367 1.867 . . . . 0.0 113.483 -170.048 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -153.82 24.41 0.72 Allowed Glycine 0 C--N 1.334 0.437 0 C-N-CA 124.548 1.07 . . . . 0.0 114.351 177.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 66.78 -18.48 0.12 Allowed 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 130.53 3.532 . . . . 0.0 115.083 169.354 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 62.4 m -114.92 162.86 16.37 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 129.067 2.947 . . . . 0.0 110.677 173.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.0 t -64.41 -56.92 13.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.645 0 CA-C-N 119.075 0.852 . . . . 0.0 110.578 -175.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -63.2 -38.79 92.55 Favored 'General case' 0 N--CA 1.447 -0.608 0 O-C-N 123.925 0.766 . . . . 0.0 109.2 -171.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -57.62 -56.74 17.95 Favored 'General case' 0 CA--C 1.506 -0.735 0 C-N-CA 124.228 1.011 . . . . 0.0 110.011 173.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.42 -40.37 86.5 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-O 117.823 -1.084 . . . . 0.0 110.107 -173.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.0 -49.45 75.76 Favored 'General case' 0 CA--C 1.547 0.842 0 CA-C-N 119.377 0.99 . . . . 0.0 111.87 171.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.3 t -59.55 -57.56 12.44 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 126.603 1.961 . . . . 0.0 110.592 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.5 mm-40 -60.97 -40.2 92.5 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 124.49 1.116 . . . . 0.0 110.273 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -58.46 -47.6 83.48 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-O 118.727 -0.654 . . . . 0.0 110.392 -179.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 6.2 ptt85 -62.43 -31.48 72.19 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.549 0.613 . . . . 0.0 110.214 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.417 ' OE2' ' HE2' ' A' ' 36' ' ' LYS . 4.9 mm-40 -71.38 -49.01 46.34 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.869 0.468 . . . . 0.0 110.855 175.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -66.73 -33.18 75.06 Favored 'General case' 0 C--N 1.329 -0.286 0 O-C-N 121.136 -0.978 . . . . 0.0 110.268 -173.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 19.7 mt -52.5 -57.21 10.63 Favored 'General case' 0 N--CA 1.458 -0.047 0 C-N-CA 123.693 0.797 . . . . 0.0 110.162 168.599 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HE2' ' OE2' ' A' ' 33' ' ' GLU . 0.0 OUTLIER -59.51 -46.13 89.72 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.412 1.485 . . . . 0.0 111.287 -179.644 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.0 m-80 -65.57 -18.74 65.55 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 123.91 0.884 . . . . 0.0 112.035 179.279 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.75 -2.31 87.87 Favored Glycine 0 CA--C 1.533 1.184 0 C-N-CA 125.639 1.59 . . . . 0.0 112.893 -172.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 35.4 p -89.87 39.9 0.98 Allowed 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 125.921 1.689 . . . . 0.0 110.844 -170.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.1 t -127.22 149.6 49.92 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.569 1.148 . . . . 0.0 109.412 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.75 169.23 23.94 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 127.043 2.259 . . . . 0.0 110.665 171.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 18.2 tp -103.38 150.41 23.84 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.15 1.78 . . . . 0.0 109.199 -176.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 12.4 t -125.34 127.8 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.504 0 C-N-CA 126.718 2.007 . . . . 0.0 108.262 169.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -77.15 132.27 38.72 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 176.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 9.8 mt -71.14 126.35 29.36 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 123.707 0.803 . . . . 0.0 110.639 177.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.427 ' HB2' HG23 ' A' ' 49' ' ' VAL . 50.8 mm-40 -140.97 167.66 21.64 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.58 1.952 . . . . 0.0 107.807 174.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.5 ttpm? -54.82 -45.15 74.39 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.901 0.881 . . . . 0.0 112.306 176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.2 1.61 86.44 Favored Glycine 0 CA--C 1.523 0.569 0 CA-C-O 118.724 -1.042 . . . . 0.0 112.613 -174.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' A' ' 46' ' ' GLU . 11.5 t -81.28 -57.2 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.357 0 CA-C-N 120.302 2.051 . . . . 0.0 111.068 -175.271 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -44.24 -50.29 21.83 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 117.64 -1.171 . . . . 0.0 112.323 178.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -76.5 -7.8 17.98 Favored 'Trans proline' 0 CA--C 1.543 0.938 0 C-N-CA 121.613 1.542 . . . . 0.0 113.984 -178.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 44.3 mt-30 -90.48 -21.56 21.8 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.217 1.407 . . . . 0.0 111.987 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -79.44 176.27 9.84 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 120.015 1.28 . . . . 0.0 109.109 175.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -77.82 -86.73 0.06 Allowed 'General case' 0 CA--C 1.511 -0.532 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 -179.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.71 -56.42 0.02 OUTLIER Pre-proline 0 N--CA 1.441 -0.883 0 CA-C-O 115.646 -2.121 . . . . 0.0 114.725 177.428 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -72.77 97.29 0.89 Allowed 'Trans proline' 0 N--CA 1.446 -1.323 0 CA-C-N 122.641 1.979 . . . . 0.0 107.975 -176.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -86.23 101.86 13.42 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 114.615 -1.175 . . . . 0.0 107.945 -172.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 48.4 t -76.72 89.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.643 ' CD1' HG22 ' A' ' 95' ' ' VAL . 62.1 m-85 -79.39 169.88 17.42 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.026 -1.046 . . . . 0.0 112.039 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.1 pt -132.4 125.15 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 CA-C-N 114.583 -1.19 . . . . 0.0 108.655 175.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.1 OUTLIER -123.28 149.48 44.72 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.166 -0.921 . . . . 0.0 109.358 176.824 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.4 47.45 0.09 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 127.277 2.231 . . . . 0.0 115.766 -170.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 14.2 t 52.15 -176.43 0.02 OUTLIER 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 124.674 1.189 . . . . 0.0 108.737 -160.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -133.65 2.94 3.51 Favored 'General case' 0 N--CA 1.468 0.469 0 O-C-N 120.613 -1.304 . . . . 0.0 110.905 170.141 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -126.86 53.55 1.68 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 124.694 1.197 . . . . 0.0 110.108 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 19.0 mt -149.03 164.58 34.19 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 130.195 3.398 . . . . 0.0 106.548 170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.9 p -165.46 76.33 0.25 Allowed 'General case' 0 C--O 1.234 0.281 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 173.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.1 p -135.55 176.19 8.9 Favored 'General case' 0 C--O 1.24 0.562 0 O-C-N 121.6 -0.687 . . . . 0.0 111.076 -172.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -120.3 9.18 10.96 Favored 'General case' 0 N--CA 1.467 0.391 0 C-N-CA 124.149 0.98 . . . . 0.0 111.569 -177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -62.24 177.84 0.45 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.752 0.821 . . . . 0.0 112.803 -171.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -59.36 -9.01 7.56 Favored Glycine 0 CA--C 1.533 1.21 0 CA-C-O 118.629 -1.095 . . . . 0.0 115.262 -174.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 74.4 m80 -136.74 -171.48 2.93 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 119.428 1.614 . . . . 0.0 108.33 171.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -134.51 4.34 3.38 Favored 'General case' 0 C--O 1.224 -0.253 0 O-C-N 121.28 -0.887 . . . . 0.0 112.318 174.138 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.314 0.9 OUTLIER 52.5 177.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 129.241 3.016 . . . . 0.0 112.09 -157.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 18.1 m -148.77 -179.68 0.61 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 C-N-CA 127.303 2.241 . . . . 0.0 110.215 158.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -139.57 167.39 22.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 127.408 2.283 . . . . 0.0 108.395 169.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 10.5 mt -77.86 148.81 34.47 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.902 1.281 . . . . 0.0 109.213 168.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.465 ' CG2' ' HE2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -148.53 161.98 5.84 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 126.252 1.821 . . . . 0.0 106.103 170.252 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.5 148.31 30.09 Favored 'General case' 0 C--O 1.236 0.351 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 171.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.4 mm-40 -146.86 151.88 37.8 Favored 'General case' 0 N--CA 1.463 0.203 0 C-N-CA 125.873 1.669 . . . . 0.0 108.822 -178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.7 tpt -73.09 -75.31 0.15 Allowed 'General case' 0 C--O 1.223 -0.322 0 C-N-CA 125.4 1.48 . . . . 0.0 109.966 -177.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -77.35 -4.44 45.16 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 124.672 1.189 . . . . 0.0 110.503 177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.66 22.91 71.29 Favored Glycine 0 CA--C 1.528 0.864 0 CA-C-O 119.052 -0.86 . . . . 0.0 112.605 -164.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.9 mp -28.19 -67.55 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 128.277 2.631 . . . . 0.0 113.578 178.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 4.8 mm-40 -105.38 165.94 10.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.467 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 7.4 m-85 72.77 -37.72 0.4 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.025 1.73 . . . . 0.0 112.136 170.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -48.91 108.59 0.43 Allowed Glycine 0 C--N 1.335 0.525 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 169.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? 49.32 45.23 23.67 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 125.285 1.434 . . . . 0.0 111.429 -175.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 14.6 m -87.31 154.41 20.71 Favored 'General case' 0 CA--C 1.539 0.54 0 O-C-N 120.076 -1.64 . . . . 0.0 108.09 155.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.32 -26.52 74.08 Favored Glycine 0 N--CA 1.474 1.186 0 CA-C-N 119.572 1.078 . . . . 0.0 113.743 -175.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 7.3 tt -62.92 -27.03 42.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 C-N-CA 125.841 1.656 . . . . 0.0 111.944 167.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 21.3 m -90.17 134.63 34.16 Favored 'General case' 0 N--CA 1.441 -0.904 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 8.7 mt -89.78 -62.55 1.45 Allowed 'General case' 0 N--CA 1.448 -0.543 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 -177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -154.08 -159.15 9.01 Favored Glycine 0 CA--C 1.527 0.791 0 C-N-CA 126.21 1.862 . . . . 0.0 109.422 -176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 59' ' ' PHE . 75.6 t -120.07 159.02 21.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 C-N-CA 128.316 2.646 . . . . 0.0 107.13 175.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.1 mt -113.5 149.84 33.75 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 125.279 1.432 . . . . 0.0 108.869 176.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.1 m -150.87 161.89 28.62 Favored Pre-proline 0 C--N 1.321 -0.663 0 C-N-CA 126.0 1.72 . . . . 0.0 107.287 -173.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -63.14 145.25 93.55 Favored 'Trans proline' 0 N--CA 1.447 -1.215 0 CA-C-N 119.985 1.03 . . . . 0.0 110.691 172.549 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 19.2 t-80 -96.11 119.62 34.93 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 159.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.1 m -125.95 39.58 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 124.99 1.316 . . . . 0.0 109.817 175.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.84 4.76 90.36 Favored Glycine 0 N--CA 1.446 -0.653 0 CA-C-O 116.622 -2.21 . . . . 0.0 115.723 166.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 25.9 mm-40 -55.56 -100.38 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 120.128 1.964 . . . . 0.0 112.816 -174.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 15.8 m -164.88 96.89 0.87 Allowed Pre-proline 0 N--CA 1.464 0.272 0 CA-C-N 120.377 1.444 . . . . 0.0 108.096 -172.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.03 145.17 17.34 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 CA-C-N 120.641 1.265 . . . . 0.0 112.044 176.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -91.77 -15.82 8.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 125.217 1.407 . . . . 0.0 111.755 175.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.74 -179.77 6.07 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 124.791 1.236 . . . . 0.0 109.309 -178.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -132.87 136.78 46.41 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 126.686 1.995 . . . . 0.0 107.722 172.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.4 tpt180 -113.78 150.16 33.85 Favored 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 125.243 1.417 . . . . 0.0 107.352 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 2.0 m120 -127.04 144.68 50.96 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 171.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.0 m -141.99 167.13 16.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 C-N-CA 126.282 1.833 . . . . 0.0 106.59 179.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 2' ' ' HIS . 3.2 mm? -102.34 162.02 13.25 Favored 'General case' 0 C--N 1.327 -0.401 0 O-C-N 120.394 -1.441 . . . . 0.0 107.87 162.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -139.47 133.25 30.67 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 125.342 1.457 . . . . 0.0 108.472 -171.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.6 mtt-85 -50.66 112.56 0.72 Allowed 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.581 1.152 . . . . 0.0 111.894 177.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.5 mttm -103.12 174.28 5.94 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 155.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 23.8 m120 -92.55 -88.98 0.2 Allowed 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 102.529 -3.137 . . . . 0.0 102.529 153.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 N-CA-C 104.934 -3.267 . . . . 0.0 104.934 151.506 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.049 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 42.9 m80 67.79 166.41 0.24 Allowed 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 127.216 2.207 . . . . 0.0 110.837 -167.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 42.8 t -105.09 143.52 16.25 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 C-N-CA 127.208 2.203 . . . . 0.0 106.658 172.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -87.58 143.51 27.16 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 170.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.4 mt -137.93 142.39 40.57 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 167.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -126.75 151.9 47.58 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 123.186 0.594 . . . . 0.0 109.813 179.387 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.4 mt -143.34 145.24 31.3 Favored Pre-proline 0 C--O 1.232 0.15 0 CA-C-O 118.249 -0.881 . . . . 0.0 110.119 -170.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -69.32 129.1 17.45 Favored 'Trans proline' 0 N--CA 1.448 -1.188 0 C-N-CA 123.686 2.924 . . . . 0.0 108.076 168.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.8 t -83.6 109.31 17.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 169.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.9 mt -93.81 171.89 8.59 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.553 1.541 . . . . 0.0 107.568 176.222 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -97.08 146.02 25.43 Favored 'General case' 0 CA--C 1.516 -0.329 0 C-N-CA 124.39 1.076 . . . . 0.0 108.585 166.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 13.6 p -55.8 -26.08 19.82 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 O-C-N 121.278 -0.889 . . . . 0.0 110.368 172.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 94.5 mtt180 -76.76 -17.21 59.19 Favored 'General case' 0 C--O 1.231 0.114 0 C-N-CA 125.988 1.715 . . . . 0.0 112.754 -175.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -101.23 -32.84 10.33 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 125.081 1.352 . . . . 0.0 110.42 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.265 14.1 t -70.1 64.02 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.232 0 C-N-CA 128.117 2.567 . . . . 0.0 111.43 179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.8 mt -49.82 -8.45 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.766 2.027 . . . . 0.0 115.404 177.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.4 p -145.85 113.13 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.519 -0.215 0 CA-C-N 121.127 1.785 . . . . 0.0 108.379 156.264 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.609 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.1 OUTLIER -88.64 10.42 20.67 Favored 'General case' 0 CA--C 1.533 0.305 0 C-N-CA 123.503 0.721 . . . . 0.0 112.096 177.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -101.36 113.12 4.57 Favored Glycine 0 N--CA 1.443 -0.853 0 N-CA-C 109.116 -1.594 . . . . 0.0 109.116 -172.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.7 m-85 -76.7 -16.1 59.6 Favored 'General case' 0 CA--C 1.53 0.206 0 CA-C-O 118.972 -0.537 . . . . 0.0 111.785 161.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -168.1 -144.17 4.08 Favored Glycine 0 CA--C 1.521 0.42 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -160.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -157.42 -39.99 0.07 Allowed 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 126.333 1.853 . . . . 0.0 109.201 -175.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.4 m -106.55 160.89 15.09 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.584 1.554 . . . . 0.0 108.853 169.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.405 ' HA ' ' HB3' ' A' ' 56' ' ' PRO . 60.0 t -56.22 -54.52 26.67 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 C-N-CA 124.295 1.038 . . . . 0.0 111.105 -172.162 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -67.61 -31.12 70.94 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.923 -170.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -56.13 -62.37 1.76 Allowed 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.69 -40.12 86.82 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-O 118.168 -0.92 . . . . 0.0 111.178 -176.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.06 -41.49 88.08 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 119.579 1.081 . . . . 0.0 111.141 176.37 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.9 m -68.01 -47.92 67.15 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 123.562 0.745 . . . . 0.0 110.92 -179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -39.43 76.31 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.798 -0.62 . . . . 0.0 110.097 -177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.67 10.74 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.248 1.419 . . . . 0.0 110.228 172.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.0 ttt180 -56.85 -36.23 69.78 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.437 1.095 . . . . 0.0 112.076 177.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -72.37 -47.17 51.58 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-N 119.329 0.968 . . . . 0.0 109.193 178.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -67.77 -28.46 67.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.509 0.724 . . . . 0.0 109.81 -176.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 38.9 mt -62.43 -47.44 84.08 Favored 'General case' 0 CA--C 1.527 0.077 0 CA-C-N 119.022 0.828 . . . . 0.0 111.151 166.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.417 ' HB3' ' HE2' ' A' ' 36' ' ' LYS . 22.8 ttpt -64.55 -35.52 81.23 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 124.446 1.098 . . . . 0.0 110.851 -174.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -76.17 -48.28 21.1 Favored 'General case' 0 CA--C 1.522 -0.103 0 C-N-CA 124.565 1.146 . . . . 0.0 110.04 173.114 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 113.26 0.08 25.18 Favored Glycine 0 CA--C 1.532 1.104 0 C-N-CA 125.747 1.641 . . . . 0.0 112.959 -171.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.1 p -84.24 41.06 0.8 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.108 1.763 . . . . 0.0 110.776 -177.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.8 t -129.14 148.42 51.08 Favored 'General case' 0 N--CA 1.446 -0.653 0 C-N-CA 125.718 1.607 . . . . 0.0 107.545 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.26 -177.51 14.9 Favored Glycine 0 CA--C 1.53 0.98 0 C-N-CA 126.067 1.794 . . . . 0.0 111.193 168.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 37.8 tp -123.75 149.61 45.38 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 126.748 2.019 . . . . 0.0 107.551 178.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 3.0 t -126.83 148.98 31.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 165.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -73.28 151.58 41.3 Favored 'General case' 0 CA--C 1.516 -0.334 0 O-C-N 120.846 -1.159 . . . . 0.0 111.453 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 3.8 mt -78.29 83.95 4.51 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.671 -1.149 . . . . 0.0 111.129 175.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.419 ' HB2' HG23 ' A' ' 49' ' ' VAL . 3.9 mm-40 -79.35 169.61 17.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.231 176.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -71.43 -20.23 62.14 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 121.495 -0.753 . . . . 0.0 112.379 168.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -132.01 50.27 0.89 Allowed Glycine 0 C--N 1.335 0.527 0 CA-C-O 118.848 -0.973 . . . . 0.0 111.577 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.419 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.2 t -106.84 -50.06 8.09 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.331 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 170.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.46 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 9.2 mp -41.03 -51.57 7.4 Favored Pre-proline 0 CA--C 1.541 0.607 0 C-N-CA 125.72 1.608 . . . . 0.0 113.764 173.3 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -75.35 3.58 5.66 Favored 'Trans proline' 0 CA--C 1.547 1.134 0 C-N-CA 122.627 2.218 . . . . 0.0 114.397 -179.67 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 59.4 mt-30 -112.33 -24.62 9.68 Favored 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 125.465 1.506 . . . . 0.0 111.396 170.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.609 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -78.92 169.4 18.27 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.635 1.574 . . . . 0.0 107.354 -177.732 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.4 mt-10 -72.07 -89.2 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.383 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -160.48 -62.1 0.02 OUTLIER Pre-proline 0 N--CA 1.447 -0.6 0 CA-C-O 116.89 -1.528 . . . . 0.0 110.427 -178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.405 ' HB3' ' HA ' ' A' ' 24' ' ' VAL . 57.1 Cg_endo -72.94 88.86 0.91 Allowed 'Trans proline' 0 N--CA 1.451 -0.983 0 CA-C-N 122.105 1.787 . . . . 0.0 110.108 -179.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.46 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 3.8 m-85 -79.29 108.93 13.17 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.211 -1.403 . . . . 0.0 107.211 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 38.2 t -77.9 94.43 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.614 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.8 m-85 -79.51 162.98 25.07 Favored 'General case' 0 CA--C 1.512 -0.495 0 CA-C-O 122.534 1.159 . . . . 0.0 111.962 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 32.7 pt -126.67 119.1 52.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.847 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.398 169.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HG2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -130.91 146.39 52.31 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.04 -177.023 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.2 ptm180 -68.47 76.75 0.27 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 125.519 1.528 . . . . 0.0 111.757 -177.941 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 12.8 t 45.29 -149.61 0.08 Allowed 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 129.109 2.964 . . . . 0.0 109.948 177.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -91.49 55.11 2.68 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 165.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 63.29 20.08 12.05 Favored 'General case' 0 N--CA 1.468 0.447 0 C-N-CA 128.29 2.636 . . . . 0.0 114.006 -176.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.6 mt -76.1 8.63 3.07 Favored 'General case' 0 C--N 1.323 -0.574 0 C-N-CA 125.321 1.448 . . . . 0.0 113.715 -172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.1 m -67.67 -18.48 64.95 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 116.096 1.887 . . . . 0.0 116.096 -173.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 12.2 t 43.04 -147.73 0.05 OUTLIER 'General case' 0 CA--C 1.551 0.981 0 C-N-CA 125.345 1.458 . . . . 0.0 112.474 171.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 30.1 t30 -88.48 -69.16 0.72 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.631 1.572 . . . . 0.0 110.081 166.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -69.83 159.9 32.76 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-O 121.022 0.439 . . . . 0.0 111.873 -171.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 80.31 132.02 1.04 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 109.274 -1.531 . . . . 0.0 109.274 -174.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 94.4 m-70 -59.2 163.21 3.9 Favored 'General case' 0 CA--C 1.529 0.157 0 O-C-N 121.691 -0.888 . . . . 0.0 110.432 169.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 6.4 ttpm? -49.39 96.32 0.01 OUTLIER 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.431 1.893 . . . . 0.0 111.644 177.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.8 t -65.13 150.06 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.709 1.603 . . . . 0.0 107.528 166.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.86 178.48 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 123.898 0.879 . . . . 0.0 108.802 159.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 84.0 mt-10 -135.88 150.1 49.24 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 176.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 78.6 mt -68.24 130.96 44.47 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 164.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.2 OUTLIER -137.01 161.1 36.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 103.753 -2.684 . . . . 0.0 103.753 169.259 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -151.8 134.02 15.18 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 119.909 1.231 . . . . 0.0 107.792 177.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 6.1 mp0 -145.86 114.12 6.64 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 123.475 0.71 . . . . 0.0 109.392 -167.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.3 ptm -61.42 -24.95 66.88 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 -169.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 40.9 t0 -127.75 22.43 6.34 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-O 122.594 1.187 . . . . 0.0 108.625 -179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.82 27.62 13.78 Favored Glycine 0 CA--C 1.535 1.322 0 O-C-N 120.822 -1.174 . . . . 0.0 113.932 -164.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 71.3 mt -25.6 -70.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.33 0 C-N-CA 131.195 3.798 . . . . 0.0 112.437 -173.286 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.7 tp-100 -113.86 168.28 9.93 Favored 'General case' 0 N--CA 1.446 -0.657 0 N-CA-C 104.336 -2.468 . . . . 0.0 104.336 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 31.7 m-85 72.46 -48.99 0.69 Allowed 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 125.405 1.482 . . . . 0.0 111.31 177.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.89 147.03 1.71 Allowed Glycine 0 C--N 1.345 1.059 0 C-N-CA 127.382 2.42 . . . . 0.0 111.931 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.4 ttp180 58.02 -133.24 1.17 Allowed 'General case' 0 CA--C 1.533 0.323 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 -167.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.2 m 65.85 -173.09 0.18 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 123.989 0.916 . . . . 0.0 110.275 -178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -105.13 -15.21 20.49 Favored Glycine 0 CA--C 1.523 0.555 0 C-N-CA 123.897 0.76 . . . . 0.0 111.678 167.218 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 9.6 tt -61.23 -31.73 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 CA-C-N 117.754 0.777 . . . . 0.0 111.119 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.2 m -97.23 146.69 24.86 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.63 0.728 . . . . 0.0 110.351 -169.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.6 mt -106.41 -37.16 6.59 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.842 0.857 . . . . 0.0 110.936 -178.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.26 -170.28 40.9 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 176.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.614 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.9 t -115.03 133.13 62.2 Favored 'Isoleucine or valine' 0 C--O 1.235 0.323 0 C-N-CA 125.377 1.471 . . . . 0.0 107.345 173.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -79.49 146.04 32.91 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 124.978 1.311 . . . . 0.0 109.597 172.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 3.3 m -141.52 164.67 33.44 Favored Pre-proline 0 C--N 1.319 -0.722 0 C-N-CA 127.306 2.243 . . . . 0.0 107.208 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.1 Cg_exo -57.3 155.7 28.74 Favored 'Trans proline' 0 N--CA 1.449 -1.139 0 CA-C-N 119.688 0.924 . . . . 0.0 110.041 165.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.8 t-80 -108.61 126.76 53.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 155.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.292 2.2 p -133.54 61.98 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 CA-C-O 123.165 1.46 . . . . 0.0 109.724 171.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.73 23.78 77.57 Favored Glycine 0 C--N 1.336 0.565 0 CA-C-N 114.877 -1.056 . . . . 0.0 113.998 167.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -82.46 1.01 39.61 Favored 'General case' 0 CA--C 1.548 0.882 0 C-N-CA 125.648 1.579 . . . . 0.0 113.682 -160.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m 61.0 105.58 0.03 OUTLIER Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 127.508 2.323 . . . . 0.0 111.015 -168.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -77.98 164.34 27.48 Favored 'Trans proline' 0 N--CA 1.451 -0.992 0 C-N-CA 122.077 1.851 . . . . 0.0 112.067 166.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.12 -30.54 4.29 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 114.401 -1.272 . . . . 0.0 110.814 172.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.19 -179.74 8.19 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 126.187 1.795 . . . . 0.0 109.328 -169.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 10.2 m-85 -130.63 159.93 35.73 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.108 0.963 . . . . 0.0 109.752 169.738 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.9 tpt180 -116.68 153.91 31.51 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 126.729 2.012 . . . . 0.0 106.869 170.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -128.31 142.63 51.08 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 159.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.4 m -144.53 175.08 3.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 127.378 2.271 . . . . 0.0 107.321 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -116.56 159.26 22.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 169.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -128.81 146.62 50.86 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 128.309 2.644 . . . . 0.0 107.666 175.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.28 154.29 10.71 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -157.46 130.53 7.67 Favored 'General case' 0 C--N 1.332 -0.179 0 C-N-CA 126.922 2.089 . . . . 0.0 106.753 159.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.64 -76.34 0.07 Allowed 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 108.727 -0.842 . . . . 0.0 108.727 172.403 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 N-CA-C 107.528 -2.229 . . . . 0.0 107.528 -175.32 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.652 0 N-CA-C 110.72 -0.952 . . . . 0.0 110.72 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 3.1 m80 66.74 158.23 0.12 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 126.897 2.079 . . . . 0.0 109.893 -161.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.48 122.88 67.54 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 C-N-CA 124.634 1.174 . . . . 0.0 109.002 -170.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.4 tt0 -70.05 144.89 52.05 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 119.107 0.867 . . . . 0.0 109.464 178.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 85.3 mt -140.52 150.61 43.93 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 124.685 1.194 . . . . 0.0 108.009 169.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -118.84 160.6 21.62 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 168.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.57 128.06 16.86 Favored Pre-proline 0 C--O 1.236 0.364 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.4 Cg_endo -66.54 134.53 35.91 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 N-CA-C 108.122 -1.53 . . . . 0.0 108.122 168.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 16.2 t -93.01 115.43 31.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 105.872 -1.899 . . . . 0.0 105.872 176.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.413 ' HB2' ' CG2' ' A' ' 15' ' ' VAL . 4.0 mt -110.36 148.62 31.6 Favored 'General case' 0 C--O 1.238 0.473 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 176.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 25.2 mt-30 -66.8 138.45 57.36 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 177.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.7 p -59.57 -14.14 5.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 C-N-CA 124.292 1.037 . . . . 0.0 111.635 178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -85.65 -39.53 17.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 C-N-CA 126.957 2.103 . . . . 0.0 110.86 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.9 m-20 -71.33 -46.22 61.12 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.413 ' CG2' ' HB2' ' A' ' 10' ' ' LEU . 14.1 t -59.61 65.4 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.222 -0.358 0 C-N-CA 130.957 3.703 . . . . 0.0 113.115 -179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 73.1 mt -36.13 -35.95 0.08 Allowed 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.97 1.308 . . . . 0.0 114.15 173.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.1 p -121.08 101.22 10.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 CA-C-O 122.565 1.174 . . . . 0.0 111.056 -178.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CB ' HD12 ' A' ' 53' ' ' LEU . 1.7 mpt_? -102.21 16.37 26.35 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 125.132 1.373 . . . . 0.0 112.187 -175.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -150.89 103.12 0.24 Allowed Glycine 0 N--CA 1.442 -0.919 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -169.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.405 ' HB3' ' CB ' ' A' ' 30' ' ' GLU . 24.8 m-85 -52.78 -29.9 29.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 126.705 2.002 . . . . 0.0 113.233 177.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.32 175.59 33.21 Favored Glycine 0 C--O 1.239 0.444 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 175.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.3 p30 -94.68 -16.53 23.03 Favored 'General case' 0 C--N 1.329 -0.299 0 O-C-N 124.204 0.59 . . . . 0.0 111.476 176.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -117.52 150.34 39.12 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.89 -39.0 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 O-C-N 120.606 -1.309 . . . . 0.0 110.291 -169.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -70.38 -28.74 65.34 Favored 'General case' 0 CA--C 1.527 0.095 0 CA-C-N 118.441 0.564 . . . . 0.0 111.303 -174.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.3 mt-10 -60.21 -64.44 0.95 Allowed 'General case' 0 CA--C 1.515 -0.39 0 N-CA-C 107.688 -1.226 . . . . 0.0 107.688 167.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.75 89.32 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.805 0.842 . . . . 0.0 111.211 -168.443 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -61.57 -45.8 92.58 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.378 0.671 . . . . 0.0 112.014 175.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.9 t -65.3 -51.73 58.77 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.435 0.694 . . . . 0.0 109.403 -179.089 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.405 ' CB ' ' HB3' ' A' ' 20' ' ' PHE . 16.3 mm-40 -51.9 -41.31 61.86 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 127.144 2.178 . . . . 0.0 111.073 176.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.29 -50.13 66.89 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-O 118.936 -0.554 . . . . 0.0 110.2 -178.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 49.1 mtp180 -54.56 -36.87 64.81 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 118.842 0.746 . . . . 0.0 110.467 171.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -68.32 -51.15 47.84 Favored 'General case' 0 N--CA 1.443 -0.779 0 CA-C-N 117.488 0.131 . . . . 0.0 111.312 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 42.2 m80 -71.46 -24.19 61.97 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 120.654 -1.279 . . . . 0.0 109.744 -174.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -66.78 -40.21 88.08 Favored 'General case' 0 CA--C 1.534 0.35 0 O-C-N 121.314 -0.866 . . . . 0.0 111.4 166.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . 0.441 ' HB3' ' HE3' ' A' ' 36' ' ' LYS . 0.4 OUTLIER -69.48 -43.24 73.6 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.379 1.072 . . . . 0.0 110.257 177.449 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -53.07 -52.3 59.02 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 168.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 107.58 -2.47 34.36 Favored Glycine 0 CA--C 1.534 1.224 0 C-N-CA 126.647 2.07 . . . . 0.0 111.585 -171.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.4 p -90.16 54.04 2.68 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.703 1.601 . . . . 0.0 108.894 -173.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -139.12 138.04 36.68 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.895 -1.128 . . . . 0.0 110.985 -174.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.92 -177.76 15.02 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 127.755 2.598 . . . . 0.0 113.544 -177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.9 tp -130.85 135.72 47.99 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.979 1.312 . . . . 0.0 112.013 -169.743 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.3 t -109.22 120.47 60.6 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -73.12 120.78 19.22 Favored 'General case' 0 C--N 1.331 -0.205 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 22.3 mt -73.93 126.54 30.69 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 113.097 0.777 . . . . 0.0 113.097 -174.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -142.94 172.89 12.09 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 126.128 1.771 . . . . 0.0 109.372 -164.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.1 tppp? -47.82 -60.94 2.21 Favored 'General case' 0 N--CA 1.466 0.35 0 C-N-CA 125.119 1.368 . . . . 0.0 109.696 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.02 15.49 59.26 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-O 117.738 -1.59 . . . . 0.0 113.444 -168.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.6 t -76.18 -55.85 10.02 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.396 0 CA-C-N 119.961 1.88 . . . . 0.0 112.232 -175.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -48.03 -49.53 59.27 Favored Pre-proline 0 CA--C 1.539 0.531 0 CA-C-O 117.627 -1.178 . . . . 0.0 111.044 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -74.38 3.36 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 CA-C-N 121.55 1.589 . . . . 0.0 114.133 -177.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.4 mt-30 -95.53 -23.58 17.02 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 120.386 1.448 . . . . 0.0 110.67 170.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.526 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -79.06 -176.0 4.86 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 125.626 1.57 . . . . 0.0 110.873 178.962 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 -76.54 -85.43 0.06 Allowed 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -169.6 -57.83 0.0 OUTLIER Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-O 117.146 -1.407 . . . . 0.0 110.305 -178.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -73.39 89.88 0.92 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 CA-C-N 123.005 2.109 . . . . 0.0 109.78 176.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.429 ' HB3' HG21 ' A' ' 95' ' ' VAL . 13.6 m-85 -78.59 108.08 11.73 Favored 'General case' 0 N--CA 1.44 -0.941 0 C-N-CA 128.161 2.584 . . . . 0.0 108.344 -178.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.401 ' C ' HG23 ' A' ' 95' ' ' VAL . 13.5 t -81.22 85.99 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 CA-C-O 121.827 0.822 . . . . 0.0 110.285 -179.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -79.17 163.1 25.31 Favored 'General case' 0 CA--C 1.512 -0.502 0 CA-C-O 122.04 0.924 . . . . 0.0 112.175 -173.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 37.7 pt -124.42 109.13 21.84 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.779 0 CA-C-N 113.623 -1.626 . . . . 0.0 108.751 173.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.517 ' HD3' ' CE1' ' A' ' 86' ' ' TYR . 6.2 pttt -111.32 150.65 29.4 Favored 'General case' 0 CA--C 1.496 -1.132 0 O-C-N 121.51 -0.744 . . . . 0.0 110.622 173.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 16.9 ptm180 -55.39 112.45 1.11 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-O 123.471 1.605 . . . . 0.0 109.078 165.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -45.95 144.68 1.74 Allowed 'General case' 0 C--O 1.237 0.427 0 CA-C-N 114.034 -1.439 . . . . 0.0 107.259 144.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -146.86 28.93 1.02 Allowed 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 118.614 -1.235 . . . . 0.0 113.241 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.76 27.08 4.66 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.301 1.441 . . . . 0.0 111.97 -179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.8 mt -128.73 106.11 8.71 Favored 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 105.959 -1.867 . . . . 0.0 105.959 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.4 p -159.8 118.21 2.74 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.889 0.876 . . . . 0.0 109.174 -169.459 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.3 m -157.36 -59.62 0.09 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.278 1.431 . . . . 0.0 109.326 175.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.8 t30 -121.36 -12.38 8.62 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 -175.724 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 21.1 m-70 -147.87 139.6 23.91 Favored 'General case' 0 C--O 1.237 0.426 0 C-N-CA 123.559 0.744 . . . . 0.0 109.237 -167.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.71 -113.58 3.23 Favored Glycine 0 N--CA 1.449 -0.485 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 160.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 5.6 m80 61.73 150.13 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.862 2.065 . . . . 0.0 109.318 -146.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 33.1 mttm -71.74 96.82 1.66 Allowed 'General case' 0 C--O 1.242 0.708 0 O-C-N 120.609 -1.307 . . . . 0.0 108.092 174.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.423 HG12 ' HB2' ' A' ' 111' ' ' LEU . 3.4 m -81.44 162.22 3.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 125.795 1.638 . . . . 0.0 109.655 171.52 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.546 HG11 HD12 ' A' ' 93' ' ' LEU . 34.9 m -143.35 178.61 1.91 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.324 0 C-N-CA 123.797 0.839 . . . . 0.0 109.804 168.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -146.49 156.07 43.0 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 124.604 1.162 . . . . 0.0 108.861 -171.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 17.1 mt -82.3 131.92 35.23 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.064 1.346 . . . . 0.0 109.58 -174.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.474 HG21 ' HG2' ' A' ' 61' ' ' LYS . 1.0 OUTLIER -141.91 160.55 20.78 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 -177.159 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -148.9 137.11 20.91 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.823 -1.547 . . . . 0.0 106.823 175.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.1 mm-40 -143.46 125.84 15.69 Favored 'General case' 0 CA--C 1.529 0.149 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 -176.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -54.63 -61.94 1.98 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 128.755 2.822 . . . . 0.0 113.924 -172.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -90.97 1.42 57.07 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 125.853 1.661 . . . . 0.0 110.231 173.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 60.84 34.69 88.15 Favored Glycine 0 CA--C 1.534 1.238 0 O-C-N 120.064 -1.648 . . . . 0.0 112.364 -162.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.3 mt -38.24 -56.71 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 C-N-CA 126.508 1.923 . . . . 0.0 111.132 174.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.15 167.81 9.91 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 170.038 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.517 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 12.4 m-85 76.4 -43.7 0.47 Allowed 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 126.724 2.01 . . . . 0.0 113.385 166.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.23 -48.88 83.82 Favored Glycine 0 CA--C 1.523 0.553 0 CA-C-N 120.403 1.456 . . . . 0.0 112.025 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -75.91 1.83 14.13 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.229 1.411 . . . . 0.0 112.456 178.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.95 128.92 56.61 Favored 'General case' 0 CA--C 1.529 0.135 0 O-C-N 120.398 -1.439 . . . . 0.0 110.614 -150.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.44 -8.84 72.18 Favored Glycine 0 CA--C 1.532 1.146 0 C-N-CA 124.116 0.865 . . . . 0.0 114.067 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.6 tt -65.97 -27.07 40.0 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 O-C-N 121.369 -1.077 . . . . 0.0 111.095 165.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 31.2 m -83.66 140.88 31.89 Favored 'General case' 0 N--CA 1.44 -0.955 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -176.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.546 HD12 HG11 ' A' ' 75' ' ' VAL . 69.2 mt -98.49 -30.63 12.42 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-O 118.461 -0.781 . . . . 0.0 110.877 178.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.32 28.43 Favored Glycine 0 C--N 1.339 0.713 0 N-CA-C 110.647 -0.981 . . . . 0.0 110.647 166.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.429 HG21 ' HB3' ' A' ' 57' ' ' TYR . 8.1 p -129.22 140.0 50.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 C-N-CA 123.738 0.815 . . . . 0.0 111.417 179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 4.1 mp -90.83 140.23 30.0 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-O 121.15 0.5 . . . . 0.0 110.938 -168.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 26.7 m -137.58 158.72 71.38 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 126.258 1.823 . . . . 0.0 107.968 -177.127 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -67.37 123.93 11.46 Favored 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 121.479 1.453 . . . . 0.0 108.897 171.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.4 t-160 -75.82 102.92 5.67 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 172.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 5.2 p -112.73 53.19 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 125.347 1.459 . . . . 0.0 109.659 179.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 70.27 18.22 74.83 Favored Glycine 0 C--N 1.337 0.608 0 O-C-N 121.286 -0.884 . . . . 0.0 114.776 168.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -73.8 0.29 13.59 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 124.393 1.077 . . . . 0.0 113.823 -166.323 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER 72.29 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 128.319 2.648 . . . . 0.0 111.141 178.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 66.8 Cg_endo -78.65 148.78 23.17 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 121.55 1.5 . . . . 0.0 112.101 -178.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -94.17 -15.22 7.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 C-N-CA 125.355 1.462 . . . . 0.0 111.601 171.07 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.54 172.93 14.67 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.225 1.01 . . . . 0.0 109.42 -171.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -131.83 145.17 51.41 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.959 1.303 . . . . 0.0 107.709 170.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 23.7 mmt180 -126.49 149.89 49.06 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 178.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -140.08 128.32 22.5 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 125.77 1.628 . . . . 0.0 107.438 -158.257 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.9 m -147.7 174.49 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 124.857 1.263 . . . . 0.0 108.362 -172.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.423 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.2 mm? -109.5 165.33 11.74 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 106.692 -1.596 . . . . 0.0 106.692 163.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -121.74 149.41 43.32 Favored 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 127.423 2.289 . . . . 0.0 107.448 170.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 20.5 mtm105 -59.52 151.44 24.3 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.134 0.974 . . . . 0.0 110.727 174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 5.7 mttm -135.27 152.59 51.66 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 106.785 -1.561 . . . . 0.0 106.785 161.433 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -120.45 -72.23 0.7 Allowed 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 103.921 -2.622 . . . . 0.0 103.921 159.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.773 0 N-CA-C 104.606 -3.398 . . . . 0.0 104.606 161.78 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.888 0 N-CA-C 110.774 -0.931 . . . . 0.0 110.774 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 8.7 m80 58.64 174.88 0.07 Allowed 'General case' 0 CA--C 1.552 1.036 0 C-N-CA 124.89 1.276 . . . . 0.0 109.89 -164.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.19 114.64 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 O-C-N 120.098 -1.626 . . . . 0.0 107.574 -177.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER -66.25 144.95 56.29 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 120.115 1.325 . . . . 0.0 110.459 178.437 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 84.4 mt -133.47 165.28 25.25 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 126.087 1.755 . . . . 0.0 108.515 172.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -138.29 138.35 38.33 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 125.406 1.482 . . . . 0.0 109.473 174.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 53.5 mt -126.66 134.11 25.71 Favored Pre-proline 0 C--N 1.331 -0.224 0 C-N-CA 125.432 1.493 . . . . 0.0 108.346 -176.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -66.46 135.53 39.71 Favored 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 121.952 1.768 . . . . 0.0 107.983 162.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.3 t -90.31 120.19 38.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 30.5 mt -122.25 144.27 49.08 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.723 1.609 . . . . 0.0 107.38 -169.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.8 mt-30 -76.7 142.75 40.4 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 119.624 1.102 . . . . 0.0 110.418 -176.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.9 p -58.39 -30.84 41.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 121.357 -0.839 . . . . 0.0 110.377 177.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 18.1 ptp180 -69.6 -37.54 76.93 Favored 'General case' 0 C--N 1.341 0.214 0 CA-C-N 118.12 0.418 . . . . 0.0 110.733 -178.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -81.13 -37.37 28.96 Favored 'General case' 0 CA--C 1.512 -0.512 0 C-N-CA 125.259 1.423 . . . . 0.0 111.138 -173.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 42.4 t -63.14 65.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.736 0 C-N-CA 129.586 3.155 . . . . 0.0 109.66 171.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 78.8 mt -36.07 -56.29 0.74 Allowed 'General case' 0 C--N 1.328 -0.339 0 O-C-N 121.024 -1.047 . . . . 0.0 111.379 169.041 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -95.02 105.25 16.75 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 124.805 1.242 . . . . 0.0 109.927 -176.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.502 ' HD3' HD22 ' A' ' 53' ' ' LEU . 58.3 mtt180 -104.42 18.01 23.01 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 125.048 1.339 . . . . 0.0 111.326 -169.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -148.99 148.64 20.23 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 109.953 -1.259 . . . . 0.0 109.953 177.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.0 m-85 -85.67 -15.16 43.27 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.794 0.837 . . . . 0.0 112.054 171.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -179.4 177.08 48.16 Favored Glycine 0 C--O 1.236 0.246 0 N-CA-C 108.638 -1.785 . . . . 0.0 108.638 -177.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.9 t0 -99.44 -6.8 27.03 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 -165.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 53.5 m -129.76 164.82 23.19 Favored 'General case' 0 C--O 1.233 0.232 0 C-N-CA 124.852 1.261 . . . . 0.0 110.865 169.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 55.6 t -57.16 -55.85 18.27 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 C-N-CA 125.169 1.387 . . . . 0.0 110.049 -170.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -74.28 -24.83 59.31 Favored 'General case' 0 N--CA 1.446 -0.658 0 O-C-N 123.819 0.699 . . . . 0.0 111.446 -168.521 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.6 mm-40 -63.86 -59.1 4.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 173.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -56.62 -42.33 78.64 Favored 'General case' 0 N--CA 1.443 -0.817 0 C-N-CA 123.294 0.638 . . . . 0.0 111.371 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.06 -49.66 75.17 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 119.065 0.848 . . . . 0.0 112.504 176.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.8 m -62.54 -49.24 76.11 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 123.65 0.78 . . . . 0.0 111.68 178.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -61.26 -35.32 76.97 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 123.975 0.91 . . . . 0.0 109.706 -179.212 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -63.82 -45.35 90.02 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.674 -0.679 . . . . 0.0 110.124 179.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.3 mtt180 -54.25 -40.42 67.72 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 119.377 0.99 . . . . 0.0 110.504 170.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -67.49 -47.08 71.07 Favored 'General case' 0 N--CA 1.446 -0.644 0 CA-C-N 118.372 0.533 . . . . 0.0 111.679 -179.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 62.6 m80 -69.45 -30.78 68.77 Favored 'General case' 0 C--N 1.328 -0.344 0 O-C-N 120.856 -1.152 . . . . 0.0 109.911 -178.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 87.4 mt -66.72 -32.89 74.49 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 119.013 0.824 . . . . 0.0 111.3 168.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -49.97 65.1 Favored 'General case' 0 CA--C 1.519 -0.215 0 C-N-CA 124.814 1.245 . . . . 0.0 110.3 176.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -61.17 -52.58 64.22 Favored 'General case' 0 CA--C 1.529 0.152 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 176.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 115.29 -3.58 22.09 Favored Glycine 0 CA--C 1.532 1.117 0 C-N-CA 127.601 2.524 . . . . 0.0 111.488 -172.06 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.0 p -85.99 46.27 1.31 Allowed 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 127.577 2.351 . . . . 0.0 109.76 -171.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 40.1 t -128.91 140.14 51.81 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.699 1.6 . . . . 0.0 106.928 -176.195 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.06 177.91 17.38 Favored Glycine 0 CA--C 1.528 0.905 0 C-N-CA 126.234 1.873 . . . . 0.0 110.881 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 13.4 tp -119.4 129.07 54.61 Favored 'General case' 0 C--N 1.334 -0.104 0 C-N-CA 126.128 1.771 . . . . 0.0 109.321 -171.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 25.2 t -113.28 120.72 63.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.474 -2.047 . . . . 0.0 105.474 171.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -69.91 155.78 40.06 Favored 'General case' 0 C--O 1.234 0.28 0 O-C-N 121.274 -0.891 . . . . 0.0 109.509 -178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 12.3 mt -80.4 79.3 7.01 Favored 'General case' 0 CA--C 1.517 -0.299 0 O-C-N 121.446 -0.784 . . . . 0.0 108.99 177.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.405 ' HB2' HG23 ' A' ' 49' ' ' VAL . 75.8 mt-10 -79.12 157.29 27.98 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 172.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 47.3 tttp -51.57 -51.22 57.22 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 124.25 1.02 . . . . 0.0 111.236 178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.73 13.03 68.5 Favored Glycine 0 N--CA 1.448 -0.546 0 CA-C-O 117.548 -1.695 . . . . 0.0 113.45 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.405 HG23 ' HB2' ' A' ' 46' ' ' GLU . 0.9 OUTLIER -73.63 -52.3 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 121.231 2.515 . . . . 0.0 111.519 -177.314 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.461 HD22 ' CD2' ' A' ' 57' ' ' TYR . 5.3 mt -51.03 -50.2 76.48 Favored Pre-proline 0 CA--C 1.54 0.564 0 CA-C-O 117.588 -1.196 . . . . 0.0 111.497 -173.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -65.09 -15.85 52.36 Favored 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 121.667 1.631 . . . . 0.0 114.464 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 54.7 mt-30 -89.96 -19.87 23.98 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 119.821 1.191 . . . . 0.0 111.017 175.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.502 HD22 ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -79.77 173.55 12.47 Favored 'General case' 0 CA--C 1.535 0.384 0 N-CA-C 108.053 -1.091 . . . . 0.0 108.053 -177.153 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -72.18 -78.89 0.08 Allowed 'General case' 0 CA--C 1.521 -0.151 0 O-C-N 121.944 -0.472 . . . . 0.0 110.339 -175.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.429 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 22.1 tp60 -164.64 -56.2 0.01 OUTLIER Pre-proline 0 N--CA 1.432 -1.329 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.146 170.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.429 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 50.5 Cg_endo -80.12 86.75 1.61 Allowed 'Trans proline' 0 N--CA 1.447 -1.247 0 CA-C-N 122.886 2.066 . . . . 0.0 108.46 -175.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.461 ' CD2' HD22 ' A' ' 50' ' ' LEU . 2.5 m-85 -78.22 100.09 6.51 Favored 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 113.966 -1.47 . . . . 0.0 107.303 -175.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.7 t -69.8 96.19 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 125.095 1.358 . . . . 0.0 108.924 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.565 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.9 m-85 -80.68 165.73 21.72 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 122.478 1.132 . . . . 0.0 112.105 -178.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.1 pt -127.77 129.02 69.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 CA-C-N 113.925 -1.489 . . . . 0.0 107.402 170.863 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.571 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 7.0 ptpt -128.43 145.22 51.16 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 6.8 ptt180 -81.29 90.21 6.11 Favored 'General case' 0 CA--C 1.515 -0.375 0 CA-C-O 121.656 0.741 . . . . 0.0 112.128 -174.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.424 ' HB2' ' CG2' ' A' ' 74' ' ' VAL . 3.7 t 23.93 84.62 0.01 OUTLIER 'General case' 0 CA--C 1.51 -0.562 0 C-N-CA 130.164 3.386 . . . . 0.0 110.846 177.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -57.07 -46.2 82.68 Favored 'General case' 0 N--CA 1.43 -1.458 0 CA-C-N 113.575 -1.648 . . . . 0.0 109.969 -174.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.48 100.72 1.13 Allowed 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 153.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -60.32 108.17 0.76 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 124.073 0.949 . . . . 0.0 109.042 175.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 p -83.44 -80.94 0.17 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 125.139 1.375 . . . . 0.0 110.627 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 21.8 m -62.71 157.16 21.66 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.292 1.037 . . . . 0.0 109.915 -175.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -52.83 -59.84 4.01 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 122.875 0.47 . . . . 0.0 110.13 167.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 14.3 t-80 -147.36 -75.59 0.19 Allowed 'General case' 0 C--N 1.333 -0.152 0 O-C-N 121.154 -0.966 . . . . 0.0 110.351 164.186 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 47.87 -89.98 0.01 OUTLIER Glycine 0 CA--C 1.525 0.658 0 C-N-CA 127.47 2.462 . . . . 0.0 114.156 -174.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -128.85 131.53 47.69 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 125.485 1.514 . . . . 0.0 107.327 -165.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 37.3 mtmt -70.61 94.24 0.98 Allowed 'General case' 0 C--O 1.239 0.505 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.424 ' CG2' ' HB2' ' A' ' 63' ' ' SER . 2.2 m -74.47 174.76 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 C-N-CA 125.018 1.327 . . . . 0.0 109.748 177.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 30.3 m -136.59 179.93 3.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-O 121.939 0.876 . . . . 0.0 110.883 161.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -146.46 169.22 19.34 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 125.584 1.554 . . . . 0.0 106.844 170.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -80.51 141.45 35.16 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 123.663 0.785 . . . . 0.0 111.096 -178.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.6 t -138.36 170.22 17.11 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.443 0 C-N-CA 127.556 2.342 . . . . 0.0 106.184 163.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.17 136.64 7.81 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.759 2.024 . . . . 0.0 105.637 177.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 52.9 mm-40 -141.28 165.96 26.07 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.925 1.69 . . . . 0.0 107.314 168.392 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ttm -95.36 -59.67 1.83 Allowed 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 127.628 2.371 . . . . 0.0 109.865 -178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -89.11 13.77 12.34 Favored 'General case' 0 N--CA 1.471 0.625 0 O-C-N 121.015 -1.053 . . . . 0.0 109.311 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 44.65 60.63 3.69 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 126.282 1.896 . . . . 0.0 109.763 -163.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.459 65.3 mt -39.82 66.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.466 0.371 0 C-N-CA 129.355 3.062 . . . . 0.0 115.76 160.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 90.04 -142.6 0.0 OUTLIER 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 127.554 2.342 . . . . 0.0 104.688 175.337 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.571 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 40.1 m-85 60.06 -81.06 0.02 OUTLIER 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.26 1.424 . . . . 0.0 113.827 170.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -63.2 -17.52 59.32 Favored Glycine 0 CA--C 1.529 0.93 0 C-N-CA 125.985 1.755 . . . . 0.0 113.642 -166.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.78 28.1 9.05 Favored 'General case' 0 C--O 1.239 0.524 0 O-C-N 121.412 -1.052 . . . . 0.0 112.7 174.204 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 2.2 t -131.17 162.88 28.94 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-O 121.797 0.808 . . . . 0.0 112.603 176.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -80.28 86.76 1.3 Allowed Glycine 0 C--N 1.337 0.585 0 C-N-CA 125.739 1.638 . . . . 0.0 109.706 179.436 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 2.5 tt -178.38 -42.68 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 128.236 2.614 . . . . 0.0 108.82 175.709 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.3 m -83.72 135.29 34.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 -172.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 21.4 mt -96.77 -45.76 6.53 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 119.001 0.818 . . . . 0.0 111.25 -173.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.79 -169.74 22.56 Favored Glycine 0 CA--C 1.52 0.401 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 -177.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.565 HG22 ' CD1' ' A' ' 59' ' ' PHE . 87.2 t -115.08 146.65 19.24 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 C-N-CA 127.235 2.214 . . . . 0.0 105.725 165.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 92.0 mt -92.92 149.13 21.45 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 120.941 -1.099 . . . . 0.0 108.454 176.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.8 m -138.05 156.64 73.95 Favored Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 124.857 1.263 . . . . 0.0 108.503 176.609 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -68.19 122.15 9.19 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 N-CA-C 107.497 -1.77 . . . . 0.0 107.497 170.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -73.41 113.14 10.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 21.8 m -126.52 39.12 0.94 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.462 0 CA-C-O 121.859 0.838 . . . . 0.0 111.6 -179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.33 33.45 19.96 Favored Glycine 0 CA--C 1.528 0.887 0 O-C-N 121.2 -0.937 . . . . 0.0 113.401 168.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -88.73 0.88 56.04 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 125.495 1.518 . . . . 0.0 113.727 -172.541 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 8.1 m 76.31 100.86 0.03 OUTLIER Pre-proline 0 CA--C 1.542 0.666 0 C-N-CA 128.444 2.698 . . . . 0.0 112.522 172.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -70.66 152.08 64.42 Favored 'Trans proline' 0 N--CA 1.451 -0.985 0 C-N-CA 121.092 1.194 . . . . 0.0 113.66 179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.446 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -95.42 -20.9 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 125.017 1.327 . . . . 0.0 111.289 167.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.81 -179.25 7.68 Favored 'General case' 0 N--CA 1.457 -0.124 0 C-N-CA 124.754 1.221 . . . . 0.0 109.353 -179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -130.76 149.33 52.45 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.8 mmt85 -128.08 108.17 10.43 Favored 'General case' 0 CA--C 1.512 -0.506 0 C-N-CA 126.781 2.032 . . . . 0.0 107.469 -177.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -79.89 135.07 36.35 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 165.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.26 154.56 15.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 174.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.435 ' HA ' ' HA ' ' A' ' 4' ' ' GLN . 3.7 mm? -83.2 160.09 21.87 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 167.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.9 tp -106.67 120.06 40.96 Favored 'General case' 0 C--N 1.323 -0.554 0 C-N-CA 126.817 2.047 . . . . 0.0 105.629 160.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 6.1 ppt_? -65.73 159.72 24.48 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 168.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 68.6 mttt -124.1 -177.16 3.68 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.606 1.963 . . . . 0.0 109.108 173.339 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -88.57 -88.57 0.15 Allowed 'General case' 0 N--CA 1.462 0.157 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 117.848 -1.529 . . . . 0.0 110.071 176.29 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.902 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 81.98 169.93 0.12 Allowed 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 126.543 1.937 . . . . 0.0 111.705 176.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.416 HG23 ' HB3' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -122.29 129.68 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.647 0 C-N-CA 128.419 2.687 . . . . 0.0 106.816 -175.208 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.5 tt0 -74.94 150.65 39.01 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 120.344 1.429 . . . . 0.0 109.671 174.743 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 78.7 mt -143.99 158.43 43.71 Favored 'General case' 0 C--O 1.238 0.478 0 C-N-CA 126.058 1.743 . . . . 0.0 108.161 174.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -142.72 132.23 23.71 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 -174.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 89.6 mt -120.71 151.46 54.43 Favored Pre-proline 0 N--CA 1.466 0.349 0 CA-C-O 118.12 -0.943 . . . . 0.0 110.414 -179.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -72.55 142.13 35.88 Favored 'Trans proline' 0 N--CA 1.455 -0.793 0 C-N-CA 122.864 2.376 . . . . 0.0 108.619 163.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.445 HG22 HD23 ' A' ' 42' ' ' LEU . 41.7 t -94.98 107.39 19.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.558 -2.016 . . . . 0.0 105.558 173.073 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 50.1 mt -96.48 177.93 5.52 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.834 1.654 . . . . 0.0 108.156 179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.426 ' O ' HG23 ' A' ' 15' ' ' VAL . 28.2 mt-30 -104.68 146.91 28.27 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 123.863 0.865 . . . . 0.0 110.443 173.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.9 p -57.14 -24.9 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 CA-C-N 119.176 0.898 . . . . 0.0 110.585 177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.3 ptt85 -77.73 -38.22 47.57 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 123.139 0.576 . . . . 0.0 111.954 179.552 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -78.74 -34.56 45.74 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 125.291 1.437 . . . . 0.0 109.72 -176.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 11' ' ' GLN . 16.2 t -68.33 63.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.725 0 C-N-CA 127.961 2.504 . . . . 0.0 109.223 170.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 72.3 mt -34.88 -33.81 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.828 2.451 . . . . 0.0 113.969 173.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -134.61 120.57 32.71 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.198 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 177.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.443 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -109.84 7.43 24.03 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 124.057 0.943 . . . . 0.0 113.056 -172.489 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -124.21 95.76 0.51 Allowed Glycine 0 CA--C 1.509 -0.304 0 N-CA-C 107.363 -2.295 . . . . 0.0 107.363 -162.31 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB3' ' HB2' ' A' ' 30' ' ' GLU . 33.9 m-85 -57.2 -23.52 48.3 Favored 'General case' 0 N--CA 1.453 -0.29 0 CA-C-N 118.264 1.032 . . . . 0.0 112.552 -176.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.43 179.76 32.94 Favored Glycine 0 N--CA 1.447 -0.63 0 N-CA-C 108.019 -2.032 . . . . 0.0 108.019 177.656 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -109.06 3.87 22.51 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.557 1.143 . . . . 0.0 111.268 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.95 153.3 41.42 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 127.553 2.341 . . . . 0.0 107.658 166.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -59.18 -41.55 84.13 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 CA-C-O 118.795 -0.622 . . . . 0.0 109.734 166.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -69.81 -25.15 63.64 Favored 'General case' 0 N--CA 1.454 -0.249 0 CA-C-N 118.485 0.584 . . . . 0.0 112.555 -174.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -67.21 -67.37 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 163.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -52.91 -42.56 65.47 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 124.812 1.245 . . . . 0.0 112.365 -164.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -52.96 -50.48 64.0 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 125.472 1.509 . . . . 0.0 111.693 175.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 75.1 m -78.68 -35.36 45.21 Favored 'General case' 0 C--O 1.234 0.253 0 C-N-CA 123.837 0.855 . . . . 0.0 111.491 -174.143 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 20' ' ' PHE . 72.6 mm-40 -63.36 -45.59 90.47 Favored 'General case' 0 CA--C 1.512 -0.5 0 C-N-CA 124.429 1.092 . . . . 0.0 109.985 173.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.527 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -58.15 -50.69 72.62 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 124.62 1.168 . . . . 0.0 109.706 -177.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 41.6 ttt-85 -53.34 -39.58 64.21 Favored 'General case' 0 C--N 1.334 -0.072 0 C-N-CA 124.979 1.311 . . . . 0.0 111.356 171.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -73.02 -40.42 65.17 Favored 'General case' 0 N--CA 1.442 -0.828 0 O-C-N 121.429 -0.794 . . . . 0.0 110.127 -179.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 59.7 m80 -69.88 -32.17 70.37 Favored 'General case' 0 N--CA 1.451 -0.39 0 O-C-N 120.808 -1.182 . . . . 0.0 109.955 -179.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 29.9 mt -60.68 -48.57 81.2 Favored 'General case' 0 CA--C 1.52 -0.211 0 C-N-CA 124.123 0.969 . . . . 0.0 110.092 169.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 27.5 ttpt -65.82 -45.95 80.39 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.021 0.928 . . . . 0.0 109.628 -170.065 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -62.85 -50.35 71.31 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.067 0.947 . . . . 0.0 110.254 171.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 117.24 -0.4 18.97 Favored Glycine 0 CA--C 1.526 0.749 0 C-N-CA 125.155 1.36 . . . . 0.0 113.483 -177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.401 HG22 ' H ' ' A' ' 39' ' ' THR . 2.7 t -83.74 50.9 1.9 Allowed 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.437 1.118 . . . . 0.0 108.252 -179.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 31.5 t -136.78 139.03 41.5 Favored 'General case' 0 N--CA 1.444 -0.764 0 O-C-N 121.135 -0.978 . . . . 0.0 108.448 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.37 -179.25 15.64 Favored Glycine 0 N--CA 1.44 -1.049 0 C-N-CA 125.841 1.686 . . . . 0.0 110.475 167.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.445 HD23 HG22 ' A' ' 9' ' ' VAL . 17.7 tp -119.74 147.65 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 127.011 2.124 . . . . 0.0 107.979 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.2 t -126.4 142.35 43.25 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 124.457 1.103 . . . . 0.0 108.037 166.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -64.43 128.47 35.92 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 125.219 1.408 . . . . 0.0 110.76 174.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 4.9 mt -66.95 145.64 55.22 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.245 170.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -163.27 172.7 14.33 Favored 'General case' 0 N--CA 1.444 -0.759 0 C-N-CA 127.286 2.235 . . . . 0.0 105.567 171.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -60.82 -47.33 86.86 Favored 'General case' 0 CA--C 1.531 0.233 0 O-C-N 121.836 -0.54 . . . . 0.0 110.417 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.65 20.15 29.18 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 118.05 -1.417 . . . . 0.0 115.742 -169.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 1.5 t -93.71 -52.31 9.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 CA-C-N 120.35 2.075 . . . . 0.0 105.522 173.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.521 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 10.7 mp -33.92 -59.05 0.54 Allowed Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 126.9 2.08 . . . . 0.0 113.77 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -70.06 -6.43 18.73 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 122.017 1.812 . . . . 0.0 114.208 -175.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 -107.59 -3.82 18.93 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.807 2.043 . . . . 0.0 111.699 174.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -92.06 -177.94 4.84 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 126.221 1.809 . . . . 0.0 107.35 179.791 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 48.9 mm-40 -74.69 -87.06 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.644 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 173.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.2 mm100 -168.44 -51.6 0.0 OUTLIER Pre-proline 0 N--CA 1.445 -0.719 0 CA-C-O 116.677 -1.63 . . . . 0.0 111.43 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.58 88.14 0.77 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 N-CA-C 108.035 -1.563 . . . . 0.0 108.035 172.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.521 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 6.1 m-85 -79.96 113.84 18.43 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 108.296 -1.002 . . . . 0.0 108.296 179.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.527 HG11 ' CB ' ' A' ' 31' ' ' ALA . 88.8 t -79.58 89.36 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 123.587 0.755 . . . . 0.0 109.135 179.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.598 ' CD1' HG22 ' A' ' 95' ' ' VAL . 24.1 m-85 -79.57 167.62 20.5 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-O 122.488 1.137 . . . . 0.0 113.163 178.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 36.7 pt -130.04 121.68 52.41 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.819 0 CA-C-N 113.282 -1.781 . . . . 0.0 108.161 170.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.3 OUTLIER -115.7 154.45 29.52 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 121.767 -0.583 . . . . 0.0 109.551 172.819 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.5 ptm180 -70.3 71.2 0.43 Allowed 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 125.938 1.695 . . . . 0.0 110.044 178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 38.4 -131.82 0.17 Allowed 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 128.557 2.743 . . . . 0.0 107.919 -172.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.3 t70 -132.58 162.55 30.99 Favored 'General case' 0 C--O 1.238 0.496 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 146.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 52.13 76.71 0.17 Allowed 'General case' 0 C--O 1.238 0.451 0 C-N-CA 127.045 2.138 . . . . 0.0 114.205 172.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 85.6 mt -134.84 77.99 1.72 Allowed 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.862 1.265 . . . . 0.0 111.016 -178.06 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -91.92 -43.82 9.26 Favored 'General case' 0 CA--C 1.535 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 110.496 170.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.0 m -73.7 159.87 32.37 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 119.123 0.874 . . . . 0.0 112.49 -160.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -51.99 -33.38 37.94 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 126.459 1.903 . . . . 0.0 114.544 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.2 m170 -69.94 138.32 52.24 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 -175.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 74.88 89.58 0.2 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 176.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -67.45 87.21 0.19 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.972 1.709 . . . . 0.0 111.621 -172.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 50.7 mttp 40.39 74.94 0.09 Allowed 'General case' 0 C--O 1.238 0.447 0 C-N-CA 126.442 1.897 . . . . 0.0 111.253 -168.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.4 m -69.75 155.24 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 CA-C-N 114.452 -1.249 . . . . 0.0 108.549 174.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.0 m -131.04 -178.82 2.84 Favored 'Isoleucine or valine' 0 C--O 1.237 0.408 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -132.72 167.05 20.82 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 125.618 1.567 . . . . 0.0 107.442 171.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mt -88.57 130.21 35.3 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.591 1.556 . . . . 0.0 107.139 164.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.444 HG21 ' CG ' ' A' ' 61' ' ' LYS . 4.8 t -131.39 158.53 43.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 172.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.08 128.47 20.02 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 105.088 -2.189 . . . . 0.0 105.088 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -131.53 123.69 28.52 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 107.49 -1.3 . . . . 0.0 107.49 -172.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 2.8 ppp? -74.18 -19.9 60.39 Favored 'General case' 0 CA--C 1.53 0.207 0 CA-C-O 118.327 -0.844 . . . . 0.0 112.43 -171.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 30.8 t0 -141.05 5.84 1.94 Allowed 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 125.129 1.371 . . . . 0.0 111.814 -177.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 56.23 54.67 34.08 Favored Glycine 0 CA--C 1.527 0.785 0 O-C-N 121.088 -1.008 . . . . 0.0 112.054 -168.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . 0.411 23.6 mt -48.44 65.66 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.54 0.562 0 C-N-CA 130.669 3.588 . . . . 0.0 114.149 159.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.3 mt-30 96.19 -86.11 0.0 OUTLIER 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 130.216 3.406 . . . . 0.0 108.349 163.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 14.1 m-30 23.18 -85.42 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.387 0 C-N-CA 127.045 2.138 . . . . 0.0 115.125 150.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.44 -39.16 5.56 Favored Glycine 0 CA--C 1.532 1.106 0 C-N-CA 125.293 1.425 . . . . 0.0 113.824 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.95 47.22 0.91 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 125.168 1.387 . . . . 0.0 110.437 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.6 t -134.45 153.7 51.79 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 123.546 0.738 . . . . 0.0 109.889 176.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -78.15 -7.13 87.76 Favored Glycine 0 CA--C 1.523 0.577 0 C-N-CA 123.671 0.653 . . . . 0.0 112.741 178.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 15.3 tt -70.18 -20.24 22.82 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.125 0 CA-C-N 118.677 1.239 . . . . 0.0 110.566 164.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.9 m -108.24 139.7 42.54 Favored 'General case' 0 N--CA 1.446 -0.649 0 CA-C-N 118.908 0.776 . . . . 0.0 109.221 -168.15 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.7 mt -95.63 -60.31 1.68 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 -175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -158.33 -173.18 26.4 Favored Glycine 0 CA--C 1.527 0.792 0 C-N-CA 123.773 0.702 . . . . 0.0 111.776 -169.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.598 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.8 t -114.1 130.27 68.61 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 125.79 1.636 . . . . 0.0 106.721 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mp -80.24 147.24 31.3 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 125.367 1.467 . . . . 0.0 110.061 171.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.4 m -150.94 165.15 17.99 Favored Pre-proline 0 C--N 1.323 -0.569 0 C-N-CA 126.715 2.006 . . . . 0.0 107.793 -171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -62.96 147.9 94.07 Favored 'Trans proline' 0 N--CA 1.449 -1.11 0 CA-C-N 119.864 0.987 . . . . 0.0 112.106 170.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.2 t-80 -100.1 109.05 21.34 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 158.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.271 28.1 t -115.49 57.3 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-O 123.258 1.504 . . . . 0.0 107.29 174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.65 10.62 84.78 Favored Glycine 0 CA--C 1.527 0.802 0 CA-C-O 117.657 -1.635 . . . . 0.0 115.559 160.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -75.23 -101.5 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.497 1.648 . . . . 0.0 112.294 -162.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.5 m -162.37 100.93 1.1 Allowed Pre-proline 0 N--CA 1.448 -0.529 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 -170.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -80.76 162.52 21.31 Favored 'Trans proline' 0 N--CA 1.442 -1.55 0 C-N-CA 121.404 1.403 . . . . 0.0 111.797 164.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.3 pt -124.43 -15.22 4.91 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 127.411 2.284 . . . . 0.0 111.108 -177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -158.95 -178.99 7.65 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 126.541 1.936 . . . . 0.0 107.617 171.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -136.43 134.79 38.08 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.026 2.13 . . . . 0.0 107.022 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -112.31 138.4 49.08 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.292 1.437 . . . . 0.0 109.254 -176.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -107.23 146.27 31.62 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.909 2.084 . . . . 0.0 110.145 174.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -152.43 171.94 0.93 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 125.735 1.614 . . . . 0.0 108.123 177.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -108.06 161.62 14.79 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 159.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 ' HB3' HG23 ' A' ' 3' ' ' VAL . 0.2 OUTLIER -115.78 129.85 56.61 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 127.775 2.43 . . . . 0.0 106.962 172.294 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.3 ttt-85 -76.77 68.05 2.94 Favored 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 126.131 1.773 . . . . 0.0 110.877 176.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.0 mtpt 28.53 95.02 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 130.893 3.677 . . . . 0.0 113.06 172.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -110.7 -0.96 16.92 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 114.411 1.263 . . . . 0.0 114.411 -163.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.123 0 N-CA-C 108.524 -1.831 . . . . 0.0 108.524 -174.163 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.609 0 N-CA-C 109.377 -1.489 . . . . 0.0 109.377 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.9 m80 -141.13 164.95 28.88 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 126.541 1.936 . . . . 0.0 107.123 177.582 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.04 128.47 75.8 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 125.409 1.484 . . . . 0.0 108.479 -173.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -76.6 131.65 39.02 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.917 0.781 . . . . 0.0 109.742 -177.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 74.7 mt -126.47 155.38 42.36 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.806 0.842 . . . . 0.0 109.549 173.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 3.5 m -133.77 163.77 28.73 Favored 'General case' 0 N--CA 1.435 -1.212 0 C-N-CA 123.298 0.639 . . . . 0.0 109.594 171.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 78.8 mt -142.24 151.54 58.7 Favored Pre-proline 0 N--CA 1.449 -0.484 0 C-N-CA 125.166 1.386 . . . . 0.0 108.746 -179.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HB2' ' HB3' ' A' ' 104' ' ' PRO . 96.4 Cg_endo -67.47 162.6 38.23 Favored 'Trans proline' 0 N--CA 1.448 -1.161 0 C-N-CA 121.861 1.707 . . . . 0.0 109.508 157.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.3 t -117.32 127.11 74.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 105.004 -2.221 . . . . 0.0 105.004 169.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 14.7 mt -121.62 151.25 40.61 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 125.969 1.708 . . . . 0.0 106.73 -170.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -76.26 131.35 39.21 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.4 p -52.39 -32.84 16.77 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 C-N-CA 124.804 1.242 . . . . 0.0 110.31 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.3 ptm180 -70.08 -36.51 74.98 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 122.926 0.49 . . . . 0.0 111.45 -175.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.72 -29.0 25.91 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 123.981 0.913 . . . . 0.0 110.375 -172.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 18.0 t -72.82 62.45 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 126.512 1.925 . . . . 0.0 110.077 176.3 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 13.4 mt -41.01 -32.75 0.26 Allowed 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 127.64 2.376 . . . . 0.0 114.883 -173.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 4.0 p -123.37 116.28 47.96 Favored 'Isoleucine or valine' 0 N--CA 1.461 0.104 0 CA-C-N 119.703 1.138 . . . . 0.0 109.18 163.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.549 ' HB3' HD13 ' A' ' 53' ' ' LEU . 1.3 mpt_? -100.35 1.45 41.52 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.848 1.659 . . . . 0.0 112.226 177.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -110.3 99.84 1.22 Allowed Glycine 0 N--CA 1.445 -0.711 0 N-CA-C 107.291 -2.324 . . . . 0.0 107.291 -169.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -53.99 -24.19 15.96 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.793 0.664 . . . . 0.0 112.793 171.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -165.73 -172.69 33.42 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -105.29 -6.17 19.91 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.903 1.281 . . . . 0.0 111.132 -176.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 68.1 m -128.88 155.66 44.91 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 125.221 1.408 . . . . 0.0 110.66 175.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 59.6 t -53.55 -55.08 14.88 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.339 0 C-N-CA 125.901 1.68 . . . . 0.0 109.939 178.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.62 -37.65 88.29 Favored 'General case' 0 N--CA 1.446 -0.639 0 O-C-N 123.871 0.732 . . . . 0.0 111.143 -171.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.05 -57.53 12.41 Favored 'General case' 0 CA--C 1.518 -0.288 0 C-N-CA 124.602 1.161 . . . . 0.0 108.852 177.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.73 -46.25 89.69 Favored 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.102 -0.954 . . . . 0.0 110.24 -174.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -54.83 -45.22 74.43 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 174.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.91 -51.93 62.22 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -59.96 -39.08 84.38 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.091 0.957 . . . . 0.0 110.508 -177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.38 -53.84 53.55 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 124.368 1.067 . . . . 0.0 109.641 175.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -51.64 -40.92 60.84 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-N 119.226 0.921 . . . . 0.0 111.116 172.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -64.84 -56.17 15.06 Favored 'General case' 0 N--CA 1.442 -0.866 0 C-N-CA 123.185 0.594 . . . . 0.0 111.648 -179.67 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 8.6 m80 -69.95 -26.75 64.27 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 123.714 0.806 . . . . 0.0 109.811 -173.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 67.3 mt -64.36 -36.43 84.12 Favored 'General case' 0 CA--C 1.528 0.103 0 CA-C-N 119.134 0.879 . . . . 0.0 111.001 170.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.26 -41.59 73.27 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.354 0.662 . . . . 0.0 110.066 174.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 4.3 m-80 -61.11 -44.24 97.66 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 123.644 0.778 . . . . 0.0 110.909 175.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.83 17.57 27.65 Favored Glycine 0 CA--C 1.535 1.317 0 C-N-CA 126.49 1.995 . . . . 0.0 112.903 -170.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 40.1 p -108.41 39.92 1.88 Allowed 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.942 1.697 . . . . 0.0 110.234 -174.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 52.4 t -118.74 153.32 34.6 Favored 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 173.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.42 -178.5 15.56 Favored Glycine 0 N--CA 1.442 -0.943 0 N-CA-C 109.14 -1.584 . . . . 0.0 109.14 164.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.9 tp -114.37 144.02 43.97 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 125.865 1.666 . . . . 0.0 108.211 -178.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 8.4 t -123.64 126.24 72.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 104.904 -2.258 . . . . 0.0 104.904 166.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 6.6 mp0 -64.45 153.02 40.05 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 121.559 -0.713 . . . . 0.0 109.577 177.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 7.6 mt -79.21 95.34 5.61 Favored 'General case' 0 CA--C 1.516 -0.343 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 170.187 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.431 ' HB2' HG23 ' A' ' 49' ' ' VAL . 20.2 mt-10 -79.77 173.07 12.96 Favored 'General case' 0 C--N 1.331 -0.23 0 C-N-CA 119.933 -0.707 . . . . 0.0 109.891 162.312 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -55.98 -44.13 78.27 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.816 0.846 . . . . 0.0 111.107 166.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -111.79 37.63 3.61 Favored Glycine 0 CA--C 1.523 0.581 0 C-N-CA 124.684 1.135 . . . . 0.0 113.002 -173.272 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.431 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.9 t -89.37 -47.74 14.88 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.293 0 CA-C-N 119.313 1.557 . . . . 0.0 110.459 173.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -50.97 -44.68 87.1 Favored Pre-proline 0 CA--C 1.545 0.752 0 CA-C-O 116.919 -1.515 . . . . 0.0 112.769 -176.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -79.49 -2.93 12.63 Favored 'Trans proline' 0 CA--C 1.543 0.932 0 C-N-CA 122.091 1.86 . . . . 0.0 112.942 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -102.34 -10.4 19.51 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.366 1.866 . . . . 0.0 111.014 173.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.549 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -89.63 172.05 9.23 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 126.535 1.934 . . . . 0.0 108.319 174.918 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 71.6 mm-40 -71.92 -90.0 0.02 OUTLIER 'General case' 0 C--N 1.339 0.115 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 177.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.471 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 2.2 tp60 -155.81 -57.4 0.02 OUTLIER Pre-proline 0 N--CA 1.437 -1.087 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.35 177.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.471 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 90.1 Cg_endo -78.32 90.55 1.26 Allowed 'Trans proline' 0 N--CA 1.442 -1.523 0 CA-C-N 122.07 1.775 . . . . 0.0 107.552 -178.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -78.44 104.83 9.3 Favored 'General case' 0 N--CA 1.439 -0.979 0 C-N-CA 126.83 2.052 . . . . 0.0 106.436 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.0 t -77.58 99.05 2.35 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.093 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -81.82 165.01 21.25 Favored 'General case' 0 N--CA 1.446 -0.652 0 C-N-CA 124.577 1.151 . . . . 0.0 112.411 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.4 pt -125.39 129.79 72.93 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.776 0 CA-C-N 112.772 -2.013 . . . . 0.0 107.782 170.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.482 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 6.5 pttt -132.6 158.93 40.98 Favored 'General case' 0 N--CA 1.469 0.476 0 C-N-CA 124.894 1.278 . . . . 0.0 108.471 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 38.6 mtt180 -67.08 18.11 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 -166.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 7.2 t 66.81 153.64 0.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 127.493 2.317 . . . . 0.0 109.494 -164.473 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -82.77 -0.06 46.03 Favored 'General case' 0 C--N 1.329 -0.309 0 O-C-N 121.395 -0.816 . . . . 0.0 111.865 -169.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -125.21 7.39 7.84 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.646 1.178 . . . . 0.0 112.592 173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 24.33 93.19 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 128.953 2.901 . . . . 0.0 116.462 161.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.8 m 48.1 52.06 13.74 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 124.723 1.209 . . . . 0.0 111.924 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 3.7 m -45.04 -58.73 3.0 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 125.716 1.606 . . . . 0.0 110.334 -175.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -120.76 49.93 1.4 Allowed 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.513 1.125 . . . . 0.0 108.647 171.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.0 m-70 45.01 72.13 0.22 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 126.547 1.939 . . . . 0.0 114.346 177.452 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -124.23 72.65 0.42 Allowed Glycine 0 CA--C 1.524 0.622 0 C-N-CA 124.796 1.189 . . . . 0.0 110.629 171.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.4 m80 58.4 170.95 0.06 Allowed 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 128.239 2.615 . . . . 0.0 115.245 174.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.55 83.76 0.42 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.506 1.122 . . . . 0.0 109.05 167.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.8 t -67.64 144.74 14.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 160.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -129.4 171.33 17.26 Favored 'Isoleucine or valine' 0 C--O 1.238 0.461 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 159.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -137.43 161.74 35.52 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 124.286 1.034 . . . . 0.0 108.785 -172.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 93.4 mt -102.26 126.87 49.38 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.02 1.328 . . . . 0.0 108.787 -175.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.432 HG21 ' HG2' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -146.71 140.97 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 104.298 -2.482 . . . . 0.0 104.298 -173.827 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -120.64 157.76 28.86 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-N 119.492 1.042 . . . . 0.0 109.321 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.7 mm-40 -155.92 141.44 17.75 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 -175.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 9.1 ptm -113.56 20.71 15.77 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.074 1.35 . . . . 0.0 112.301 -169.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t0 -166.84 -37.98 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 127.432 2.293 . . . . 0.0 105.268 -175.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 96.68 31.41 7.08 Favored Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -178.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 28.8 mt -39.81 -53.4 0.5 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.636 2.375 . . . . 0.0 110.246 178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 52.0 mm-40 -124.89 164.17 20.65 Favored 'General case' 0 N--CA 1.439 -0.995 0 C-N-CA 124.785 1.234 . . . . 0.0 107.937 175.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.482 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 11.5 m-85 68.51 -44.31 0.51 Allowed 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 127.667 2.387 . . . . 0.0 112.847 175.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.22 130.06 8.52 Favored Glycine 0 CA--C 1.525 0.688 0 C-N-CA 125.771 1.653 . . . . 0.0 111.119 179.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.7 ttm180 57.32 2.9 0.14 Allowed 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 125.73 1.612 . . . . 0.0 115.157 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.1 t -73.82 154.19 39.61 Favored 'General case' 0 N--CA 1.456 -0.172 0 O-C-N 120.005 -1.684 . . . . 0.0 109.853 176.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -71.15 -20.69 78.18 Favored Glycine 0 CA--C 1.53 0.976 0 O-C-N 121.742 -0.599 . . . . 0.0 113.094 -177.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 16.6 tt -63.3 -23.94 34.61 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 CA-C-N 118.402 1.101 . . . . 0.0 111.075 168.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.6 m -101.38 132.83 46.76 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 -166.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.57 -33.89 10.13 Favored 'General case' 0 C--N 1.332 -0.183 0 O-C-N 121.71 -0.619 . . . . 0.0 110.269 -167.352 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.19 -169.7 38.69 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 177.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 2.3 t -111.55 145.0 18.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 126.371 1.869 . . . . 0.0 106.73 169.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.6 154.65 28.58 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 123.658 0.783 . . . . 0.0 109.211 167.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 22.2 m -146.88 152.87 45.17 Favored Pre-proline 0 CA--C 1.539 0.539 0 C-N-CA 124.626 1.17 . . . . 0.0 109.974 175.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -69.95 107.85 1.99 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.156 2.571 . . . . 0.0 113.126 171.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -69.37 122.41 18.87 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 125.644 1.578 . . . . 0.0 108.552 173.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.53 38.1 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.57 1.548 . . . . 0.0 110.881 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 89.8 14.32 59.69 Favored Glycine 0 CA--C 1.525 0.711 0 O-C-N 120.205 -1.559 . . . . 0.0 115.019 170.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -66.36 0.51 2.08 Favored 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 128.302 2.641 . . . . 0.0 115.365 -167.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 18.8 m 71.97 103.08 0.03 OUTLIER Pre-proline 0 C--N 1.324 -0.535 0 C-N-CA 131.02 3.728 . . . . 0.0 110.01 178.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 8' ' ' PRO . 72.2 Cg_endo -71.1 168.37 23.46 Favored 'Trans proline' 0 N--CA 1.447 -1.223 0 C-N-CA 121.507 1.471 . . . . 0.0 111.943 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.65 -21.56 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.5 0 CA-C-N 113.827 -1.533 . . . . 0.0 110.565 178.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.23 -177.95 6.96 Favored 'General case' 0 C--O 1.231 0.12 0 C-N-CA 125.367 1.467 . . . . 0.0 109.317 177.2 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.7 m-85 -129.08 156.5 43.76 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.339 1.456 . . . . 0.0 108.244 168.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -131.65 142.05 49.76 Favored 'General case' 0 C--N 1.332 -0.169 0 C-N-CA 126.865 2.066 . . . . 0.0 107.248 178.192 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -131.54 138.9 49.1 Favored 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.143 0.977 . . . . 0.0 109.068 -176.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.4 m -146.31 178.29 1.2 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 C-N-CA 126.766 2.026 . . . . 0.0 108.989 -174.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.6 157.44 17.68 Favored 'General case' 0 C--O 1.236 0.377 0 N-CA-C 108.205 -1.035 . . . . 0.0 108.205 163.232 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.89 141.12 48.52 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 126.495 1.918 . . . . 0.0 108.235 170.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -77.57 42.08 0.35 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 126.625 1.97 . . . . 0.0 113.014 -179.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 52.2 -160.6 0.1 Allowed 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 125.121 1.368 . . . . 0.0 110.498 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 -120.73 -90.73 0.57 Allowed 'General case' 0 CA--C 1.517 -0.321 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 170.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.244 0.778 0 N-CA-C 107.105 -2.398 . . . . 0.0 107.105 142.237 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.461 0.359 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -66.54 169.24 7.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.706 0.802 . . . . 0.0 110.721 172.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.7 t -82.66 161.52 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 C-N-CA 125.556 1.542 . . . . 0.0 106.898 168.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.9 tt0 -115.45 134.06 55.44 Favored 'General case' 0 N--CA 1.442 -0.863 0 C-N-CA 125.977 1.711 . . . . 0.0 109.552 177.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -140.46 159.32 42.46 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 123.107 0.563 . . . . 0.0 110.036 177.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.5 m -138.69 159.27 42.52 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 125.314 1.446 . . . . 0.0 109.464 178.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 98.7 mt -148.94 158.19 39.42 Favored Pre-proline 0 N--CA 1.464 0.245 0 C-N-CA 125.075 1.35 . . . . 0.0 108.546 -173.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -69.94 172.88 12.0 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.771 2.314 . . . . 0.0 109.647 166.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 18.2 t -123.63 142.46 40.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.484 0 C-N-CA 126.838 2.055 . . . . 0.0 105.522 172.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.6 mt -136.59 120.88 17.97 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 103.008 -2.96 . . . . 0.0 103.008 -170.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.517 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.4 mt-30 -61.02 149.35 37.13 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.957 -1.127 . . . . 0.0 107.957 -177.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 HD21 ' A' ' 53' ' ' LEU . 11.6 p -54.9 -27.55 18.98 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 C-N-CA 124.025 0.93 . . . . 0.0 110.089 -177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 8.9 ptm180 -67.95 -38.18 82.51 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 122.994 0.518 . . . . 0.0 111.821 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -92.79 -22.21 19.47 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.621 1.968 . . . . 0.0 110.032 -170.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 11' ' ' GLN 0.324 0.4 OUTLIER -62.76 65.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.509 0 C-N-CA 126.578 1.951 . . . . 0.0 112.542 161.221 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 76.6 mt -35.9 -43.61 0.32 Allowed 'General case' 0 CA--C 1.539 0.547 0 O-C-N 120.674 -1.266 . . . . 0.0 112.777 167.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 24.9 t -125.47 108.96 20.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.359 0 CA-C-N 119.682 1.128 . . . . 0.0 110.257 -177.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.81 22.04 15.82 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 124.392 1.077 . . . . 0.0 111.892 -172.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -131.21 112.84 1.27 Allowed Glycine 0 N--CA 1.44 -1.077 0 N-CA-C 104.222 -3.551 . . . . 0.0 104.222 174.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -58.46 -36.63 73.98 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 119.203 -0.427 . . . . 0.0 111.023 162.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -157.38 179.12 33.37 Favored Glycine 0 C--N 1.335 0.506 0 C-N-CA 126.305 1.907 . . . . 0.0 109.644 -178.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -91.94 -26.29 18.49 Favored 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 114.081 1.141 . . . . 0.0 114.081 -169.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.1 m -114.93 166.37 11.85 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 124.75 1.22 . . . . 0.0 110.974 176.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 3.1 t -60.01 -51.13 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.522 0 CA-C-O 118.037 -0.982 . . . . 0.0 109.018 -177.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -65.26 -35.28 80.54 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 119.349 -0.941 . . . . 0.0 111.551 -175.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 78.0 mm-40 -58.88 -62.41 1.9 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.904 1.281 . . . . 0.0 109.027 177.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.69 -41.88 96.04 Favored 'General case' 0 N--CA 1.444 -0.735 0 CA-C-O 118.45 -0.785 . . . . 0.0 109.929 -174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.21 -37.41 77.42 Favored 'General case' 0 CA--C 1.54 0.578 0 CA-C-N 119.442 1.019 . . . . 0.0 112.174 175.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.5 t -70.49 -54.82 10.73 Favored 'General case' 0 CA--C 1.52 -0.207 0 CA-C-O 121.841 0.829 . . . . 0.0 109.401 -178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.7 mm-40 -55.25 -43.92 75.09 Favored 'General case' 0 N--CA 1.44 -0.925 0 C-N-CA 125.474 1.51 . . . . 0.0 109.573 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -56.69 -49.64 74.52 Favored 'General case' 0 N--CA 1.438 -1.051 0 C-N-CA 124.88 1.272 . . . . 0.0 110.625 178.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.1 ttt180 -54.55 -42.64 71.17 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.865 0.866 . . . . 0.0 110.79 173.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -68.67 -44.06 74.86 Favored 'General case' 0 N--CA 1.44 -0.944 0 CA-C-N 118.182 0.446 . . . . 0.0 111.767 178.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 31.3 m80 -70.65 -30.59 67.25 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.29 -0.881 . . . . 0.0 109.416 -174.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 45.1 mt -60.71 -48.59 81.12 Favored 'General case' 0 CA--C 1.52 -0.176 0 C-N-CA 124.487 1.115 . . . . 0.0 111.038 167.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.3 tppp? -65.21 -47.59 76.35 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 44.1 m-80 -64.2 -38.28 90.48 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.018 1.327 . . . . 0.0 111.528 -178.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 111.18 -3.48 28.37 Favored Glycine 0 CA--C 1.534 1.225 0 C-N-CA 125.463 1.506 . . . . 0.0 112.98 -178.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.8 t -95.83 49.24 1.15 Allowed 'General case' 0 CA--C 1.519 -0.243 0 C-N-CA 125.908 1.683 . . . . 0.0 108.864 -174.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 35.8 t -125.96 147.97 49.37 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 107.741 -1.207 . . . . 0.0 107.741 171.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -132.79 -178.5 15.58 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 126.457 1.98 . . . . 0.0 108.674 165.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.44 ' HG ' ' H ' ' A' ' 43' ' ' VAL . 14.4 tp -114.99 179.83 3.84 Favored 'General case' 0 C--N 1.324 -0.516 0 C-N-CA 126.3 1.84 . . . . 0.0 108.927 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.515 ' CG1' ' HB ' ' A' ' 95' ' ' VAL . 9.6 p -150.13 153.4 10.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 C-N-CA 127.674 2.39 . . . . 0.0 106.259 167.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 22.2 mt-10 -94.61 132.47 39.28 Favored 'General case' 0 C--O 1.236 0.368 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 177.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.9 mt -73.71 105.26 4.94 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 125.786 1.634 . . . . 0.0 111.798 -178.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.509 ' H ' ' CG2' ' A' ' 49' ' ' VAL . 2.7 mm-40 -99.45 176.57 5.46 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 125.93 1.692 . . . . 0.0 109.636 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.3 ttmt -58.32 -53.27 60.17 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.582 -0.699 . . . . 0.0 109.339 173.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.28 67.13 3.55 Favored Glycine 0 CA--C 1.52 0.397 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 172.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.509 ' CG2' ' H ' ' A' ' 46' ' ' GLU . 63.4 t -120.45 -63.51 1.78 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.393 0 CA-C-N 118.414 1.107 . . . . 0.0 110.649 161.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -50.16 -51.18 64.88 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 124.895 1.278 . . . . 0.0 110.169 -176.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.86 15.97 1.21 Allowed 'Trans proline' 0 CA--C 1.547 1.17 0 C-N-CA 122.13 1.887 . . . . 0.0 113.109 -179.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.8 4.11 10.01 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.663 1.985 . . . . 0.0 111.043 167.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD21 HG23 ' A' ' 12' ' ' VAL . 0.2 OUTLIER -100.59 -177.69 3.56 Favored 'General case' 0 CA--C 1.535 0.399 0 O-C-N 120.554 -1.341 . . . . 0.0 108.844 -177.499 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -71.42 -89.74 0.02 OUTLIER 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 108.612 175.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.0 -65.19 0.01 OUTLIER Pre-proline 0 N--CA 1.447 -0.607 0 CA-C-O 116.936 -1.507 . . . . 0.0 107.593 -174.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -72.77 90.29 0.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 CA-C-N 122.365 1.88 . . . . 0.0 109.734 179.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -79.36 102.04 8.45 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 125.661 1.585 . . . . 0.0 107.86 -179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 18.7 t -77.1 87.95 0.9 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.495 ' CD1' HG22 ' A' ' 95' ' ' VAL . 28.2 m-85 -82.97 171.42 13.85 Favored 'General case' 0 CA--C 1.509 -0.605 0 O-C-N 120.661 -1.275 . . . . 0.0 113.298 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 15.3 pt -127.7 126.4 66.91 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-N 112.632 -2.076 . . . . 0.0 107.92 166.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 4.1 pttt -128.3 152.71 47.81 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 122.772 0.429 . . . . 0.0 110.82 174.126 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.475 ' HA ' ' HA ' ' A' ' 75' ' ' VAL . 7.1 ptm180 -78.08 55.61 1.5 Allowed 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -166.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 11.8 t 56.67 -95.94 0.06 Allowed 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 126.753 2.021 . . . . 0.0 108.553 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 50.62 42.85 27.52 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 126.855 2.062 . . . . 0.0 110.518 -179.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -158.26 6.38 0.12 Allowed 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 126.552 1.941 . . . . 0.0 111.545 -169.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.8 mt -131.29 174.88 9.61 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 120.499 -1.376 . . . . 0.0 109.877 -178.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 12.7 p -73.66 103.52 4.27 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.134 1.374 . . . . 0.0 111.207 -176.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.281 6.3 t 36.47 88.84 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 129.756 3.222 . . . . 0.0 113.23 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -64.34 -45.35 88.22 Favored 'General case' 0 C--O 1.234 0.251 0 O-C-N 121.272 -0.893 . . . . 0.0 111.592 -170.263 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.5 t-160 25.18 89.07 0.01 OUTLIER 'General case' 0 C--O 1.244 0.801 0 C-N-CA 129.819 3.247 . . . . 0.0 114.395 177.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.47 -150.82 8.43 Favored Glycine 0 N--CA 1.447 -0.601 0 CA-C-O 121.592 0.551 . . . . 0.0 112.511 172.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -57.48 174.14 0.23 Allowed 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 125.028 1.331 . . . . 0.0 111.085 173.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -68.05 94.13 0.47 Allowed 'General case' 0 C--O 1.235 0.34 0 O-C-N 121.039 -1.038 . . . . 0.0 109.909 172.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 49.1 t -85.7 152.79 3.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 125.709 1.604 . . . . 0.0 107.35 168.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 25.2 m -144.34 -178.74 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.261 0 C-N-CA 126.24 1.816 . . . . 0.0 108.286 161.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -130.35 175.99 8.5 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 119.388 0.994 . . . . 0.0 110.056 174.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 4.6 mt -80.32 136.66 36.45 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.403 HG21 ' CG ' ' A' ' 61' ' ' LYS . 2.8 t -140.44 160.8 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 N-CA-C 105.611 -1.996 . . . . 0.0 105.611 170.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -143.63 157.85 44.1 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 164.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -158.0 125.88 5.29 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 106.587 -1.634 . . . . 0.0 106.587 -171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.1 ptp -75.04 -25.5 58.74 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.731 1.15 . . . . 0.0 113.739 -176.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -128.49 3.53 5.61 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.277 1.037 . . . . 0.0 110.806 -176.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 51.57 49.0 47.98 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 125.288 1.423 . . . . 0.0 110.725 -168.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 33.6 mt -47.07 -49.62 7.35 Favored 'Isoleucine or valine' 0 C--O 1.237 0.401 0 C-N-CA 124.862 1.265 . . . . 0.0 108.753 173.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 17.1 mt-30 -121.07 172.62 7.82 Favored 'General case' 0 N--CA 1.436 -1.162 0 N-CA-C 107.236 -1.394 . . . . 0.0 107.236 171.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 0.9 OUTLIER 73.1 -42.79 0.54 Allowed 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 127.934 2.494 . . . . 0.0 111.803 169.224 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -45.15 129.47 8.29 Favored Glycine 0 CA--C 1.524 0.595 0 N-CA-C 109.511 -1.436 . . . . 0.0 109.511 168.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.2 ttt-85 58.54 5.72 0.49 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.002 1.721 . . . . 0.0 115.381 178.425 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 9.8 t -80.54 149.91 29.8 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 120.053 1.297 . . . . 0.0 109.608 176.424 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.7 -10.44 84.83 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 123.544 0.593 . . . . 0.0 113.282 175.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 10.8 tt -65.63 -22.34 30.65 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 CA-C-N 118.615 1.207 . . . . 0.0 110.277 165.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m -102.49 141.61 35.02 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -167.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.427 HD12 HG11 ' A' ' 75' ' ' VAL . 43.0 mt -110.79 -23.3 11.11 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.675 -173.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -176.05 47.63 Favored Glycine 0 N--CA 1.463 0.441 0 N-CA-C 111.017 -0.833 . . . . 0.0 111.017 173.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.515 ' HB ' ' CG1' ' A' ' 43' ' ' VAL . 47.1 t -102.69 142.99 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.469 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 166.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 72.1 mt -90.26 134.76 34.09 Favored 'General case' 0 N--CA 1.439 -1.021 0 C-N-CA 125.499 1.52 . . . . 0.0 107.852 172.129 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.81 157.85 68.9 Favored Pre-proline 0 C--N 1.32 -0.682 0 C-N-CA 125.405 1.482 . . . . 0.0 108.681 -171.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -71.31 124.57 10.54 Favored 'Trans proline' 0 N--CA 1.456 -0.699 0 C-N-CA 121.978 1.786 . . . . 0.0 110.779 177.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.2 t-80 -91.22 102.45 15.18 Favored 'General case' 0 C--N 1.339 0.148 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 173.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 31.5 m -105.88 39.15 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 CA-C-O 120.969 0.414 . . . . 0.0 110.473 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.78 11.39 79.52 Favored Glycine 0 CA--C 1.533 1.163 0 CA-C-O 117.439 -1.756 . . . . 0.0 114.387 175.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.3 tp10 -65.57 -101.35 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.221 2.608 . . . . 0.0 112.298 -164.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 49.0 m -165.12 105.68 0.79 Allowed Pre-proline 0 N--CA 1.473 0.699 0 CA-C-N 122.355 2.343 . . . . 0.0 108.738 -177.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -91.76 158.06 3.45 Favored 'Trans proline' 0 N--CA 1.452 -0.944 0 C-N-CA 122.533 2.155 . . . . 0.0 113.064 178.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -108.64 -18.36 7.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 114.402 -1.272 . . . . 0.0 111.852 176.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -164.63 178.94 6.95 Favored 'General case' 0 CA--C 1.521 -0.135 0 C-N-CA 124.06 0.944 . . . . 0.0 109.505 -174.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -126.25 156.04 40.92 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.192 1.397 . . . . 0.0 108.796 167.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 26.5 mmt-85 -137.53 135.94 37.19 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 127.323 2.249 . . . . 0.0 106.636 179.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 12.5 p30 -120.74 153.83 36.45 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.019 1.328 . . . . 0.0 110.561 -178.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.0 m -147.27 178.85 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 C-N-CA 126.421 1.888 . . . . 0.0 108.363 -171.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -110.62 164.41 12.76 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 155.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -132.84 120.23 21.28 Favored 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 127.648 2.379 . . . . 0.0 107.677 -178.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 2.2 mtp85 -48.27 129.57 15.56 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 126.626 1.97 . . . . 0.0 110.863 -178.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 6.6 ptpt -133.1 151.0 52.03 Favored 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 106.726 -1.583 . . . . 0.0 106.726 162.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 34.9 m120 -76.83 -34.88 57.86 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 108.461 -0.94 . . . . 0.0 108.461 165.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 N-CA-C 107.165 -2.374 . . . . 0.0 107.165 -163.029 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.794 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 49.2 m80 59.82 174.07 0.08 Allowed 'General case' 0 CA--C 1.554 1.134 0 C-N-CA 125.016 1.326 . . . . 0.0 110.544 -171.296 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 p -124.53 136.09 61.72 Favored 'Isoleucine or valine' 0 CA--C 1.495 -1.144 0 O-C-N 119.659 -1.9 . . . . 0.0 109.848 175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -78.1 136.17 37.84 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 179.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 66.2 mt -135.78 153.99 51.36 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 170.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.7 t -135.29 150.65 50.06 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 170.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.8 mt -139.95 143.98 36.53 Favored Pre-proline 0 C--O 1.235 0.291 0 C-N-CA 124.644 1.178 . . . . 0.0 108.152 -172.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -65.53 131.32 27.51 Favored 'Trans proline' 0 N--CA 1.451 -1.017 0 C-N-CA 122.455 2.103 . . . . 0.0 108.779 174.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.4 t -79.78 117.48 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 N-CA-C 104.481 -2.414 . . . . 0.0 104.481 164.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 16.0 mt -113.79 153.86 28.38 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 106.385 -1.709 . . . . 0.0 106.385 -178.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 -79.83 148.85 31.22 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-N 119.25 0.932 . . . . 0.0 110.249 175.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 14.8 p -59.8 -26.56 35.69 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 O-C-N 120.957 -1.089 . . . . 0.0 109.958 177.44 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 -40.9 67.89 Favored 'General case' 0 C--N 1.344 0.361 0 O-C-N 121.623 -0.673 . . . . 0.0 111.97 174.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -73.15 -38.7 66.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 122.743 1.259 . . . . 0.0 109.154 -171.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 5.1 t -66.25 64.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.443 -0.808 0 C-N-CA 128.366 2.666 . . . . 0.0 110.527 170.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 79.1 mt -34.83 -51.39 0.5 Allowed 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 125.146 1.378 . . . . 0.0 112.075 170.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 88.3 t -108.94 113.79 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 119.717 1.144 . . . . 0.0 110.404 178.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.58 ' HB3' HD13 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -106.53 15.92 25.27 Favored 'General case' 0 C--O 1.236 0.392 0 N-CA-C 113.89 1.071 . . . . 0.0 113.89 -179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.04 134.34 11.56 Favored Glycine 0 N--CA 1.449 -0.459 0 N-CA-C 108.5 -1.84 . . . . 0.0 108.5 178.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 66.2 m-85 -82.97 -18.83 38.53 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-O 118.899 -0.572 . . . . 0.0 109.988 161.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 177.68 -176.12 47.88 Favored Glycine 0 C--N 1.336 0.542 0 C-N-CA 124.977 1.275 . . . . 0.0 110.009 -173.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -105.66 -18.01 14.21 Favored 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -170.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 14.9 m -111.81 161.91 15.83 Favored 'General case' 0 N--CA 1.467 0.416 0 O-C-N 121.13 -0.981 . . . . 0.0 110.681 174.287 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -58.38 -58.6 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.443 0 C-N-CA 123.474 0.71 . . . . 0.0 110.43 -178.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -65.02 -35.98 82.92 Favored 'General case' 0 N--CA 1.442 -0.865 0 CA-C-O 117.51 -1.233 . . . . 0.0 110.941 -173.537 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 75.7 mm-40 -54.74 -60.33 3.51 Favored 'General case' 0 N--CA 1.461 0.124 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 177.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.82 -40.25 94.6 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.446 -174.072 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.21 -45.46 93.1 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 118.25 0.477 . . . . 0.0 111.745 177.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 4.0 m -63.44 -50.88 68.01 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-N 118.525 0.602 . . . . 0.0 110.618 179.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -59.73 -38.25 81.2 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 123.874 0.87 . . . . 0.0 109.955 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.74 -51.11 71.15 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.224 1.01 . . . . 0.0 110.198 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.529 ' HG3' HD13 ' A' ' 77' ' ' LEU . 0.1 OUTLIER -56.06 -32.82 64.42 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 123.546 0.738 . . . . 0.0 110.578 173.918 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -72.43 -49.2 35.25 Favored 'General case' 0 N--CA 1.447 -0.614 0 C-N-CA 123.983 0.913 . . . . 0.0 112.303 176.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m80 -66.72 -30.46 70.7 Favored 'General case' 0 CA--C 1.531 0.245 0 O-C-N 120.593 -1.317 . . . . 0.0 108.592 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.651 ' CD1' HD11 ' A' ' 77' ' ' LEU . 76.8 mt -69.46 -26.27 64.5 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.19 -0.944 . . . . 0.0 112.537 173.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -70.22 -49.21 52.48 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 119.381 0.992 . . . . 0.0 109.056 170.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.4 m-80 -63.02 -48.19 79.85 Favored 'General case' 0 CA--C 1.516 -0.346 0 C-N-CA 123.993 0.917 . . . . 0.0 111.533 -175.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 120.54 -8.43 11.03 Favored Glycine 0 CA--C 1.533 1.212 0 C-N-CA 126.06 1.79 . . . . 0.0 112.947 -172.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 5.3 p -83.96 39.85 0.72 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 129.119 2.967 . . . . 0.0 111.271 -169.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 39.0 t -134.95 139.19 44.72 Favored 'General case' 0 N--CA 1.45 -0.461 0 O-C-N 120.527 -1.358 . . . . 0.0 108.326 -176.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -130.33 -176.99 14.64 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 126.483 1.992 . . . . 0.0 109.693 174.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 4.8 tp -126.43 146.61 50.01 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 126.293 1.837 . . . . 0.0 109.302 -172.266 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 47.3 t -118.46 127.52 75.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 C-N-CA 126.227 1.811 . . . . 0.0 108.146 168.547 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 75.5 mt-10 -65.24 126.21 27.45 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 170.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.9 mt -71.82 130.08 40.19 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 178.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -143.36 167.41 22.25 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 172.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 18.6 ttmm -65.4 -16.5 63.68 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 -175.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -94.76 8.22 70.87 Favored Glycine 0 CA--C 1.524 0.598 0 CA-C-O 117.8 -1.556 . . . . 0.0 113.983 177.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 69.8 t -89.45 -52.28 11.02 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-N 120.146 1.973 . . . . 0.0 111.416 -172.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -42.87 -52.6 11.12 Favored Pre-proline 0 CA--C 1.544 0.732 0 CA-C-O 117.034 -1.46 . . . . 0.0 112.744 177.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -83.3 42.19 1.22 Allowed 'Trans proline' 0 CA--C 1.542 0.888 0 CA-C-N 122.057 1.77 . . . . 0.0 112.15 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -149.11 -24.94 0.3 Allowed 'General case' 0 C--N 1.33 -0.275 0 C-N-CA 127.423 2.289 . . . . 0.0 110.202 175.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.58 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.36 173.19 12.83 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -179.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -71.36 -81.13 0.05 Allowed 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 -176.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -171.01 -59.44 0.0 OUTLIER Pre-proline 0 N--CA 1.44 -0.936 0 CA-C-O 116.695 -1.621 . . . . 0.0 109.758 179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.19 91.88 0.83 Allowed 'Trans proline' 0 N--CA 1.449 -1.138 0 CA-C-N 123.05 2.125 . . . . 0.0 108.654 174.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.3 m-85 -78.81 103.46 8.77 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 126.158 1.783 . . . . 0.0 106.302 -178.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 31.3 t -75.71 101.96 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.126 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 176.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.649 ' CD1' HG22 ' A' ' 95' ' ' VAL . 31.0 m-85 -92.09 168.78 11.14 Favored 'General case' 0 N--CA 1.441 -0.885 0 CA-C-O 122.837 1.303 . . . . 0.0 111.738 -179.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 42.5 pt -125.35 130.1 72.92 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.91 0 CA-C-N 112.918 -1.946 . . . . 0.0 108.225 170.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.649 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 0.6 OUTLIER -119.99 150.33 40.71 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 118.499 0.591 . . . . 0.0 109.748 171.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -75.78 35.45 0.13 Allowed 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 125.559 1.544 . . . . 0.0 115.095 -167.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 t 65.13 -55.66 0.31 Allowed 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 129.004 2.922 . . . . 0.0 111.621 -174.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 33.5 t70 57.64 14.19 2.27 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.202 2.201 . . . . 0.0 112.18 -172.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.09 33.7 4.13 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 125.244 1.418 . . . . 0.0 113.169 -169.63 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.2 mt -144.22 -38.5 0.3 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.933 1.293 . . . . 0.0 111.07 176.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 61.0 57.03 2.65 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.858 1.263 . . . . 0.0 110.642 -176.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 2.8 p -60.74 -18.08 52.48 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.07 1.348 . . . . 0.0 114.067 -173.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 35.07 62.26 0.56 Allowed 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 126.703 2.001 . . . . 0.0 115.055 168.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 93.75 113.04 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 128.643 2.777 . . . . 0.0 109.336 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 151.07 -96.62 0.17 Allowed Glycine 0 CA--C 1.52 0.364 0 N-CA-C 110.512 -1.035 . . . . 0.0 110.512 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 19.2 m80 -125.38 168.1 14.02 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 124.68 1.192 . . . . 0.0 109.361 -176.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -132.81 78.92 1.82 Allowed 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 107.143 -1.429 . . . . 0.0 107.143 -173.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.6 m -64.88 160.29 3.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 CA-C-N 114.251 -1.34 . . . . 0.0 110.266 -178.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 3.7 m -137.24 173.42 13.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.419 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 169.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -141.16 162.56 35.19 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 124.012 0.925 . . . . 0.0 110.733 175.481 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.651 HD11 ' CD1' ' A' ' 35' ' ' LEU . 4.3 mt -91.27 125.84 36.16 Favored 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.182 2.593 . . . . 0.0 110.592 -170.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.504 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -145.26 156.17 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -177.389 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.95 161.89 34.8 Favored 'General case' 0 N--CA 1.465 0.291 0 O-C-N 120.766 -1.209 . . . . 0.0 109.422 171.544 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -162.93 135.04 5.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 105.423 -2.066 . . . . 0.0 105.423 -168.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 4.6 ppp? -100.39 -29.39 12.43 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 119.926 1.239 . . . . 0.0 112.639 -176.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -108.09 2.32 22.95 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.83 0.852 . . . . 0.0 110.18 174.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 62.3 27.08 68.67 Favored Glycine 0 CA--C 1.526 0.78 0 CA-C-O 117.511 -1.716 . . . . 0.0 112.86 177.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 34.4 mt -25.27 -49.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 131.086 3.755 . . . . 0.0 114.564 -171.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.2 tp-100 -145.99 -47.29 0.21 Allowed 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 123.973 0.909 . . . . 0.0 110.297 -166.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.649 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 12.1 m-30 -59.3 -46.47 88.48 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 118.17 -0.919 . . . . 0.0 108.674 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -69.39 33.81 0.33 Allowed Glycine 0 C--N 1.344 1.011 0 C-N-CA 129.087 3.232 . . . . 0.0 114.484 -179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 5.62 0.06 Allowed 'General case' 0 C--O 1.237 0.416 0 N-CA-C 115.004 1.483 . . . . 0.0 115.004 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 m -123.7 161.16 25.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 121.496 1.953 . . . . 0.0 115.527 -158.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.98 -22.81 76.17 Favored Glycine 0 C--N 1.34 0.755 0 C-N-CA 124.088 0.852 . . . . 0.0 111.629 178.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.0 tt -65.35 -24.55 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-O 117.982 -1.009 . . . . 0.0 112.059 171.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.88 123.75 48.26 Favored 'General case' 0 C--O 1.234 0.271 0 CA-C-N 120.387 1.449 . . . . 0.0 109.713 -164.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -96.81 -38.45 9.86 Favored 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 123.038 0.535 . . . . 0.0 111.801 -160.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.37 -173.09 31.65 Favored Glycine 0 C--N 1.335 0.498 0 N-CA-C 108.691 -1.763 . . . . 0.0 108.691 172.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.649 HG22 ' CD1' ' A' ' 59' ' ' PHE . 81.6 t -107.14 158.53 7.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 C-N-CA 125.914 1.686 . . . . 0.0 107.02 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 78.2 mt -111.81 146.79 37.03 Favored 'General case' 0 N--CA 1.445 -0.698 0 C-N-CA 126.078 1.751 . . . . 0.0 108.596 177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.2 m -143.28 159.11 56.56 Favored Pre-proline 0 C--N 1.323 -0.564 0 C-N-CA 125.925 1.69 . . . . 0.0 108.562 -171.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -66.53 125.09 13.31 Favored 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 121.64 1.56 . . . . 0.0 108.122 168.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-160 -82.4 129.06 34.8 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 163.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.1 m -130.1 39.37 0.82 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 O-C-N 124.375 1.047 . . . . 0.0 109.32 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 59.44 45.25 95.83 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-O 119.376 -0.68 . . . . 0.0 114.172 172.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 79.9 mm-40 -82.36 -101.05 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 167.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.2 m -153.97 107.78 2.48 Favored Pre-proline 0 N--CA 1.451 -0.409 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -172.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -70.44 149.24 62.28 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.099 1.866 . . . . 0.0 110.661 164.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -93.41 -32.03 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.329 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.681 164.567 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -155.72 -176.78 6.13 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.988 1.715 . . . . 0.0 107.487 -177.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -124.56 155.76 38.52 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 125.312 1.445 . . . . 0.0 107.883 169.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 6.6 tpt180 -127.85 98.76 5.27 Favored 'General case' 0 CA--C 1.512 -0.493 0 C-N-CA 124.885 1.274 . . . . 0.0 108.584 -178.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 46.9 p30 -63.81 145.52 55.63 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-N 114.684 -1.144 . . . . 0.0 110.387 169.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.3 m -153.88 176.1 0.5 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 127.199 2.2 . . . . 0.0 107.798 172.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.3 mm? -108.06 160.54 15.72 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 157.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -109.19 150.05 28.48 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 130.617 3.567 . . . . 0.0 108.616 170.583 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 28.4 mtp180 -69.19 145.08 53.54 Favored 'General case' 0 C--O 1.237 0.398 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 28.7 mtmt -121.49 128.34 51.97 Favored 'General case' 0 CA--C 1.513 -0.47 0 C-N-CA 124.567 1.147 . . . . 0.0 108.125 175.251 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 73.9 m-20 -70.34 -62.31 1.44 Allowed 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 172.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.872 0 CA-C-O 116.5 -2.278 . . . . 0.0 110.428 179.793 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.767 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.434 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 0.4 OUTLIER 62.55 174.51 0.14 Allowed 'General case' 0 CA--C 1.55 0.948 0 C-N-CA 125.93 1.692 . . . . 0.0 109.768 -179.821 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.591 HG22 ' HE3' ' A' ' 114' ' ' LYS . 0.9 OUTLIER -109.94 115.03 48.63 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 O-C-N 118.914 -2.366 . . . . 0.0 107.351 -166.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -72.61 126.2 29.31 Favored 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -176.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 95.6 mt -128.26 157.25 41.41 Favored 'General case' 0 N--CA 1.451 -0.408 0 O-C-N 124.044 0.84 . . . . 0.0 108.907 174.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -131.52 141.9 49.84 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -173.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.496 HD22 ' SG ' ' A' ' 40' ' ' CYS . 97.4 mt -138.54 156.59 73.17 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 118.342 -0.837 . . . . 0.0 110.027 -168.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -74.48 161.72 39.49 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.016 1.81 . . . . 0.0 109.174 172.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 15.9 t -120.45 110.87 29.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 N-CA-C 104.247 -2.501 . . . . 0.0 104.247 171.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 13.4 mt -101.65 150.25 23.3 Favored 'General case' 0 C--O 1.236 0.372 0 C-N-CA 126.407 1.883 . . . . 0.0 106.853 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 27.3 mt-30 -68.28 153.06 44.5 Favored 'General case' 0 CA--C 1.521 -0.149 0 CA-C-N 118.972 0.805 . . . . 0.0 110.304 175.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.51 HG23 ' CD2' ' A' ' 53' ' ' LEU . 8.7 p -58.24 -31.79 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.282 0 C-N-CA 123.532 0.733 . . . . 0.0 111.164 177.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.3 ptp180 -68.9 -34.13 74.9 Favored 'General case' 0 CA--C 1.534 0.328 0 N-CA-C 112.694 0.628 . . . . 0.0 112.694 -179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -86.36 -28.63 23.52 Favored 'General case' 0 C--O 1.224 -0.267 0 C-N-CA 124.69 1.196 . . . . 0.0 110.86 -160.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.26 53.6 t -58.59 63.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.444 -0.743 1 C-N-CA 133.054 4.542 . . . . 0.0 112.632 -178.388 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 14.7 mt -50.24 -12.77 0.09 Allowed 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 127.592 2.357 . . . . 0.0 114.997 -175.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.9 t -129.24 99.32 4.63 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -89.07 15.37 8.82 Favored 'General case' 0 CA--C 1.537 0.449 0 O-C-N 120.855 -1.153 . . . . 0.0 112.029 -174.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.47 111.79 0.49 Allowed Glycine 0 N--CA 1.44 -1.046 0 N-CA-C 104.376 -3.489 . . . . 0.0 104.376 -177.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.414 ' HB2' ' HA ' ' A' ' 27' ' ' ALA . 63.8 m-85 -42.7 -45.07 4.59 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 118.584 1.192 . . . . 0.0 112.451 178.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -155.01 171.42 33.29 Favored Glycine 0 N--CA 1.45 -0.433 0 N-CA-C 108.399 -1.88 . . . . 0.0 108.399 173.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -91.42 27.45 1.96 Allowed 'General case' 0 CA--C 1.542 0.636 0 CA-C-O 122.448 1.118 . . . . 0.0 111.87 -157.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 7.4 m -151.22 164.53 36.37 Favored 'General case' 0 CA--C 1.532 0.283 0 O-C-N 119.503 -1.998 . . . . 0.0 110.041 162.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.426 HG13 ' HG2' ' A' ' 81' ' ' MET . 0.0 OUTLIER -50.56 -55.42 6.5 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.45 0 C-N-CA 126.4 1.88 . . . . 0.0 109.88 177.634 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -70.35 -26.91 63.96 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 124.458 1.103 . . . . 0.0 111.564 -171.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.7 mm-40 -63.1 -66.07 0.6 Allowed 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 167.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 20' ' ' PHE . . . -61.81 -37.3 83.9 Favored 'General case' 0 N--CA 1.438 -1.071 0 CA-C-N 114.735 -1.12 . . . . 0.0 112.143 -166.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -56.45 -47.8 78.39 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.806 0.843 . . . . 0.0 111.884 172.044 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -64.11 -55.81 19.36 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -178.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.7 mt-10 -61.06 -32.06 71.71 Favored 'General case' 0 N--CA 1.443 -0.811 0 CA-C-O 118.397 -0.811 . . . . 0.0 110.308 -175.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.453 ' HB1' HD11 ' A' ' 77' ' ' LEU . . . -55.42 -55.75 28.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 117.673 -1.156 . . . . 0.0 110.297 169.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.463 ' HA ' HD12 ' A' ' 35' ' ' LEU . 0.4 OUTLIER -57.95 -25.78 61.4 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 120.278 1.399 . . . . 0.0 111.917 178.824 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -85.87 -46.56 10.49 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 123.745 0.818 . . . . 0.0 109.694 -174.382 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -73.39 -28.69 62.15 Favored 'General case' 0 CA--C 1.519 -0.245 0 C-N-CA 125.591 1.556 . . . . 0.0 109.202 -176.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.639 HD23 ' SG ' ' A' ' 40' ' ' CYS . 22.9 mt -54.02 -57.89 9.34 Favored 'General case' 0 N--CA 1.445 -0.696 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.129 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.16 -48.65 78.18 Favored 'General case' 0 N--CA 1.457 -0.114 0 C-N-CA 125.434 1.494 . . . . 0.0 109.365 179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 74.1 m-20 -67.31 -11.51 57.77 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.539 0.736 . . . . 0.0 112.26 -176.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.93 4.02 87.42 Favored Glycine 0 CA--C 1.533 1.192 0 O-C-N 120.501 -1.374 . . . . 0.0 112.582 177.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.8 t -115.76 50.56 1.01 Allowed 'General case' 0 N--CA 1.463 0.184 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 -167.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.639 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.79 158.41 38.74 Favored 'General case' 0 N--CA 1.44 -0.945 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 172.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.95 164.3 25.25 Favored Glycine 0 CA--C 1.529 0.923 0 N-CA-C 110.939 -0.864 . . . . 0.0 110.939 173.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 31.5 tp -101.47 127.11 48.29 Favored 'General case' 0 N--CA 1.463 0.182 0 C-N-CA 125.949 1.699 . . . . 0.0 108.653 -179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 40.6 t -104.7 132.94 50.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 C-N-CA 125.4 1.48 . . . . 0.0 107.969 172.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 26.5 mt-10 -80.7 137.89 36.32 Favored 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 125.416 1.486 . . . . 0.0 108.388 -173.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 23.5 mt -80.16 121.53 25.7 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 21.6 mt-10 -135.35 173.5 11.65 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 126.087 1.755 . . . . 0.0 107.854 167.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 39.6 tttt -54.12 -60.07 3.82 Favored 'General case' 0 C--O 1.233 0.197 0 O-C-N 121.915 -0.491 . . . . 0.0 111.848 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -87.62 41.31 3.08 Favored Glycine 0 C--O 1.225 -0.429 0 CA-C-O 117.978 -1.457 . . . . 0.0 112.476 -176.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 40.5 t -101.13 -56.59 5.07 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.279 0 CA-C-N 119.376 1.588 . . . . 0.0 110.979 178.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -41.46 -52.38 7.98 Favored Pre-proline 0 CA--C 1.548 0.899 0 CA-C-O 117.449 -1.262 . . . . 0.0 112.539 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -78.92 0.78 9.72 Favored 'Trans proline' 0 CA--C 1.541 0.838 0 C-N-CA 121.874 1.716 . . . . 0.0 113.167 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 25.3 mt-30 -102.26 -7.47 22.09 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 126.468 1.907 . . . . 0.0 111.569 170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.51 ' CD2' HG23 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -86.03 -177.6 6.34 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 106.133 -1.803 . . . . 0.0 106.133 170.841 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -74.51 -93.48 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 106.797 -1.557 . . . . 0.0 106.797 170.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.74 -62.45 0.02 OUTLIER Pre-proline 0 C--O 1.223 -0.303 0 CA-C-O 116.52 -1.705 . . . . 0.0 111.693 -170.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -74.06 89.88 1.01 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 CA-C-N 122.948 2.089 . . . . 0.0 109.766 -177.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -79.21 95.96 5.77 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.26 1.824 . . . . 0.0 108.997 -178.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.0 t -78.75 89.74 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -177.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.453 ' CD1' HG22 ' A' ' 95' ' ' VAL . 59.1 m-85 -79.52 159.64 26.83 Favored 'General case' 0 CA--C 1.514 -0.419 0 O-C-N 120.911 -1.118 . . . . 0.0 112.369 -176.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 30.9 pt -112.41 114.18 46.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.962 0 CA-C-N 113.214 -1.812 . . . . 0.0 108.762 169.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.435 ' CG ' HG21 ' A' ' 78' ' ' VAL . 0.6 OUTLIER -116.53 156.36 27.07 Favored 'General case' 0 CA--C 1.506 -0.734 0 C-N-CA 122.98 0.512 . . . . 0.0 110.081 171.741 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.586 ' HA ' ' HA ' ' A' ' 75' ' ' VAL 0.266 10.0 ptt180 -72.33 52.84 0.28 Allowed 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.244 1.818 . . . . 0.0 115.733 -169.814 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 64.96 -62.43 0.2 Allowed 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 129.311 3.044 . . . . 0.0 107.659 -167.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 31.4 t0 91.73 156.78 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.205 1 C-N-CA 131.964 4.106 . . . . 0.0 107.605 -173.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 82.62 14.09 0.45 Allowed 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.64 2.376 . . . . 0.0 114.814 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -152.56 46.34 0.72 Allowed 'General case' 0 C--O 1.236 0.356 0 C-N-CA 124.487 1.115 . . . . 0.0 111.861 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 p -54.96 102.97 0.08 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.918 1.287 . . . . 0.0 110.171 177.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 25.1 m -158.17 131.41 7.51 Favored 'General case' 0 C--O 1.235 0.311 0 N-CA-C 106.373 -1.714 . . . . 0.0 106.373 -175.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -88.26 -24.7 23.15 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.209 1.004 . . . . 0.0 112.114 -174.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 17.6 m170 -59.93 161.96 6.04 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.824 0.738 . . . . 0.0 110.849 172.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 83.08 -170.77 49.81 Favored Glycine 0 C--N 1.338 0.672 0 C-N-CA 123.479 0.561 . . . . 0.0 113.19 174.482 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 76.2 m80 -82.55 161.95 22.13 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 122.2 1.0 . . . . 0.0 110.023 165.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 45.1 mtmt -79.81 90.46 5.27 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.195 177.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.6 t -60.19 150.43 6.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 172.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 62' ' ' ARG . 10.2 m -142.11 -178.13 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.234 0 C-N-CA 125.365 1.466 . . . . 0.0 111.243 161.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -149.21 173.88 12.98 Favored 'General case' 0 N--CA 1.449 -0.502 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 169.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.58 HD21 HD11 ' A' ' 35' ' ' LEU . 1.2 mm? -89.18 137.21 32.52 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 127.64 2.376 . . . . 0.0 111.085 176.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.435 HG21 ' CG ' ' A' ' 61' ' ' LYS . 0.6 OUTLIER -145.87 153.38 13.55 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 C-N-CA 126.042 1.737 . . . . 0.0 106.584 -179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -137.68 126.93 24.59 Favored 'General case' 0 CA--C 1.538 0.481 0 CA-C-N 120.002 1.273 . . . . 0.0 108.944 178.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 14.2 mm-40 -128.07 160.71 31.14 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 128.076 2.55 . . . . 0.0 107.586 174.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.426 ' HG2' HG13 ' A' ' 24' ' ' VAL . 50.6 mtp -105.11 -56.12 2.22 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 126.71 2.004 . . . . 0.0 110.166 -171.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -83.43 3.25 32.78 Favored 'General case' 0 N--CA 1.464 0.257 0 O-C-N 121.78 -0.575 . . . . 0.0 110.467 171.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 61.11 37.88 94.66 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-O 118.686 -1.064 . . . . 0.0 110.869 -164.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 8.4 mt -47.86 -42.4 9.7 Favored 'Isoleucine or valine' 0 C--N 1.343 0.291 0 C-N-CA 124.635 1.174 . . . . 0.0 112.341 -170.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -129.11 175.74 8.46 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 72.81 -55.7 0.67 Allowed 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 128.397 2.679 . . . . 0.0 111.388 172.434 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -52.46 -57.05 14.73 Favored Glycine 0 CA--C 1.526 0.738 0 CA-C-N 119.852 1.205 . . . . 0.0 111.84 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.64 8.02 21.13 Favored 'General case' 0 N--CA 1.471 0.621 0 O-C-N 121.889 -0.771 . . . . 0.0 112.971 176.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 49.2 m -77.44 179.87 6.2 Favored 'General case' 0 CA--C 1.54 0.592 0 O-C-N 120.868 -1.145 . . . . 0.0 110.991 179.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -102.85 -16.07 22.64 Favored Glycine 0 CA--C 1.524 0.654 0 N-CA-C 111.845 -0.502 . . . . 0.0 111.845 172.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 14.4 tt -62.03 173.57 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.839 0 CA-C-N 118.185 0.993 . . . . 0.0 109.063 145.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 8.6 m 95.52 150.14 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 128.959 2.903 . . . . 0.0 109.537 167.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.434 HD12 HG11 ' A' ' 75' ' ' VAL . 23.7 mt -121.53 -35.26 3.27 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.931 0.892 . . . . 0.0 111.027 -176.435 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.79 -166.82 34.96 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 177.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG22 ' CD1' ' A' ' 59' ' ' PHE . 63.4 t -115.67 154.74 17.09 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.548 0 C-N-CA 126.778 2.031 . . . . 0.0 108.538 170.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 mt -102.34 142.41 33.59 Favored 'General case' 0 N--CA 1.441 -0.903 0 O-C-N 124.08 0.862 . . . . 0.0 109.991 171.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 18.7 m -139.01 168.22 16.35 Favored Pre-proline 0 C--O 1.241 0.647 0 C-N-CA 129.423 3.089 . . . . 0.0 106.521 177.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -60.3 158.6 30.26 Favored 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 121.297 1.331 . . . . 0.0 111.079 166.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.0 t-80 -112.24 115.66 29.15 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 124.711 1.205 . . . . 0.0 108.659 157.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.03 58.28 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 C-N-CA 127.2 2.2 . . . . 0.0 107.369 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 62.3 28.03 70.25 Favored Glycine 0 CA--C 1.531 1.083 0 O-C-N 120.756 -1.215 . . . . 0.0 113.577 168.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -76.26 2.17 13.99 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.791 2.036 . . . . 0.0 113.557 -173.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 46.9 m 71.21 105.8 0.03 OUTLIER Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 129.499 3.12 . . . . 0.0 112.063 179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -76.98 155.17 33.84 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 121.93 1.754 . . . . 0.0 114.179 174.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.81 -23.55 4.58 Favored 'Isoleucine or valine' 0 C--O 1.237 0.421 0 C-N-CA 125.684 1.594 . . . . 0.0 111.983 171.281 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -160.34 179.68 8.45 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.986 1.714 . . . . 0.0 108.009 -177.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.5 m-85 -126.48 163.37 23.49 Favored 'General case' 0 C--O 1.239 0.507 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 169.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 3.6 tpt180 -141.62 139.63 33.11 Favored 'General case' 0 C--N 1.334 -0.086 0 O-C-N 120.91 -1.119 . . . . 0.0 109.956 178.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -88.69 143.22 27.07 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.363 1.465 . . . . 0.0 110.404 174.11 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 15.1 m -142.12 170.16 12.57 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 C-N-CA 126.903 2.081 . . . . 0.0 107.981 178.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -113.54 160.48 18.46 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.388 -1.445 . . . . 0.0 108.807 163.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 21.0 tp -124.15 144.57 49.83 Favored 'General case' 0 C--O 1.221 -0.43 0 C-N-CA 126.735 2.014 . . . . 0.0 110.294 170.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.434 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -56.09 156.12 5.81 Favored 'General case' 0 N--CA 1.441 -0.9 0 CA-C-O 122.199 1.0 . . . . 0.0 112.661 174.711 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.591 ' HE3' HG22 ' A' ' 3' ' ' VAL . 1.0 OUTLIER -149.06 150.75 33.29 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 105.404 -2.073 . . . . 0.0 105.404 173.456 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -120.83 -95.04 0.49 Allowed 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 107.188 -1.412 . . . . 0.0 107.188 157.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.256 1.523 0 N-CA-C 106.024 -2.83 . . . . 0.0 106.024 169.231 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.377 0 N-CA-C 110.171 -1.172 . . . . 0.0 110.171 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.9 m80 -127.66 149.65 50.11 Favored 'General case' 0 N--CA 1.452 -0.363 0 N-CA-C 105.68 -1.971 . . . . 0.0 105.68 155.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 79.3 t -96.12 134.77 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.547 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 -178.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -76.8 129.8 36.77 Favored 'General case' 0 N--CA 1.439 -0.988 0 N-CA-C 106.863 -1.532 . . . . 0.0 106.863 167.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -122.31 157.64 31.3 Favored 'General case' 0 N--CA 1.438 -1.074 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 166.662 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 41.7 t -134.05 145.45 49.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 176.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 49.3 mt -135.46 149.74 70.35 Favored Pre-proline 0 C--N 1.325 -0.465 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 -175.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.07 172.15 7.8 Favored 'Trans proline' 0 N--CA 1.453 -0.887 0 C-N-CA 121.673 1.582 . . . . 0.0 110.387 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 92.6 t -120.55 111.55 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 N-CA-C 103.054 -2.943 . . . . 0.0 103.054 174.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.3 mt -123.56 132.48 53.9 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 104.785 -2.302 . . . . 0.0 104.785 -170.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -63.81 137.69 58.16 Favored 'General case' 0 C--N 1.33 -0.242 0 O-C-N 122.085 -0.384 . . . . 0.0 110.085 179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 4.0 p -51.98 -29.09 10.99 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 124.734 1.214 . . . . 0.0 110.447 175.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.7 ptm180 -68.88 -48.25 63.88 Favored 'General case' 0 N--CA 1.449 -0.499 0 O-C-N 122.017 -0.427 . . . . 0.0 110.957 -178.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -66.86 -42.06 86.29 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.304 1.042 . . . . 0.0 109.657 -169.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 20.7 t -61.14 65.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.338 1 C-N-CA 132.342 4.257 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.483 ' C ' HD12 ' A' ' 16' ' ' LEU . 0.2 OUTLIER -32.86 -27.7 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 128.892 2.877 . . . . 0.0 116.196 -179.168 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.401 HG12 ' HG ' ' A' ' 16' ' ' LEU . 0.5 OUTLIER -138.08 104.19 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.653 0 C-N-CA 124.698 1.199 . . . . 0.0 110.283 -177.004 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -105.91 51.3 0.75 Allowed 'General case' 0 C--O 1.235 0.324 0 C-N-CA 124.397 1.079 . . . . 0.0 109.764 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -155.99 112.01 0.51 Allowed Glycine 0 CA--C 1.52 0.401 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 178.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . 0.579 ' CZ ' ' CE1' ' A' ' 34' ' ' HIS . 55.8 m-85 -72.08 -17.04 62.03 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.049 0.924 . . . . 0.0 112.059 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -174.66 177.05 46.91 Favored Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 128.864 3.126 . . . . 0.0 105.476 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -97.12 -7.2 33.21 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.057 0.391 . . . . 0.0 112.057 -171.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -120.74 159.26 25.76 Favored 'General case' 0 C--N 1.344 0.336 0 C-N-CA 123.868 0.867 . . . . 0.0 110.518 172.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 79' ' ' ALA . 0.2 OUTLIER -58.99 -47.37 90.08 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.133 0 C-N-CA 124.323 1.049 . . . . 0.0 110.671 178.259 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -71.3 -24.29 62.11 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 118.172 0.442 . . . . 0.0 112.129 -175.631 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.4 mm-40 -63.37 -67.94 0.38 Allowed 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.602 -1.629 . . . . 0.0 106.602 164.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.3 -43.18 99.3 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.893 0.877 . . . . 0.0 112.136 -161.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -39.22 83.61 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 122.95 0.5 . . . . 0.0 111.33 178.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -73.1 -48.91 31.7 Favored 'General case' 0 CA--C 1.512 -0.488 0 C-N-CA 124.798 1.239 . . . . 0.0 111.58 178.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.3 mm-40 -59.84 -37.43 79.22 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 109.495 -0.557 . . . . 0.0 109.495 -179.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.66 -56.35 23.01 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-O 117.891 -1.052 . . . . 0.0 110.298 175.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 91.8 mtt-85 -53.07 -38.04 62.17 Favored 'General case' 0 CA--C 1.512 -0.515 0 CA-C-N 119.376 0.989 . . . . 0.0 112.106 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -69.74 -51.53 33.4 Favored 'General case' 0 N--CA 1.423 -1.778 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 -178.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . 0.679 ' CE1' ' HB2' ' A' ' 40' ' ' CYS . 0.6 OUTLIER -80.49 -15.31 57.04 Favored 'General case' 0 CA--C 1.548 0.896 0 O-C-N 120.314 -1.491 . . . . 0.0 109.621 -168.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.43 HD23 ' HB3' ' A' ' 40' ' ' CYS . 42.3 mt -70.18 -45.5 66.56 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 127.195 2.198 . . . . 0.0 110.413 165.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmt? -59.97 -40.29 88.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.169 0.988 . . . . 0.0 111.288 172.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 55.4 m-80 -63.75 -24.96 67.98 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.283 0.633 . . . . 0.0 111.795 172.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.81 58.5 4.81 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 125.517 1.532 . . . . 0.0 109.855 -175.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.5 p -142.76 39.25 1.5 Allowed 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.234 1.414 . . . . 0.0 110.821 -176.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.679 ' HB2' ' CE1' ' A' ' 34' ' ' HIS . 44.8 t -127.69 155.13 44.44 Favored 'General case' 0 CA--C 1.519 -0.223 0 O-C-N 121.301 -0.874 . . . . 0.0 110.064 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.79 -141.64 7.11 Favored Glycine 0 N--CA 1.435 -1.367 0 C-N-CA 127.943 2.687 . . . . 0.0 109.98 170.707 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 19.9 tp -160.59 150.72 17.92 Favored 'General case' 0 C--N 1.324 -0.51 0 C-N-CA 130.085 3.354 . . . . 0.0 106.632 -170.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 2.5 t -125.72 122.98 63.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 127.427 2.291 . . . . 0.0 105.826 169.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -64.89 143.84 57.68 Favored 'General case' 0 C--O 1.236 0.378 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 173.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -88.82 122.41 32.18 Favored 'General case' 0 CA--C 1.517 -0.315 0 CA-C-O 122.231 1.015 . . . . 0.0 111.308 179.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -138.8 175.34 9.64 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.989 1.716 . . . . 0.0 108.242 -161.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.5 tttt -60.65 -71.24 0.14 Allowed 'General case' 0 C--O 1.236 0.375 0 CA-C-N 119.007 0.821 . . . . 0.0 110.164 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -86.69 50.41 4.19 Favored Glycine 0 CA--C 1.521 0.464 0 CA-C-O 118.825 -0.986 . . . . 0.0 111.232 -174.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.5 t -102.74 -63.41 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.514 -0.417 0 CA-C-N 119.258 1.529 . . . . 0.0 109.804 175.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -49.04 -44.68 72.96 Favored Pre-proline 0 CA--C 1.546 0.798 0 CA-C-O 116.905 -1.521 . . . . 0.0 112.635 -178.639 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.25 -7.28 20.25 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 CA-C-N 122.381 1.886 . . . . 0.0 113.57 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 27.6 mt-30 -102.37 -18.41 15.42 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.943 1.247 . . . . 0.0 111.947 172.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.4 167.82 20.32 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.7 -1.593 . . . . 0.0 106.7 176.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 12.6 mt-10 -73.82 -101.24 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.408 0 N-CA-C 106.811 -1.551 . . . . 0.0 106.811 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.1 mt-30 -151.97 -63.73 0.02 OUTLIER Pre-proline 0 C--N 1.32 -0.684 0 CA-C-O 115.894 -2.003 . . . . 0.0 111.897 -170.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -72.71 86.08 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 CA-C-N 122.698 1.999 . . . . 0.0 110.293 179.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -78.62 97.28 5.75 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 -176.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 6.5 t -72.46 92.57 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 N-CA-C 107.501 -1.296 . . . . 0.0 107.501 178.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.581 ' CD1' HG22 ' A' ' 95' ' ' VAL . 29.7 m-85 -79.83 167.77 20.14 Favored 'General case' 0 CA--C 1.511 -0.554 0 C-N-CA 124.937 1.295 . . . . 0.0 112.63 -179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 31.8 pt -122.39 123.7 69.25 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 112.799 -2.0 . . . . 0.0 107.803 165.108 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.627 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.3 ptpt -116.19 143.73 45.12 Favored 'General case' 0 CA--C 1.513 -0.47 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 75' ' ' VAL . 8.6 ptt180 -75.27 46.62 0.34 Allowed 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 126.084 1.754 . . . . 0.0 114.965 -172.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.9 t 54.63 169.97 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 127.797 2.439 . . . . 0.0 110.784 -167.019 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -144.15 15.35 1.69 Allowed 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 125.792 1.637 . . . . 0.0 109.346 -172.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -148.67 67.48 1.06 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.688 1.195 . . . . 0.0 109.247 -177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.0 mt -142.4 -53.0 0.41 Allowed 'General case' 0 C--O 1.225 -0.21 0 C-N-CA 125.968 1.707 . . . . 0.0 108.288 176.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 59.82 -60.43 0.06 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 127.455 2.302 . . . . 0.0 115.028 -173.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 8.1 p -141.44 -179.7 6.29 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 120.598 1.545 . . . . 0.0 109.522 179.235 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 54.7 t30 42.2 61.44 1.97 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.422 1.889 . . . . 0.0 113.8 178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -121.97 165.7 15.59 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.65 0.78 . . . . 0.0 110.811 179.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.81 -144.27 7.49 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 176.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -64.21 170.71 3.51 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 117.806 0.803 . . . . 0.0 109.832 174.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 94.02 0.02 OUTLIER 'General case' 0 C--O 1.237 0.442 0 C-N-CA 125.568 1.547 . . . . 0.0 110.094 177.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -68.38 135.83 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 N-CA-C 105.754 -1.943 . . . . 0.0 105.754 159.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.9 m -126.22 177.33 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 168.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -142.85 160.53 40.15 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 172.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 20.6 mt -70.64 134.72 47.81 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.601 1.16 . . . . 0.0 108.092 167.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.499 HG21 ' HG2' ' A' ' 61' ' ' LYS . 25.0 t -130.41 165.55 30.36 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.275 0 N-CA-C 105.23 -2.137 . . . . 0.0 105.23 166.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' A' ' 24' ' ' VAL . . . -140.17 150.55 44.35 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 107.891 -1.151 . . . . 0.0 107.891 168.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -150.72 115.7 5.3 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 104.978 -2.23 . . . . 0.0 104.978 -176.033 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 15.9 ptm -81.86 -11.76 58.79 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 113.259 0.837 . . . . 0.0 113.259 -172.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -125.26 -18.61 5.33 Favored 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 118.687 0.676 . . . . 0.0 110.092 174.21 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 76.31 35.85 41.36 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.056 1.312 . . . . 0.0 110.466 -171.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 19.0 mt -42.37 -53.42 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 C-N-CA 127.086 2.154 . . . . 0.0 110.025 173.302 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 13.2 mm100 -123.04 -174.76 3.01 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 126.104 1.762 . . . . 0.0 107.204 174.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.627 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 7.9 m-85 75.53 -62.24 0.45 Allowed 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 126.887 2.075 . . . . 0.0 111.986 169.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -51.15 -67.19 2.07 Favored Glycine 0 CA--C 1.525 0.678 0 CA-C-N 119.695 1.134 . . . . 0.0 112.406 -169.613 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 2.2 ttm180 -80.32 64.44 5.14 Favored 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.569 0.748 . . . . 0.0 110.486 -176.292 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -149.28 -177.98 6.15 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 125.914 1.686 . . . . 0.0 109.126 -173.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -107.41 -28.54 4.83 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.334 0.969 . . . . 0.0 112.165 176.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 8.1 tt -54.87 -29.02 20.95 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 C-N-CA 124.695 1.198 . . . . 0.0 111.519 173.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 13.0 m -96.63 118.64 33.54 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -171.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.491 HD12 HG11 ' A' ' 75' ' ' VAL . 19.1 mt -87.91 -27.02 22.42 Favored 'General case' 0 CA--C 1.536 0.418 0 O-C-N 121.486 -0.758 . . . . 0.0 111.817 -168.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -179.25 -170.3 40.92 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 124.954 1.264 . . . . 0.0 109.973 173.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.581 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -111.16 152.37 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 127.158 2.183 . . . . 0.0 106.756 169.835 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -88.99 147.5 24.26 Favored 'General case' 0 CA--C 1.521 -0.151 0 CA-C-N 120.031 1.287 . . . . 0.0 109.037 172.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 12.2 m -145.19 155.43 54.6 Favored Pre-proline 0 C--N 1.326 -0.434 0 C-N-CA 125.26 1.424 . . . . 0.0 107.784 175.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -61.41 142.51 95.79 Favored 'Trans proline' 0 N--CA 1.451 -1.021 0 C-N-CA 121.399 1.399 . . . . 0.0 110.471 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.9 t-80 -86.38 121.56 29.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 161.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . 0.253 3.6 p -141.99 51.02 0.2 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 CA-C-O 122.72 1.248 . . . . 0.0 108.487 178.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.06 7.26 81.53 Favored Glycine 0 CA--C 1.528 0.899 0 O-C-N 120.583 -1.323 . . . . 0.0 115.255 168.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -67.37 -2.41 6.15 Favored 'General case' 0 CA--C 1.552 1.053 0 C-N-CA 127.02 2.128 . . . . 0.0 114.663 -164.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . 0.254 1.1 m 73.38 101.46 0.04 OUTLIER Pre-proline 0 CA--C 1.549 0.914 0 C-N-CA 129.205 3.002 . . . . 0.0 112.595 179.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.3 172.53 15.84 Favored 'Trans proline' 0 N--CA 1.455 -0.747 0 C-N-CA 122.763 2.309 . . . . 0.0 114.049 -178.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -116.78 -18.79 6.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.532 1.933 . . . . 0.0 111.141 175.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -163.51 -173.13 3.19 Favored 'General case' 0 C--O 1.231 0.126 0 C-N-CA 124.858 1.263 . . . . 0.0 109.536 176.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 7.3 m-85 -127.34 156.66 41.65 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 125.843 1.657 . . . . 0.0 108.37 166.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 27.4 tpt85 -123.28 159.73 28.14 Favored 'General case' 0 N--CA 1.45 -0.474 0 C-N-CA 126.01 1.724 . . . . 0.0 107.733 174.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -129.81 125.34 35.5 Favored 'General case' 0 N--CA 1.443 -0.793 0 C-N-CA 129.012 2.925 . . . . 0.0 107.769 -171.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.96 126.04 4.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 124.908 1.283 . . . . 0.0 108.1 -169.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -79.98 161.32 25.53 Favored 'General case' 0 CA--C 1.537 0.448 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 174.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.4 136.51 33.16 Favored 'General case' 0 C--O 1.235 0.333 0 C-N-CA 127.602 2.361 . . . . 0.0 106.341 -176.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 70.0 mtt180 -58.56 138.62 56.71 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 123.362 0.665 . . . . 0.0 110.042 172.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 38.3 mttt -143.76 154.5 43.51 Favored 'General case' 0 CA--C 1.519 -0.219 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 162.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -60.48 -42.85 97.09 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-O 119.223 -0.418 . . . . 0.0 110.085 172.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.442 -0.931 0 N-CA-C 103.452 -3.859 . . . . 0.0 103.452 -172.041 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.928 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -122.92 165.17 17.14 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 176.165 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -96.51 117.44 40.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 -176.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 9.1 tt0 -68.66 141.99 55.2 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 120.872 1.669 . . . . 0.0 110.012 174.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 91.3 mt -137.88 161.67 36.01 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 125.887 1.675 . . . . 0.0 109.624 177.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.56 144.64 31.41 Favored 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 127.271 2.228 . . . . 0.0 106.85 -173.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 75.0 mt -145.59 156.15 52.82 Favored Pre-proline 0 N--CA 1.464 0.252 0 CA-C-O 118.132 -0.937 . . . . 0.0 110.254 178.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 93.6 Cg_endo -67.85 169.54 16.01 Favored 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.382 2.055 . . . . 0.0 109.503 167.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.2 t -129.29 128.65 66.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 105.609 -1.997 . . . . 0.0 105.609 170.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.3 mt -116.77 155.67 28.53 Favored 'General case' 0 C--O 1.24 0.555 0 C-N-CA 125.814 1.646 . . . . 0.0 106.902 -174.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.404 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -73.41 142.85 46.93 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 167.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 11.3 p -54.59 -30.71 22.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.11 0.964 . . . . 0.0 110.227 175.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -72.32 -33.28 67.23 Favored 'General case' 0 N--CA 1.45 -0.451 0 O-C-N 121.753 -0.592 . . . . 0.0 112.023 -178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.32 -32.71 64.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.493 0.588 . . . . 0.0 109.528 -174.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 11' ' ' GLN . 7.6 t -72.58 63.84 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 129.437 3.095 . . . . 0.0 111.501 -176.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.0 mt -34.07 -43.74 0.16 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 114.903 1.446 . . . . 0.0 114.903 172.727 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.8 p -123.42 107.99 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.271 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 174.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.51 ' HD2' ' H ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -86.75 -21.02 26.81 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 124.02 0.928 . . . . 0.0 111.118 -178.063 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.441 ' CA ' ' HG2' ' A' ' 54' ' ' GLU . . . -84.92 143.13 20.36 Favored Glycine 0 N--CA 1.44 -1.094 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -172.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -82.84 -22.06 34.23 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 153.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.43 -164.29 13.98 Favored Glycine 0 C--N 1.333 0.398 0 C-N-CA 123.557 0.599 . . . . 0.0 111.94 -162.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -136.92 -0.47 2.3 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.288 1.035 . . . . 0.0 113.043 -178.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 39.4 m -131.73 160.19 36.22 Favored 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 124.901 1.281 . . . . 0.0 108.32 165.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 30.8 m -58.36 -51.08 75.71 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.652 0 CA-C-N 119.564 1.075 . . . . 0.0 111.511 -174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -74.21 -25.3 59.59 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 118.749 -0.643 . . . . 0.0 110.857 -168.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -59.63 -63.24 1.37 Allowed 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.223 1.009 . . . . 0.0 109.367 169.936 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.11 -36.92 76.0 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 -176.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -64.93 -40.39 94.98 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.737 0.699 . . . . 0.0 112.547 177.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.6 m -57.48 -58.88 6.33 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 173.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -55.6 -41.26 73.17 Favored 'General case' 0 N--CA 1.449 -0.514 0 O-C-N 124.306 1.003 . . . . 0.0 109.82 -176.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.08 -56.65 13.05 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 119.088 0.858 . . . . 0.0 109.852 -178.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 mtp85 -59.62 -19.87 52.07 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.405 0.682 . . . . 0.0 112.041 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -83.27 -59.22 2.53 Favored 'General case' 0 N--CA 1.439 -1.022 0 C-N-CA 125.988 1.715 . . . . 0.0 112.501 173.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -64.54 -30.02 71.05 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 120.771 1.623 . . . . 0.0 109.063 -175.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.604 HD23 ' SG ' ' A' ' 40' ' ' CYS . 24.6 mt -53.45 -62.61 1.54 Allowed 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 176.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -63.44 -38.33 90.74 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 125.562 1.545 . . . . 0.0 110.569 -177.485 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 79.3 m-20 -61.65 -21.15 64.16 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.696 0.798 . . . . 0.0 111.731 172.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.24 7.56 86.59 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.118 1.342 . . . . 0.0 112.979 -175.543 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.2 p -110.85 38.37 2.52 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.683 1.742 . . . . 0.0 109.734 -167.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.604 ' SG ' HD23 ' A' ' 35' ' ' LEU . 0.5 OUTLIER -128.82 165.03 21.78 Favored 'General case' 0 N--CA 1.442 -0.862 0 N-CA-C 105.265 -2.124 . . . . 0.0 105.265 -179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -143.38 176.17 22.99 Favored Glycine 0 CA--C 1.534 1.274 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 174.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 22.2 tp -110.4 147.7 33.48 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 127.766 2.426 . . . . 0.0 110.171 174.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 21.8 t -124.44 133.96 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 126.971 2.108 . . . . 0.0 105.665 163.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -81.85 156.07 25.04 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 11.2 mt -90.66 85.76 6.17 Favored 'General case' 0 C--O 1.235 0.303 0 O-C-N 121.806 -0.559 . . . . 0.0 111.973 -169.504 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.497 ' HB2' HG23 ' A' ' 49' ' ' VAL . 62.3 mt-10 -79.51 164.61 23.76 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 122.133 0.968 . . . . 0.0 110.51 177.358 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -48.2 -38.86 19.33 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 127.387 2.275 . . . . 0.0 112.299 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -112.16 13.84 26.12 Favored Glycine 0 CA--C 1.524 0.642 0 CA-C-O 117.874 -1.514 . . . . 0.0 113.418 -174.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 46' ' ' GLU . 1.7 t -77.78 -49.76 21.28 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 120.711 2.256 . . . . 0.0 112.949 -175.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.3 mt -53.03 -45.15 98.33 Favored Pre-proline 0 CA--C 1.544 0.743 0 CA-C-O 117.609 -1.186 . . . . 0.0 112.841 -177.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_endo -73.23 13.11 0.7 Allowed 'Trans proline' 0 CA--C 1.55 1.303 0 C-N-CA 122.659 2.24 . . . . 0.0 113.55 175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -125.47 -6.13 7.03 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 127.257 2.223 . . . . 0.0 111.673 171.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -89.77 176.76 6.72 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 126.865 2.066 . . . . 0.0 108.419 174.492 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.441 ' HG2' ' CA ' ' A' ' 19' ' ' GLY . 0.0 OUTLIER -68.4 -93.56 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 124.933 1.293 . . . . 0.0 110.733 175.043 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -168.57 -65.68 0.01 OUTLIER Pre-proline 0 N--CA 1.444 -0.735 0 CA-C-O 115.76 -2.066 . . . . 0.0 109.169 -170.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -75.13 80.56 2.43 Favored 'Trans proline' 0 C--N 1.354 0.851 0 CA-C-N 122.96 2.093 . . . . 0.0 111.028 -179.064 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -78.23 104.56 8.89 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 -169.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 33.1 t -72.28 93.86 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 177.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.62 ' CD1' HG22 ' A' ' 95' ' ' VAL . 21.5 m-85 -83.62 160.73 21.32 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-O 122.68 1.228 . . . . 0.0 112.301 -176.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.6 pt -117.5 112.96 41.05 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-N 112.498 -2.137 . . . . 0.0 107.693 165.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.512 ' HD3' ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -105.55 140.88 37.96 Favored 'General case' 0 CA--C 1.505 -0.753 0 N-CA-C 107.313 -1.366 . . . . 0.0 107.313 171.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.426 ' HA ' HG12 ' A' ' 75' ' ' VAL 0.26 10.6 ptt180 -70.45 105.75 3.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 177.749 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 61.5 m -40.07 124.38 1.82 Allowed 'General case' 0 N--CA 1.445 -0.685 0 C-N-CA 125.173 1.389 . . . . 0.0 109.624 166.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 37.4 t0 -78.61 51.16 1.04 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.117 2.167 . . . . 0.0 110.704 -178.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . 36.87 79.33 0.03 OUTLIER 'General case' 0 C--O 1.234 0.282 0 C-N-CA 129.811 3.244 . . . . 0.0 113.692 176.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.2 mp -94.65 -128.01 0.13 Allowed 'General case' 0 N--CA 1.445 -0.695 0 CA-C-N 113.22 -1.809 . . . . 0.0 106.588 -170.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 p -69.61 79.55 0.42 Allowed 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 119.404 1.002 . . . . 0.0 110.979 172.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 5.3 t -132.81 179.19 6.31 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.601 1.56 . . . . 0.0 109.959 -179.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -120.57 -57.1 1.93 Allowed 'General case' 0 N--CA 1.468 0.44 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -158.07 168.54 26.81 Favored 'General case' 0 C--O 1.238 0.457 0 N-CA-C 105.737 -1.949 . . . . 0.0 105.737 168.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 164.49 141.73 3.21 Favored Glycine 0 N--CA 1.447 -0.609 0 N-CA-C 111.562 -0.615 . . . . 0.0 111.562 167.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 24.0 m-70 -63.59 92.54 0.07 Allowed 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 126.887 2.075 . . . . 0.0 111.141 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 49.3 mtmt 35.35 75.82 0.05 Allowed 'General case' 0 N--CA 1.47 0.532 0 C-N-CA 127.275 2.23 . . . . 0.0 111.789 -175.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.441 HG12 ' HB2' ' A' ' 111' ' ' LEU . 1.6 m -68.18 146.11 13.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 CA-C-N 114.347 -1.297 . . . . 0.0 108.53 -175.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 62' ' ' ARG . 3.9 m -134.2 176.44 8.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 O-C-N 121.764 -0.585 . . . . 0.0 109.595 -179.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -134.88 -173.53 3.33 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.186 0.994 . . . . 0.0 109.099 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.453 HD21 HD11 ' A' ' 35' ' ' LEU . 21.6 mt -119.17 140.35 50.31 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.723 1.609 . . . . 0.0 108.146 177.349 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.433 HG21 ' HE2' ' A' ' 61' ' ' LYS . 14.6 t -145.48 163.27 11.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.516 0 N-CA-C 104.277 -2.49 . . . . 0.0 104.277 -176.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -140.49 146.24 37.94 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 166.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -152.99 115.84 4.54 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 106.688 -1.597 . . . . 0.0 106.688 -171.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.16 -17.19 57.16 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 113.693 0.998 . . . . 0.0 113.693 -175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -122.41 -19.84 6.29 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.358 1.075 . . . . 0.0 109.65 -178.751 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 75.87 40.08 31.79 Favored Glycine 0 N--CA 1.441 -0.968 0 C-N-CA 125.687 1.613 . . . . 0.0 110.657 -171.121 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 5.8 mm -35.02 -53.64 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 C-N-CA 127.518 2.327 . . . . 0.0 110.069 175.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 11.6 mm100 -134.03 -176.65 4.26 Favored 'General case' 0 N--CA 1.443 -0.782 0 C-N-CA 126.508 1.923 . . . . 0.0 107.353 178.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.512 ' CD1' ' HD3' ' A' ' 61' ' ' LYS . 4.8 m-85 74.91 -70.06 0.16 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 126.442 1.897 . . . . 0.0 110.276 171.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -46.8 -60.14 5.08 Favored Glycine 0 CA--C 1.523 0.551 0 C-N-CA 125.644 1.592 . . . . 0.0 112.215 -168.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.0 -10.7 59.79 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -178.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.421 ' HB3' HG22 ' A' ' 91' ' ' ILE . 8.2 t -66.64 -39.18 88.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.296 1.439 . . . . 0.0 113.035 -166.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 120.14 -37.97 2.91 Favored Glycine 0 CA--C 1.53 1.025 0 CA-C-N 118.973 0.806 . . . . 0.0 112.395 -177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.421 HG22 ' HB3' ' A' ' 89' ' ' SER . 17.4 tt -54.52 -20.58 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 C-N-CA 127.187 2.195 . . . . 0.0 113.254 171.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.6 m -103.95 118.73 37.37 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 122.964 0.506 . . . . 0.0 109.774 -161.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.424 HD12 HG11 ' A' ' 75' ' ' VAL . 16.6 mt -90.99 -26.72 19.09 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.968 0.907 . . . . 0.0 111.272 -163.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -178.9 -170.62 41.12 Favored Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.756 -0.937 . . . . 0.0 110.756 174.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.62 HG22 ' CD1' ' A' ' 59' ' ' PHE . 90.0 t -121.69 142.33 38.43 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 127.424 2.29 . . . . 0.0 106.622 173.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -79.96 141.38 36.05 Favored 'General case' 0 N--CA 1.444 -0.76 0 CA-C-N 115.923 -0.581 . . . . 0.0 109.581 173.337 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 34.8 m -134.97 163.97 47.39 Favored Pre-proline 0 C--O 1.239 0.526 0 C-N-CA 125.955 1.702 . . . . 0.0 108.05 176.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -67.06 145.66 74.25 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 CA-C-N 119.688 0.924 . . . . 0.0 110.128 168.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 15.0 t-160 -106.01 109.46 21.41 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 167.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.1 m -93.48 38.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.526 0 CA-C-N 119.154 0.888 . . . . 0.0 110.346 169.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 64.22 6.99 22.73 Favored Glycine 0 CA--C 1.531 1.07 0 O-C-N 121.061 -1.024 . . . . 0.0 114.194 -175.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.1 tp10 -42.41 -91.32 0.0 OUTLIER 'General case' 0 C--O 1.232 0.163 0 C-N-CA 129.936 3.295 . . . . 0.0 112.71 -161.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 2.9 m -166.33 90.61 0.82 Allowed Pre-proline 0 CA--C 1.539 0.536 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -177.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -76.48 164.04 31.22 Favored 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 121.564 1.51 . . . . 0.0 111.654 177.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.4 -21.48 5.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.794 1.238 . . . . 0.0 111.605 171.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -162.56 -179.12 6.67 Favored 'General case' 0 C--O 1.231 0.097 0 C-N-CA 124.518 1.127 . . . . 0.0 109.674 -173.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -136.12 131.63 35.01 Favored 'General case' 0 N--CA 1.465 0.306 0 C-N-CA 124.974 1.31 . . . . 0.0 109.126 177.356 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.69 158.83 16.24 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.756 1.622 . . . . 0.0 108.253 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 25.1 p30 -136.52 146.21 45.95 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.973 2.109 . . . . 0.0 110.623 -179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.1 m -149.73 174.22 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 125.348 1.459 . . . . 0.0 108.8 -178.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' HB2' HG12 ' A' ' 74' ' ' VAL . 2.5 mm? -112.33 162.22 15.78 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 157.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.29 121.44 35.85 Favored 'General case' 0 C--N 1.332 -0.173 0 C-N-CA 128.557 2.743 . . . . 0.0 108.49 -176.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -58.41 120.31 8.53 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 125.57 1.548 . . . . 0.0 110.972 176.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 77.6 mttt -74.41 173.02 10.88 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 123.461 0.704 . . . . 0.0 110.868 179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 65.1 m-80 -110.7 0.28 17.38 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 125.231 1.412 . . . . 0.0 111.143 168.605 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.997 0 C-N-CA 129.277 3.322 . . . . 0.0 106.043 -177.801 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.945 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.5 m80 61.18 -177.07 0.12 Allowed 'General case' 0 C--O 1.238 0.466 0 C-N-CA 126.553 1.941 . . . . 0.0 112.142 -174.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -142.42 126.48 15.52 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 C-N-CA 125.939 1.696 . . . . 0.0 107.46 -179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.9 146.94 41.42 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 177.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 88.3 mt -145.25 125.63 13.94 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.746 1.218 . . . . 0.0 110.213 170.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.449 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.2 OUTLIER -80.01 167.58 20.28 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 123.186 0.304 . . . . 0.0 110.605 167.813 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 90.1 mt -144.56 150.67 48.15 Favored Pre-proline 0 N--CA 1.463 0.211 0 C-N-CA 124.723 1.209 . . . . 0.0 108.678 162.305 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -68.99 157.63 61.11 Favored 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 122.169 1.912 . . . . 0.0 108.808 162.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.8 t -110.24 123.99 66.6 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 N-CA-C 104.887 -2.264 . . . . 0.0 104.887 168.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.2 mt -119.37 139.16 52.44 Favored 'General case' 0 C--O 1.235 0.321 0 N-CA-C 105.874 -1.898 . . . . 0.0 105.874 -177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -59.07 139.15 57.16 Favored 'General case' 0 N--CA 1.467 0.401 0 CA-C-N 119.598 1.09 . . . . 0.0 108.641 -176.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.8 p -56.13 -31.13 30.96 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.486 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -84.3 -20.32 32.3 Favored 'General case' 0 N--CA 1.448 -0.525 0 CA-C-O 117.783 -1.103 . . . . 0.0 112.532 -177.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -74.02 -35.98 64.42 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 120.775 1.625 . . . . 0.0 111.005 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.85 66.12 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.213 -0.847 0 C-N-CA 129.625 3.17 . . . . 0.0 115.335 -170.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.597 ' H ' HD23 ' A' ' 16' ' ' LEU . 0.3 OUTLIER -25.07 -44.02 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 172.477 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.558 HG23 ' HG ' ' A' ' 16' ' ' LEU . 1.1 t -114.71 94.54 3.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.286 0 N-CA-C 108.488 -0.931 . . . . 0.0 108.488 -173.345 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.438 ' HB3' HD13 ' A' ' 53' ' ' LEU . 6.9 mtt-85 -97.74 17.26 18.37 Favored 'General case' 0 N--CA 1.471 0.587 0 O-C-N 121.475 -0.766 . . . . 0.0 109.712 -170.695 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -161.81 99.94 0.18 Allowed Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 106.472 -2.651 . . . . 0.0 106.472 -169.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -38.66 -49.64 1.57 Allowed 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 126.062 1.745 . . . . 0.0 112.197 -170.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -133.04 -175.79 14.12 Favored Glycine 0 N--CA 1.438 -1.188 0 N-CA-C 104.829 -3.308 . . . . 0.0 104.829 160.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.84 -0.18 54.64 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 112.174 0.435 . . . . 0.0 112.174 -173.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -122.99 153.43 39.79 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.233 1.013 . . . . 0.0 111.312 -176.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -66.11 -49.35 77.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.336 0 O-C-N 121.553 -0.717 . . . . 0.0 109.495 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -68.58 -27.08 65.74 Favored 'General case' 0 CA--C 1.531 0.249 0 CA-C-N 118.092 0.405 . . . . 0.0 110.648 -173.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -64.67 -64.77 0.79 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.61 1.164 . . . . 0.0 109.382 166.35 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.74 -37.15 78.18 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.515 0.726 . . . . 0.0 110.354 -167.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -64.74 -35.67 81.81 Favored 'General case' 0 CA--C 1.543 0.677 0 CA-C-N 118.599 0.636 . . . . 0.0 112.42 175.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.8 t -62.96 -58.55 6.94 Favored 'General case' 0 C--O 1.236 0.392 0 O-C-N 121.137 -0.977 . . . . 0.0 108.934 172.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -61.45 -37.42 83.49 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-O 118.219 -0.895 . . . . 0.0 109.596 -171.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -52.24 -57.0 11.06 Favored 'General case' 0 N--CA 1.449 -0.512 0 C-N-CA 124.241 1.016 . . . . 0.0 109.772 177.151 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 16.0 mtp-105 -56.36 -37.28 69.83 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.61 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -71.34 -46.27 60.95 Favored 'General case' 0 N--CA 1.437 -1.122 0 CA-C-N 118.219 0.463 . . . . 0.0 110.298 -179.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 35.2 m80 -69.55 -40.2 76.98 Favored 'General case' 0 C--O 1.222 -0.347 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 -174.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 40.4 mt -56.28 -45.67 80.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.309 1.044 . . . . 0.0 110.795 172.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 28.0 ttpt -61.96 -40.24 94.89 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-N 118.69 0.677 . . . . 0.0 111.316 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 64.3 m-80 -74.81 -21.06 59.51 Favored 'General case' 0 CA--C 1.532 0.271 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 176.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.84 -5.52 83.36 Favored Glycine 0 CA--C 1.532 1.13 0 C-N-CA 125.926 1.727 . . . . 0.0 113.79 -169.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 32.6 p -83.94 39.81 0.72 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 126.137 1.775 . . . . 0.0 110.799 -170.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 48.6 t -129.95 151.86 50.05 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.395 1.478 . . . . 0.0 108.395 -177.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -133.76 173.61 21.15 Favored Glycine 0 CA--C 1.527 0.806 0 C-N-CA 125.941 1.734 . . . . 0.0 110.424 173.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 15.3 tp -109.36 140.34 43.17 Favored 'General case' 0 C--O 1.233 0.221 0 C-N-CA 126.111 1.765 . . . . 0.0 109.292 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 5.1 t -115.16 134.02 59.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 C-N-CA 125.461 1.504 . . . . 0.0 107.871 173.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -71.74 127.62 33.15 Favored 'General case' 0 C--O 1.234 0.258 0 C-N-CA 123.934 0.893 . . . . 0.0 108.917 -178.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.8 mt -72.67 127.25 31.98 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 122.807 0.443 . . . . 0.0 110.113 175.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.424 ' HB2' HG23 ' A' ' 49' ' ' VAL . 31.2 mt-10 -147.36 178.74 8.17 Favored 'General case' 0 C--O 1.239 0.516 0 C-N-CA 124.859 1.263 . . . . 0.0 107.808 173.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -58.37 -61.68 2.4 Favored 'General case' 0 C--O 1.234 0.262 0 C-N-CA 123.051 0.541 . . . . 0.0 110.334 169.161 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -76.21 22.74 1.95 Allowed Glycine 0 C--O 1.223 -0.546 0 C-N-CA 125.492 1.52 . . . . 0.0 113.933 -168.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.424 HG23 ' HB2' ' A' ' 46' ' ' GLU . 19.1 t -100.57 -60.83 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.379 0 CA-C-N 118.954 1.377 . . . . 0.0 108.643 -177.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -46.91 -51.47 39.19 Favored Pre-proline 0 CA--C 1.538 0.508 0 CA-C-O 117.114 -1.422 . . . . 0.0 111.52 -177.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -72.26 -8.35 22.58 Favored 'Trans proline' 0 CA--C 1.539 0.737 0 CA-C-N 122.384 1.887 . . . . 0.0 113.928 -177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 19.1 mt-30 -94.63 -22.06 18.41 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.36 1.064 . . . . 0.0 110.608 172.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -79.66 167.24 20.94 Favored 'General case' 0 C--O 1.232 0.171 0 C-N-CA 124.471 1.109 . . . . 0.0 109.306 -175.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 mm-40 -68.34 -79.58 0.05 Allowed 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.561 0.744 . . . . 0.0 109.605 -173.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.439 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 29.6 tp60 -167.58 -57.07 0.01 OUTLIER Pre-proline 0 N--CA 1.438 -1.065 0 CA-C-O 117.085 -1.436 . . . . 0.0 112.051 173.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.439 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 68.8 Cg_endo -78.34 89.3 1.36 Allowed 'Trans proline' 0 N--CA 1.44 -1.64 0 CA-C-N 122.656 1.984 . . . . 0.0 107.74 -178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -78.33 98.67 6.03 Favored 'General case' 0 N--CA 1.441 -0.893 0 N-CA-C 105.03 -2.211 . . . . 0.0 105.03 179.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 41.7 t -74.49 115.99 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.148 0 N-CA-C 106.417 -1.698 . . . . 0.0 106.417 174.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.631 ' CE1' HG22 ' A' ' 95' ' ' VAL . 70.1 m-85 -109.07 173.71 6.19 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.981 0.896 . . . . 0.0 111.112 -176.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 22.9 pt -132.15 121.44 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.539 0 C-N-CA 125.413 1.485 . . . . 0.0 107.655 174.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.69 ' HE3' HG11 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.07 144.93 46.31 Favored 'General case' 0 CA--C 1.511 -0.529 0 C-N-CA 125.631 1.572 . . . . 0.0 107.851 178.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.9 ptt180 -69.95 68.81 0.3 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 124.539 1.136 . . . . 0.0 112.916 -176.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 36.2 p 43.81 -131.21 0.75 Allowed 'General case' 0 N--CA 1.435 -1.186 0 C-N-CA 125.271 1.428 . . . . 0.0 108.353 -164.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 6.5 t0 -164.32 -48.34 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 167.122 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -78.51 85.71 4.57 Favored 'General case' 0 N--CA 1.446 -0.665 0 C-N-CA 124.323 1.049 . . . . 0.0 111.401 177.325 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -142.79 162.45 35.44 Favored 'General case' 0 C--N 1.323 -0.578 0 C-N-CA 125.647 1.579 . . . . 0.0 112.759 173.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 9.5 p -166.66 178.69 5.83 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 126.237 1.815 . . . . 0.0 109.217 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.313 6.0 t 29.51 -84.7 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 130.34 3.456 . . . . 0.0 114.38 173.106 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 38.5 m-20 -61.27 -31.85 71.67 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 117.584 -1.198 . . . . 0.0 112.312 -173.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 26.71 68.27 0.06 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 127.897 2.479 . . . . 0.0 111.49 -175.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -66.96 95.66 0.28 Allowed Glycine 0 CA--C 1.52 0.405 0 C-N-CA 124.707 1.146 . . . . 0.0 111.385 -173.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 56.55 175.85 0.04 OUTLIER 'General case' 0 C--O 1.233 0.234 0 C-N-CA 126.459 1.903 . . . . 0.0 113.05 -171.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.6 mtmm -77.35 88.11 3.75 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.155 -1.424 . . . . 0.0 107.155 159.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.2 t -67.89 152.75 9.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 N-CA-C 106.226 -1.768 . . . . 0.0 106.226 156.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 17.4 m -131.04 -174.64 1.26 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.52 0 C-N-CA 125.192 1.397 . . . . 0.0 108.956 169.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -142.15 168.08 20.59 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 166.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 61.4 mt -94.75 142.5 27.38 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.106 0.963 . . . . 0.0 108.583 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.69 HG11 ' HE3' ' A' ' 61' ' ' LYS . 0.0 OUTLIER -155.74 159.22 2.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 C-N-CA 126.531 1.933 . . . . 0.0 106.153 -171.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -147.43 133.64 19.44 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 11.0 mp0 -141.87 92.62 2.47 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 106.477 -1.675 . . . . 0.0 106.477 -170.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.1 ptm -59.35 -37.58 78.24 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 122.646 0.378 . . . . 0.0 111.908 -171.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -96.06 13.94 25.44 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.223 -0.923 . . . . 0.0 110.992 178.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.38 33.55 39.82 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 125.517 1.532 . . . . 0.0 111.373 -170.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 76.8 mt -31.86 -62.86 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.199 0 C-N-CA 129.953 3.301 . . . . 0.0 111.183 -171.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -134.0 -171.93 2.86 Favored 'General case' 0 N--CA 1.439 -0.976 0 N-CA-C 104.913 -2.254 . . . . 0.0 104.913 168.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.648 ' CE1' ' HE2' ' A' ' 61' ' ' LYS . 26.5 m-85 67.88 -61.22 0.38 Allowed 'General case' 0 C--N 1.322 -0.608 0 C-N-CA 127.398 2.279 . . . . 0.0 112.909 175.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . 0.407 ' HA3' ' CZ ' ' A' ' 59' ' ' PHE . . . -47.84 -62.78 3.92 Favored Glycine 0 CA--C 1.524 0.594 0 CA-C-N 121.094 1.77 . . . . 0.0 112.209 -175.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 tpt180 -78.89 50.3 1.0 Allowed 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 123.973 0.909 . . . . 0.0 110.206 175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.8 m -149.17 156.05 41.57 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 126.285 1.834 . . . . 0.0 108.914 179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -91.66 -12.4 59.47 Favored Glycine 0 CA--C 1.532 1.141 0 C-N-CA 125.269 1.414 . . . . 0.0 113.983 -176.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 3.0 tt -53.81 -23.28 8.25 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 119.005 1.403 . . . . 0.0 110.769 161.432 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 6.7 m -105.01 122.45 45.89 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 122.081 0.943 . . . . 0.0 108.866 -163.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.3 mt -87.48 -31.03 20.2 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.504 -165.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.69 -174.86 41.74 Favored Glycine 0 CA--C 1.527 0.811 0 CA-C-N 119.328 0.967 . . . . 0.0 111.138 170.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.631 HG22 ' CE1' ' A' ' 59' ' ' PHE . 59.4 t -98.97 164.82 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 C-N-CA 125.796 1.639 . . . . 0.0 107.514 165.13 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 87.1 mt -120.92 145.18 47.95 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.757 1.623 . . . . 0.0 109.869 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.3 m -147.45 158.57 43.47 Favored Pre-proline 0 CA--C 1.539 0.554 0 C-N-CA 125.746 1.618 . . . . 0.0 109.627 -174.117 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_endo -71.69 121.32 7.57 Favored 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.738 2.959 . . . . 0.0 110.304 171.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 9.9 t-80 -74.77 128.92 36.71 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.768 1.227 . . . . 0.0 108.806 171.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 22.6 m -134.93 39.95 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.741 0 C-N-CA 124.959 1.304 . . . . 0.0 111.258 177.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 71.1 25.64 75.29 Favored Glycine 0 CA--C 1.531 1.045 0 O-C-N 120.649 -1.282 . . . . 0.0 112.805 178.351 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.4 tp10 -67.17 1.38 2.1 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 129.312 3.045 . . . . 0.0 116.02 -171.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 99.4 m 68.2 96.03 0.05 OUTLIER Pre-proline 0 C--N 1.323 -0.57 0 C-N-CA 129.601 3.161 . . . . 0.0 110.413 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_endo -67.29 170.67 12.91 Favored 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.086 1.857 . . . . 0.0 113.614 177.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.56 -18.6 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.361 0 C-N-CA 126.54 1.936 . . . . 0.0 110.968 174.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -156.41 -179.14 7.89 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 125.389 1.476 . . . . 0.0 108.052 176.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -132.2 154.85 49.16 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 106.694 -1.595 . . . . 0.0 106.694 166.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 10.0 mmt-85 -123.93 167.22 14.41 Favored 'General case' 0 C--O 1.24 0.553 0 C-N-CA 126.486 1.914 . . . . 0.0 107.977 172.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 7.2 t30 -139.37 144.41 38.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.26 1.024 . . . . 0.0 108.645 173.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -138.13 170.72 16.57 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 126.396 1.878 . . . . 0.0 109.015 173.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -112.36 158.12 20.19 Favored 'General case' 0 C--O 1.237 0.416 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 162.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -119.44 143.95 47.21 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 126.292 1.837 . . . . 0.0 107.899 177.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 18.8 mtp180 -66.94 124.76 23.9 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 170.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 11.4 mttt -95.78 95.88 8.59 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 105.757 -1.942 . . . . 0.0 105.757 163.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -52.38 -53.13 48.88 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 123.62 0.768 . . . . 0.0 110.893 174.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.097 0 N-CA-C 105.034 -3.226 . . . . 0.0 105.034 -158.938 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.821 0 N-CA-C 111.377 -0.689 . . . . 0.0 111.377 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.402 ' CD2' ' HA ' ' A' ' 113' ' ' ARG . 28.7 m80 -59.5 152.11 22.59 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 167.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.2 t -102.32 140.99 19.32 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 C-N-CA 124.499 1.119 . . . . 0.0 108.634 179.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -83.78 131.65 34.89 Favored 'General case' 0 C--N 1.325 -0.49 0 C-N-CA 125.708 1.603 . . . . 0.0 108.538 178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 64.8 mt -126.75 104.58 8.14 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 124.58 1.152 . . . . 0.0 110.851 177.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 4.4 m -84.97 146.24 27.32 Favored 'General case' 0 N--CA 1.443 -0.786 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.588 172.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 81.9 mt -138.68 142.71 35.13 Favored Pre-proline 0 C--O 1.235 0.296 0 C-N-CA 124.668 1.187 . . . . 0.0 108.361 -177.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -72.81 129.13 14.03 Favored 'Trans proline' 0 N--CA 1.441 -1.573 0 C-N-CA 122.997 2.464 . . . . 0.0 108.79 172.903 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 40.1 t -81.3 121.94 35.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 175.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.405 HD12 ' HA3' ' A' ' 41' ' ' GLY . 19.9 mt -127.07 141.76 51.7 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 125.351 1.461 . . . . 0.0 107.445 -174.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.47 ' O ' HG23 ' A' ' 15' ' ' VAL . 9.1 mt-30 -74.88 129.14 37.14 Favored 'General case' 0 CA--C 1.518 -0.262 0 O-C-N 123.682 0.614 . . . . 0.0 109.374 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.0 p -58.76 -20.47 16.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 124.076 0.95 . . . . 0.0 111.353 -176.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.37 -46.15 74.18 Favored 'General case' 0 N--CA 1.451 -0.406 0 O-C-N 121.808 -0.557 . . . . 0.0 110.444 176.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -73.39 -30.65 63.41 Favored 'General case' 0 CA--C 1.517 -0.311 0 C-N-CA 125.262 1.425 . . . . 0.0 110.219 -176.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 11' ' ' GLN . 14.3 t -64.42 63.94 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 C-N-CA 128.64 2.776 . . . . 0.0 110.814 175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 25.6 mt -48.3 -14.7 0.06 Allowed 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.938 2.095 . . . . 0.0 114.946 174.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 95.6 t -132.95 103.28 5.76 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.145 0 C-N-CA 126.123 1.769 . . . . 0.0 109.856 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.512 ' H ' ' HD2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -106.7 22.93 15.11 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 126.887 2.075 . . . . 0.0 109.238 176.725 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -128.4 117.59 2.57 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 105.837 -2.905 . . . . 0.0 105.837 -179.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -78.22 -20.05 52.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 118.514 1.157 . . . . 0.0 111.607 166.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -178.87 178.04 48.65 Favored Glycine 0 N--CA 1.441 -0.993 0 N-CA-C 107.523 -2.231 . . . . 0.0 107.523 -173.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -117.15 3.01 12.68 Favored 'General case' 0 C--N 1.326 -0.446 0 O-C-N 124.432 0.724 . . . . 0.0 111.915 -167.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -123.21 157.84 32.16 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 125.347 1.459 . . . . 0.0 107.703 161.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.436 ' HB ' ' HB1' ' A' ' 79' ' ' ALA . 4.8 m -60.06 -39.01 79.15 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 O-C-N 121.204 -0.935 . . . . 0.0 110.069 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 21.9 mt-10 -71.85 -32.67 67.73 Favored 'General case' 0 N--CA 1.434 -1.228 0 O-C-N 124.02 0.825 . . . . 0.0 109.621 -170.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -60.03 -60.95 3.01 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 169.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.443 ' HB1' ' CG2' ' A' ' 58' ' ' VAL . . . -56.14 -39.88 72.96 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 124.205 1.002 . . . . 0.0 111.122 -169.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.59 -45.05 93.05 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 125.289 1.436 . . . . 0.0 112.706 174.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 66.6 m -66.79 -56.96 8.12 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 123.853 0.861 . . . . 0.0 110.189 178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.8 mm-40 -56.91 -46.1 82.2 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-O 118.383 -0.818 . . . . 0.0 110.344 -176.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.621 ' CB ' HG11 ' A' ' 58' ' ' VAL . . . -51.01 -60.32 3.22 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 118.714 0.688 . . . . 0.0 109.312 178.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.3 -35.6 60.31 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 118.609 -0.71 . . . . 0.0 112.732 178.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -66.92 -43.61 82.86 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-N 119.127 0.876 . . . . 0.0 110.734 174.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -77.29 -27.47 53.07 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 124.478 1.111 . . . . 0.0 108.048 -170.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 mp -67.31 -41.66 84.97 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 126.076 1.75 . . . . 0.0 111.283 167.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -62.62 -51.96 65.25 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 123.982 0.913 . . . . 0.0 108.701 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 84.8 m-20 -59.42 -47.15 86.57 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.506 1.122 . . . . 0.0 109.739 175.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 106.04 1.11 38.9 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 127.017 2.246 . . . . 0.0 112.984 -174.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 10.1 t -83.31 52.55 2.24 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 119.219 1.509 . . . . 0.0 108.669 173.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 37.2 t -134.9 141.25 46.27 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.488 -1.671 . . . . 0.0 106.488 173.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.405 ' HA3' HD12 ' A' ' 10' ' ' LEU . . . -127.18 -179.04 15.59 Favored Glycine 0 CA--C 1.532 1.103 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 168.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 23.1 tp -125.55 115.2 19.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 125.051 1.34 . . . . 0.0 110.414 -168.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 46.4 t -85.07 122.65 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 C-N-CA 126.269 1.828 . . . . 0.0 108.561 168.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -62.72 126.75 28.39 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 166.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' HG ' HG23 ' A' ' 95' ' ' VAL . 4.8 mt -59.46 134.27 56.86 Favored 'General case' 0 CA--C 1.516 -0.34 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.838 175.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.447 ' HB2' HG23 ' A' ' 49' ' ' VAL . 21.5 mt-10 -139.63 166.38 24.76 Favored 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 171.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 17.6 ttpp -67.01 -11.99 58.6 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 123.758 0.823 . . . . 0.0 112.298 178.839 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -130.09 33.6 2.89 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 125.985 1.755 . . . . 0.0 111.785 179.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.447 HG23 ' HB2' ' A' ' 46' ' ' GLU . 2.1 t -95.01 -45.27 13.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 119.33 1.565 . . . . 0.0 108.07 175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.478 ' HG ' ' CE2' ' A' ' 57' ' ' TYR . 8.6 mp -42.3 -55.7 6.32 Favored Pre-proline 0 CA--C 1.538 0.508 0 C-N-CA 126.668 1.987 . . . . 0.0 113.158 172.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -84.83 43.79 1.36 Allowed 'Trans proline' 0 N--CA 1.452 -0.947 0 C-N-CA 123.722 2.948 . . . . 0.0 111.087 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 41.5 mt-30 -141.39 -33.56 0.51 Allowed 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 127.642 2.377 . . . . 0.0 107.325 168.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD12 ' CB ' ' A' ' 18' ' ' ARG . 0.2 OUTLIER -78.02 173.81 11.79 Favored 'General case' 0 N--CA 1.443 -0.809 0 C-N-CA 124.958 1.303 . . . . 0.0 110.254 176.108 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -66.25 -94.27 0.0 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 125.302 1.441 . . . . 0.0 108.905 175.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.45 -64.63 0.02 OUTLIER Pre-proline 0 N--CA 1.442 -0.838 0 CA-C-O 117.087 -1.435 . . . . 0.0 108.528 -170.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -73.08 87.9 0.99 Allowed 'Trans proline' 0 N--CA 1.452 -0.941 0 CA-C-N 121.316 1.506 . . . . 0.0 110.042 -178.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.478 ' CE2' ' HG ' ' A' ' 50' ' ' LEU . 8.3 m-85 -79.32 119.34 22.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 125.692 1.597 . . . . 0.0 107.784 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.64 HG12 HD23 ' A' ' 96' ' ' LEU . 22.1 t -83.96 98.02 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.725 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 178.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.65 ' CD1' HG22 ' A' ' 95' ' ' VAL . 14.9 m-85 -82.54 172.16 13.3 Favored 'General case' 0 CA--C 1.507 -0.711 0 CA-C-O 121.81 0.814 . . . . 0.0 111.897 -178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.51 HG23 HD21 ' A' ' 96' ' ' LEU . 48.8 pt -126.8 134.87 65.25 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.174 0 CA-C-N 112.482 -2.145 . . . . 0.0 110.091 157.075 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.538 ' HG2' HG11 ' A' ' 78' ' ' VAL . 5.7 ptpt -131.83 154.53 49.05 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 123.624 0.77 . . . . 0.0 109.577 171.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.418 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.0 OUTLIER -70.56 62.47 0.25 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 125.445 1.498 . . . . 0.0 113.181 179.175 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 83.5 p 55.63 174.27 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 130.137 3.375 . . . . 0.0 112.206 -176.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -89.09 -9.89 49.41 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-O 118.639 -0.696 . . . . 0.0 111.003 176.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -137.7 -17.26 1.28 Allowed 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 116.894 2.183 . . . . 0.0 116.894 -173.058 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.286 0.2 OUTLIER 42.98 -90.57 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 128.031 2.532 . . . . 0.0 114.861 177.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 4.9 t 60.68 178.54 0.1 Allowed 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 126.34 1.856 . . . . 0.0 113.629 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.273 10.5 t 46.62 178.32 0.01 OUTLIER 'General case' 0 CA--C 1.547 0.831 0 C-N-CA 131.068 3.747 . . . . 0.0 114.755 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 79.2 m-20 -77.48 60.92 2.17 Favored 'General case' 0 C--O 1.235 0.335 0 C-N-CA 125.17 1.388 . . . . 0.0 107.868 165.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -57.94 158.57 6.45 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.116 1.366 . . . . 0.0 110.975 -171.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -79.5 -138.79 1.77 Allowed Glycine 0 CA--C 1.521 0.468 0 C-N-CA 124.519 1.057 . . . . 0.0 112.201 -175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.1 m80 -59.93 146.27 42.92 Favored 'General case' 0 CA--C 1.517 -0.291 0 O-C-N 121.859 -0.789 . . . . 0.0 110.246 168.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 5.6 mppt? -52.12 100.02 0.03 OUTLIER 'General case' 0 C--O 1.237 0.425 0 O-C-N 125.712 1.883 . . . . 0.0 112.2 -173.011 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 72.9 t -65.57 134.45 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 127.367 2.267 . . . . 0.0 107.666 159.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.418 HG12 ' HA ' ' A' ' 62' ' ' ARG . 24.0 m -141.74 177.63 3.19 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 171.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -144.7 159.39 42.91 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -178.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 72.5 mt -64.99 155.8 33.42 Favored 'General case' 0 C--O 1.233 0.232 0 O-C-N 124.073 0.858 . . . . 0.0 109.251 167.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.558 HG13 ' HB2' ' A' ' 59' ' ' PHE . 0.2 OUTLIER -151.09 158.37 4.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 C-N-CA 128.822 2.849 . . . . 0.0 103.786 174.052 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.436 ' HB1' ' HB ' ' A' ' 24' ' ' VAL . . . -131.97 141.52 49.32 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 173.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -151.64 125.37 9.03 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 117.587 -1.197 . . . . 0.0 109.526 -176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 23.6 ptm -77.65 -25.22 49.5 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 119.52 1.054 . . . . 0.0 113.073 -177.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -130.86 6.56 4.67 Favored 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 119.184 0.902 . . . . 0.0 111.03 -178.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.23 36.58 62.51 Favored Glycine 0 CA--C 1.527 0.818 0 N-CA-C 110.328 -1.109 . . . . 0.0 110.328 -167.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 21.1 mt -42.76 -57.81 0.52 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.313 0 C-N-CA 127.502 2.321 . . . . 0.0 108.827 179.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 3.3 tp60 -106.53 169.56 8.45 Favored 'General case' 0 N--CA 1.433 -1.284 0 N-CA-C 105.276 -2.12 . . . . 0.0 105.276 172.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.432 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 8.9 m-85 74.58 -57.37 0.61 Allowed 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 126.045 1.738 . . . . 0.0 112.849 169.233 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -59.19 -21.25 52.98 Favored Glycine 0 N--CA 1.475 1.248 0 C-N-CA 125.309 1.433 . . . . 0.0 114.704 -165.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.57 22.27 6.44 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 125.376 1.47 . . . . 0.0 113.144 173.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 4.4 m -84.67 -45.07 12.84 Favored 'General case' 0 CA--C 1.538 0.492 0 O-C-N 121.272 -0.893 . . . . 0.0 110.301 170.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 87.0 -8.87 74.64 Favored Glycine 0 CA--C 1.53 1.031 0 O-C-N 120.656 -1.278 . . . . 0.0 113.527 -178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 1.4 tt -52.7 -39.62 31.33 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.539 0 CA-C-N 119.423 1.612 . . . . 0.0 109.075 151.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -72.78 137.08 45.61 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 108.069 -1.086 . . . . 0.0 108.069 -176.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -101.06 -48.88 4.28 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 -165.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -156.47 -167.58 17.96 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 125.092 1.33 . . . . 0.0 109.937 176.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.65 HG22 ' CD1' ' A' ' 59' ' ' PHE . 84.9 t -130.01 140.43 48.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.388 0 C-N-CA 127.635 2.374 . . . . 0.0 106.316 179.22 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.64 HD23 HG12 ' A' ' 58' ' ' VAL . 2.8 mm? -86.69 150.74 23.97 Favored 'General case' 0 N--CA 1.446 -0.631 0 C-N-CA 124.705 1.202 . . . . 0.0 109.506 -179.445 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 10.6 m -142.85 155.28 62.88 Favored Pre-proline 0 C--N 1.326 -0.441 0 C-N-CA 125.1 1.36 . . . . 0.0 108.987 177.141 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 14.0 Cg_endo -70.96 121.57 7.99 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.318 2.012 . . . . 0.0 109.534 173.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 6.9 t-80 -74.63 83.39 2.06 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 -179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.2 m -79.61 38.93 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.544 0.719 0 C-N-CA 124.854 1.262 . . . . 0.0 111.649 175.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 87.3 -3.65 86.53 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 116.789 1.475 . . . . 0.0 116.789 159.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.4 mm-40 -60.08 -100.03 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 119.463 1.632 . . . . 0.0 114.548 -158.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 69.0 m -156.77 87.41 2.8 Favored Pre-proline 0 N--CA 1.466 0.368 0 O-C-N 119.694 -1.879 . . . . 0.0 108.573 -173.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -66.68 151.54 82.44 Favored 'Trans proline' 0 N--CA 1.448 -1.164 0 C-N-CA 120.937 1.092 . . . . 0.0 112.223 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -98.99 -30.5 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 124.859 1.264 . . . . 0.0 111.542 177.11 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -165.62 178.83 6.41 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 125.19 1.396 . . . . 0.0 110.003 -172.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -124.01 134.26 53.49 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.184 1.393 . . . . 0.0 109.123 177.319 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.7 168.59 9.58 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 124.444 1.098 . . . . 0.0 108.548 170.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 8.1 t30 -142.33 133.98 26.8 Favored 'General case' 0 C--O 1.232 0.143 0 C-N-CA 124.982 1.313 . . . . 0.0 108.171 173.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 6.6 m -138.26 130.66 39.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 C-N-CA 124.764 1.226 . . . . 0.0 108.011 -179.191 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -79.69 160.06 26.43 Favored 'General case' 0 CA--C 1.536 0.425 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 174.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.488 HD13 ' HE3' ' A' ' 114' ' ' LYS . 0.0 OUTLIER -134.76 139.82 45.45 Favored 'General case' 0 C--O 1.232 0.178 0 C-N-CA 127.48 2.312 . . . . 0.0 108.878 -178.1 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.402 ' HA ' ' CD2' ' A' ' 2' ' ' HIS . 0.0 OUTLIER -54.71 117.85 3.72 Favored 'General case' 0 C--O 1.235 0.297 0 CA-C-N 119.249 0.931 . . . . 0.0 112.158 176.507 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.488 ' HE3' HD13 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -138.9 169.29 18.05 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 127.135 2.174 . . . . 0.0 105.418 168.298 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 91.5 m-20 -99.65 -100.41 0.23 Allowed 'General case' 0 N--CA 1.466 0.374 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 -174.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.191 0 N-CA-C 105.093 -3.203 . . . . 0.0 105.093 155.045 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.774 0 N-CA-C 111.475 -0.65 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 70.02 145.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 129.554 3.142 . . . . 0.0 109.593 -176.206 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.8 t -87.68 149.57 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 177.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -92.89 134.43 35.1 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 123.761 0.825 . . . . 0.0 109.34 173.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 36.7 mt -130.84 150.24 52.1 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 123.596 0.758 . . . . 0.0 109.366 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.07 142.92 51.41 Favored 'General case' 0 C--N 1.325 -0.486 0 C-N-CA 125.143 1.377 . . . . 0.0 107.963 -171.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 66.7 mt -130.78 147.97 68.29 Favored Pre-proline 0 C--O 1.235 0.323 0 CA-C-O 118.358 -0.83 . . . . 0.0 109.964 176.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_endo -73.29 136.46 24.28 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 123.437 2.758 . . . . 0.0 108.319 163.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.1 t -87.38 116.94 30.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 105.448 -2.056 . . . . 0.0 105.448 170.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 42.0 mt -107.17 154.57 21.0 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 125.124 1.37 . . . . 0.0 107.32 -178.594 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -69.98 150.12 47.01 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 167.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.406 HG23 ' CD2' ' A' ' 53' ' ' LEU . 11.3 p -59.61 -23.0 24.66 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 O-C-N 121.901 -0.499 . . . . 0.0 110.682 173.059 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.2 ptt85 -84.3 -31.0 25.11 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-O 118.106 -0.949 . . . . 0.0 113.0 173.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -69.76 -34.29 73.59 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 119.722 1.146 . . . . 0.0 110.127 -178.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 16.4 t -61.46 64.54 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.445 -0.684 0 C-N-CA 128.343 2.657 . . . . 0.0 111.317 170.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 32.1 mt -31.74 -48.31 0.15 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 126.256 1.822 . . . . 0.0 112.268 170.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.6 t -118.81 106.24 19.14 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 C-N-CA 125.144 1.378 . . . . 0.0 108.191 -177.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.52 ' HB3' HD13 ' A' ' 53' ' ' LEU . 38.1 mtt85 -102.5 8.73 39.9 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.079 0.952 . . . . 0.0 112.223 -168.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.25 126.28 5.53 Favored Glycine 0 N--CA 1.433 -1.555 0 N-CA-C 104.526 -3.43 . . . . 0.0 104.526 175.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -62.56 -41.18 98.74 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 120.223 -0.591 . . . . 0.0 109.554 162.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -151.1 -176.25 23.78 Favored Glycine 0 N--CA 1.447 -0.628 0 N-CA-C 108.429 -1.868 . . . . 0.0 108.429 -177.474 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -109.98 5.35 22.23 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 124.421 1.088 . . . . 0.0 111.187 -169.372 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.1 m -128.52 165.92 19.79 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 126.055 1.742 . . . . 0.0 110.685 172.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.2 t -60.66 -63.06 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.512 0 C-N-CA 124.029 0.932 . . . . 0.0 110.259 -179.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -71.67 -24.84 61.9 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 118.274 -0.869 . . . . 0.0 111.287 -171.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.8 mt-10 -52.35 -67.98 0.21 Allowed 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 166.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.3 -40.82 78.64 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.1 0.56 . . . . 0.0 111.176 -173.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 1.4 tt -55.77 -52.55 63.56 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.208 1.003 . . . . 0.0 112.075 174.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.83 -47.7 65.37 Favored 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.762 -0.586 . . . . 0.0 110.859 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -59.28 -40.92 87.66 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.505 0.722 . . . . 0.0 109.615 -175.367 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -51.34 -60.06 3.54 Favored 'General case' 0 N--CA 1.448 -0.575 0 C-N-CA 123.855 0.862 . . . . 0.0 109.272 172.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 3.7 ttt180 -40.88 -48.88 3.18 Favored 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.44 1.096 . . . . 0.0 111.864 170.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -68.49 -22.36 64.55 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.075 1.35 . . . . 0.0 113.622 -176.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 37.4 m80 -97.5 -33.98 11.17 Favored 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.683 1.593 . . . . 0.0 108.887 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 5.2 mp -57.39 -39.54 76.29 Favored 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 119.927 1.24 . . . . 0.0 110.049 168.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.98 -22.35 65.02 Favored 'General case' 0 C--O 1.236 0.384 0 O-C-N 121.15 -0.969 . . . . 0.0 112.629 177.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 49.0 m-80 -99.85 -7.14 25.72 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.773 1.629 . . . . 0.0 112.734 174.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 72.73 1.62 54.45 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.209 1.861 . . . . 0.0 113.968 -172.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.6 p -86.66 39.41 0.84 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.535 1.934 . . . . 0.0 110.702 -171.184 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.1 t -130.58 144.04 51.15 Favored 'General case' 0 N--CA 1.451 -0.407 0 O-C-N 120.822 -1.173 . . . . 0.0 108.552 -174.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -128.16 174.23 18.81 Favored Glycine 0 N--CA 1.445 -0.713 0 C-N-CA 126.458 1.98 . . . . 0.0 111.5 173.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 46.7 tp -125.22 132.65 52.95 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 126.015 1.726 . . . . 0.0 108.445 -170.682 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 73.1 t -108.16 136.73 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.573 0 C-N-CA 125.696 1.599 . . . . 0.0 107.014 170.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -77.44 130.33 36.9 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 123.911 0.884 . . . . 0.0 109.243 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.449 HD21 ' HE1' ' A' ' 59' ' ' PHE . 7.2 mt -65.58 123.46 19.74 Favored 'General case' 0 N--CA 1.455 -0.213 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 169.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -141.67 172.61 12.45 Favored 'General case' 0 C--N 1.323 -0.572 0 C-N-CA 126.998 2.119 . . . . 0.0 107.247 -167.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -62.28 -49.57 75.16 Favored 'General case' 0 C--O 1.237 0.436 0 O-C-N 120.897 -1.127 . . . . 0.0 110.252 170.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -98.34 19.5 54.19 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 123.962 0.792 . . . . 0.0 115.03 -164.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 2.4 t -94.77 -43.68 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 119.596 1.698 . . . . 0.0 112.872 -173.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -50.94 -46.64 87.73 Favored Pre-proline 0 CA--C 1.544 0.717 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.962 177.189 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -85.37 43.8 1.29 Allowed 'Trans proline' 0 CA--C 1.546 1.088 0 C-N-CA 123.012 2.474 . . . . 0.0 110.733 178.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 50.6 mt-30 -149.45 -22.26 0.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 129.147 2.979 . . . . 0.0 109.938 169.457 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD13 ' HB3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -78.22 175.12 10.48 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 174.443 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -76.84 -93.82 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.978 -1.86 . . . . 0.0 105.978 176.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.43 -53.8 0.02 OUTLIER Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 115.482 -2.199 . . . . 0.0 113.418 -175.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -74.52 90.49 1.03 Allowed 'Trans proline' 0 N--CA 1.448 -1.181 0 CA-C-N 122.168 1.81 . . . . 0.0 108.882 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -79.45 88.11 5.05 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 114.408 -1.269 . . . . 0.0 108.156 -177.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.572 ' HA ' ' HA ' ' A' ' 79' ' ' ALA . 2.2 p -57.28 86.07 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.631 0 C-N-CA 127.044 2.138 . . . . 0.0 110.609 170.101 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.601 ' CD1' HG22 ' A' ' 95' ' ' VAL . 26.2 m-85 -79.77 166.63 21.56 Favored 'General case' 0 CA--C 1.505 -0.754 0 O-C-N 120.76 -1.213 . . . . 0.0 112.199 -175.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 40.8 pt -127.13 127.81 69.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.106 0 CA-C-N 113.44 -1.709 . . . . 0.0 108.808 167.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.604 ' HE3' ' CD1' ' A' ' 86' ' ' TYR . 6.1 ptpt -125.3 147.49 49.1 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 -179.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.69 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.3 OUTLIER -74.25 62.34 0.93 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.874 1.065 . . . . 0.0 113.874 -172.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 40.8 t 49.35 -116.8 0.91 Allowed 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 127.003 2.121 . . . . 0.0 106.319 -174.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -165.15 -39.09 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 126.642 1.977 . . . . 0.0 107.125 152.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -98.2 116.56 30.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-O 121.872 0.844 . . . . 0.0 111.096 179.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -165.5 174.11 10.28 Favored 'General case' 0 C--N 1.322 -0.623 0 C-N-CA 131.37 3.868 . . . . 0.0 106.936 -173.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t -142.94 145.12 32.71 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.446 1.098 . . . . 0.0 108.059 174.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 56.6 m -89.73 68.53 7.56 Favored 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 167.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 71.6 m-20 -121.23 -100.64 0.42 Allowed 'General case' 0 C--O 1.233 0.235 0 N-CA-C 105.618 -1.993 . . . . 0.0 105.618 153.456 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 2.2 t-160 -100.26 64.93 1.2 Allowed 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 -176.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -176.18 162.07 30.77 Favored Glycine 0 CA--C 1.519 0.328 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 177.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 93.7 m-70 -101.13 177.0 5.06 Favored 'General case' 0 C--O 1.239 0.54 0 CA-C-O 121.168 0.508 . . . . 0.0 111.771 -173.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 42.8 mtmt -70.69 91.92 0.84 Allowed 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 159.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.511 HG12 ' HG ' ' A' ' 111' ' ' LEU . 10.8 m -79.08 157.24 4.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 C-N-CA 124.805 1.242 . . . . 0.0 108.609 174.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 62' ' ' ARG . 31.3 m -133.76 177.66 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 CA-C-N 120.235 1.38 . . . . 0.0 111.288 -177.121 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -145.18 161.75 38.76 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 124.193 0.997 . . . . 0.0 108.955 177.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 12.6 mt -72.7 139.41 47.22 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.869 1.268 . . . . 0.0 109.213 169.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 33.4 t -133.89 176.27 9.33 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 128.773 2.829 . . . . 0.0 104.633 159.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . 0.572 ' HA ' ' HA ' ' A' ' 58' ' ' VAL . . . -155.97 156.18 34.07 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 127.64 2.376 . . . . 0.0 105.886 171.28 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -161.56 123.37 2.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 119.458 1.026 . . . . 0.0 109.749 -173.221 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 5.1 ptp -87.97 2.59 51.35 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-O 118.644 -0.693 . . . . 0.0 112.808 177.95 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 42.2 t0 -143.99 26.9 1.49 Allowed 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 121.008 1.731 . . . . 0.0 110.1 166.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 55.75 5.84 1.01 Allowed Glycine 0 CA--C 1.533 1.171 0 C-N-CA 126.917 2.199 . . . . 0.0 115.186 -175.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 59.7 mt -25.03 -71.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.341 0.213 0 C-N-CA 128.057 2.543 . . . . 0.0 113.078 -143.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 1.8 tp-100 -101.17 -41.05 6.88 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 124.107 0.963 . . . . 0.0 110.361 -169.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.604 ' CD1' ' HE3' ' A' ' 61' ' ' LYS . 17.1 m-85 -80.58 -32.97 36.39 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-O 119.167 -0.444 . . . . 0.0 110.868 -163.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.52 150.73 44.4 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.073 -1.611 . . . . 0.0 109.073 174.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.8 tpm_? 66.08 -19.54 0.1 Allowed 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.953 2.101 . . . . 0.0 113.161 -178.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 19.6 m -82.04 129.36 34.77 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 126.017 1.727 . . . . 0.0 110.114 178.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -76.31 -8.61 85.62 Favored Glycine 0 CA--C 1.531 1.033 0 C-N-CA 123.956 0.788 . . . . 0.0 114.856 -172.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 11.9 tt -53.38 -37.96 30.86 Favored 'Isoleucine or valine' 0 C--O 1.238 0.452 0 CA-C-N 118.783 1.292 . . . . 0.0 110.265 160.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.6 m -87.54 127.44 35.25 Favored 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 -173.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.52 HD12 HG11 ' A' ' 75' ' ' VAL . 55.8 mt -95.4 -43.66 7.91 Favored 'General case' 0 C--N 1.326 -0.428 0 O-C-N 121.553 -0.717 . . . . 0.0 110.713 -170.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -162.52 -167.99 23.78 Favored Glycine 0 C--N 1.334 0.421 0 O-C-N 120.943 -1.098 . . . . 0.0 111.734 175.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.601 HG22 ' CD1' ' A' ' 59' ' ' PHE . 99.0 t -117.09 139.01 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.405 0 C-N-CA 126.058 1.743 . . . . 0.0 107.227 172.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.455 ' O ' HG13 ' A' ' 97' ' ' VAL . 1.0 OUTLIER -88.45 148.19 24.31 Favored 'General case' 0 CA--C 1.508 -0.64 0 C-N-CA 127.336 2.255 . . . . 0.0 110.54 177.281 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.455 HG13 ' O ' ' A' ' 96' ' ' LEU . 3.7 m -156.51 161.46 29.46 Favored Pre-proline 0 C--N 1.32 -0.684 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 -175.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -67.18 138.26 46.58 Favored 'Trans proline' 0 N--CA 1.449 -1.09 0 N-CA-C 109.272 -1.088 . . . . 0.0 109.272 175.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -88.16 124.98 34.36 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 106.021 -1.844 . . . . 0.0 106.021 165.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 20.0 m -118.18 38.93 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-O 121.6 0.714 . . . . 0.0 109.82 173.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.57 -2.9 51.75 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 124.864 1.221 . . . . 0.0 115.297 174.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -47.3 -91.95 0.0 OUTLIER 'General case' 0 C--O 1.235 0.331 0 C-N-CA 126.931 2.092 . . . . 0.0 114.138 -165.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 20.6 m -166.25 103.76 0.69 Allowed Pre-proline 0 C--N 1.33 -0.28 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 -174.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -84.96 169.18 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.297 0 C-N-CA 121.559 1.506 . . . . 0.0 112.617 164.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.35 -10.02 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 C-N-CA 127.1 2.16 . . . . 0.0 111.566 -176.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.4 178.67 9.68 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.827 1.651 . . . . 0.0 107.728 168.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -133.98 136.71 44.31 Favored 'General case' 0 C--O 1.237 0.427 0 C-N-CA 126.641 1.976 . . . . 0.0 107.36 173.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.4 tpt180 -116.92 136.71 52.73 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 125.438 1.495 . . . . 0.0 107.961 -175.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 3.3 p30 -118.83 132.66 56.13 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 126.859 2.064 . . . . 0.0 108.282 -176.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.459 ' HB ' HG22 ' A' ' 75' ' ' VAL . 17.3 m -148.41 170.87 2.62 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.62 0 C-N-CA 125.234 1.414 . . . . 0.0 109.364 -174.592 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.511 ' HG ' HG12 ' A' ' 74' ' ' VAL . 1.8 mm? -105.97 175.96 5.32 Favored 'General case' 0 N--CA 1.478 0.936 0 CA-C-N 120.654 1.57 . . . . 0.0 110.077 171.078 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -137.92 128.89 27.21 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 129.384 3.073 . . . . 0.0 107.965 -174.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 93.07 0.07 Allowed 'General case' 0 C--N 1.344 0.358 0 C-N-CA 124.463 1.105 . . . . 0.0 109.261 174.55 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 15.5 mttt -108.8 112.21 24.36 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 104.976 -2.231 . . . . 0.0 104.976 163.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -65.88 -38.92 90.06 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 173.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.145 0 CA-C-O 117.486 -1.73 . . . . 0.0 110.765 176.451 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.709 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -103.49 154.03 19.89 Favored 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 106.29 -1.744 . . . . 0.0 106.29 158.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 98.7 t -96.99 129.66 46.7 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.508 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.3 tt0 -74.67 140.8 44.48 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 60.6 mt -137.4 162.49 33.47 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.105 0.962 . . . . 0.0 109.537 170.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 13.3 m -131.32 151.65 51.31 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 125.041 1.336 . . . . 0.0 108.276 172.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 41.3 mt -140.28 129.67 13.4 Favored Pre-proline 0 C--O 1.234 0.273 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -171.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -67.29 144.21 67.3 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 122.667 2.245 . . . . 0.0 108.668 170.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 50.4 t -103.29 115.67 45.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.579 -2.008 . . . . 0.0 105.579 179.192 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.5 mt -127.18 129.38 47.74 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 125.648 1.579 . . . . 0.0 107.204 -168.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.483 ' O ' HG23 ' A' ' 15' ' ' VAL . 36.1 mt-30 -60.54 153.43 23.48 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 124.095 0.958 . . . . 0.0 112.035 -172.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 6.6 p -63.34 -28.31 44.78 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.407 0 O-C-N 121.145 -0.972 . . . . 0.0 110.617 176.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.81 -31.95 61.84 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 118.785 0.72 . . . . 0.0 112.527 177.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -74.78 -39.76 61.56 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 125.002 1.321 . . . . 0.0 110.336 -175.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.52 ' CB ' HH21 ' A' ' 18' ' ' ARG . 95.3 t -73.02 64.54 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 C-N-CA 129.713 3.205 . . . . 0.0 111.656 -172.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 57.7 mt -39.27 -21.68 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 126.877 2.071 . . . . 0.0 116.257 169.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.37 95.34 2.65 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 CA-C-N 120.107 1.321 . . . . 0.0 108.886 172.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.644 HH22 HG21 ' A' ' 43' ' ' VAL . 0.5 OUTLIER -82.48 -5.24 58.59 Favored 'General case' 0 C--O 1.226 -0.165 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -176.005 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -137.98 119.13 1.77 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 109.206 -1.558 . . . . 0.0 109.206 -169.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -56.95 -28.87 62.64 Favored 'General case' 0 CA--C 1.535 0.396 0 CA-C-N 118.09 0.945 . . . . 0.0 112.936 175.763 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.89 -179.22 37.31 Favored Glycine 0 C--N 1.334 0.468 0 N-CA-C 108.259 -1.937 . . . . 0.0 108.259 -178.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.1 p30 -98.82 -5.32 31.34 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 115.327 1.603 . . . . 0.0 115.327 -173.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 72.7 m -130.6 164.09 25.69 Favored 'General case' 0 CA--C 1.528 0.126 0 CA-C-N 119.082 0.856 . . . . 0.0 111.751 -179.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 38.9 t -61.16 -45.96 97.57 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.994 0 C-N-CA 124.569 1.147 . . . . 0.0 110.273 -170.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 51.1 mt-10 -76.49 -35.93 58.09 Favored 'General case' 0 N--CA 1.432 -1.363 0 CA-C-O 117.518 -1.229 . . . . 0.0 109.905 -178.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.7 mm-40 -55.12 -63.26 1.21 Allowed 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 124.676 1.19 . . . . 0.0 109.878 179.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -60.22 -41.15 92.43 Favored 'General case' 0 N--CA 1.444 -0.751 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.4 -172.252 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.47 -40.9 96.19 Favored 'General case' 0 N--CA 1.43 -1.442 0 C-N-CA 125.205 1.402 . . . . 0.0 113.907 173.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.55 -52.37 32.66 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.336 0.589 . . . . 0.0 109.847 -178.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -59.68 -42.09 92.15 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 124.953 1.301 . . . . 0.0 109.259 179.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -47.43 -62.36 1.47 Allowed 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.568 1.147 . . . . 0.0 110.334 166.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -56.83 -24.27 49.93 Favored 'General case' 0 C--O 1.235 0.332 0 CA-C-N 119.373 0.988 . . . . 0.0 112.906 -178.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.75 -41.55 26.38 Favored 'General case' 0 N--CA 1.44 -0.972 0 C-N-CA 124.068 0.947 . . . . 0.0 110.911 172.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.1 m80 -75.47 -26.6 58.35 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 125.221 1.408 . . . . 0.0 108.053 -171.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.3 mp -56.46 -51.94 66.55 Favored 'General case' 0 N--CA 1.445 -0.715 0 C-N-CA 124.008 0.923 . . . . 0.0 110.324 167.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.36 -40.02 95.05 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.608 0.763 . . . . 0.0 110.219 177.696 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -70.04 -12.78 61.86 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 123.972 0.909 . . . . 0.0 113.376 174.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 63.77 20.8 64.56 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 127.246 2.355 . . . . 0.0 113.165 -173.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.0 p -97.28 43.32 1.07 Allowed 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 126.523 1.929 . . . . 0.0 109.885 179.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 11.3 t -130.4 137.05 49.67 Favored 'General case' 0 CA--C 1.532 0.268 0 O-C-N 120.324 -1.485 . . . . 0.0 109.756 -177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.24 173.96 18.43 Favored Glycine 0 CA--C 1.535 1.335 0 C-N-CA 127.963 2.697 . . . . 0.0 111.621 177.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 24.3 tp -128.75 138.07 51.91 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.288 1.835 . . . . 0.0 111.781 -170.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.644 HG21 HH22 ' A' ' 18' ' ' ARG . 47.5 t -116.2 125.63 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.839 1.656 . . . . 0.0 108.148 179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -62.35 125.89 25.47 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 6.3 mt -73.9 136.64 43.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.336 0.588 . . . . 0.0 111.812 178.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -151.68 173.62 14.47 Favored 'General case' 0 N--CA 1.44 -0.966 0 CA-C-N 115.261 -0.881 . . . . 0.0 112.577 -169.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.4 tptm -64.37 -69.79 0.26 Allowed 'General case' 0 C--N 1.341 0.2 0 C-N-CA 126.177 1.791 . . . . 0.0 108.787 -172.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -85.12 34.58 3.21 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 124.935 1.255 . . . . 0.0 112.333 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.2 t -103.1 -60.44 2.88 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 CA-C-N 119.257 1.528 . . . . 0.0 109.05 175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.1 mt -46.19 -48.89 43.5 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 125.206 1.403 . . . . 0.0 113.036 177.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 64.5 Cg_endo -69.61 1.15 4.59 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 CA-C-N 121.734 1.655 . . . . 0.0 114.195 -177.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 12.0 mt-30 -123.09 -1.98 8.7 Favored 'General case' 0 C--O 1.237 0.406 0 C-N-CA 126.896 2.078 . . . . 0.0 112.685 178.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.55 HD23 ' HB3' ' A' ' 18' ' ' ARG . 3.6 mt -79.85 176.56 9.61 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 125.154 1.382 . . . . 0.0 108.357 170.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -69.29 -104.64 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -160.63 -64.59 0.02 OUTLIER Pre-proline 0 N--CA 1.45 -0.444 0 CA-C-O 116.27 -1.824 . . . . 0.0 111.211 -168.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -73.13 82.67 1.54 Allowed 'Trans proline' 0 N--CA 1.455 -0.751 0 CA-C-N 122.6 1.964 . . . . 0.0 109.595 -179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 23.3 m-85 -78.21 108.54 11.6 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 -167.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 29.4 t -76.11 90.7 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 -175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.532 ' CD1' HG22 ' A' ' 95' ' ' VAL . 54.2 m-85 -79.36 165.21 23.36 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 124.932 1.293 . . . . 0.0 112.514 -178.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.6 pt -124.89 119.68 56.61 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.769 0 CA-C-N 113.333 -1.758 . . . . 0.0 108.992 169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HE3' ' CE1' ' A' ' 86' ' ' TYR . 0.9 OUTLIER -124.03 145.84 48.94 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 123.984 0.914 . . . . 0.0 110.529 -177.099 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . 0.253 2.9 ptt180 -69.18 25.21 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 118.022 2.601 . . . . 0.0 118.022 -161.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.2 t 64.75 169.93 0.19 Allowed 'General case' 0 C--N 1.319 -0.728 0 C-N-CA 126.652 1.981 . . . . 0.0 110.941 -172.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 10.2 m-20 -138.05 -17.21 1.22 Allowed 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.754 -145.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.37 44.06 1.04 Allowed 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.762 1.625 . . . . 0.0 109.09 176.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 44.3 mt -146.64 -67.8 0.27 Allowed 'General case' 0 C--O 1.224 -0.251 0 C-N-CA 124.749 1.22 . . . . 0.0 109.118 -174.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 2.2 t 46.89 78.67 0.07 Allowed 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.624 1.569 . . . . 0.0 111.109 -158.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . 0.316 9.1 t 51.09 41.88 28.0 Favored 'General case' 0 CA--C 1.548 0.892 0 C-N-CA 125.253 1.421 . . . . 0.0 112.253 173.212 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . 0.49 HD22 ' CD2' ' A' ' 70' ' ' HIS . 27.5 t30 -74.48 -67.32 0.64 Allowed 'General case' 0 C--N 1.344 0.332 0 O-C-N 121.354 -0.841 . . . . 0.0 111.015 178.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . 0.49 ' CD2' HD22 ' A' ' 69' ' ' ASN . 0.6 OUTLIER -165.7 179.75 5.82 Favored 'General case' 0 C--O 1.238 0.496 0 C-N-CA 126.011 1.725 . . . . 0.0 109.725 178.231 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 98.06 179.91 32.75 Favored Glycine 0 CA--C 1.529 0.922 0 C-N-CA 125.036 1.303 . . . . 0.0 113.602 168.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -62.45 165.55 6.04 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 124.379 1.071 . . . . 0.0 110.144 173.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.8 mtmt -80.04 69.37 6.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-O 122.231 1.015 . . . . 0.0 109.325 169.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.417 HG13 ' H ' ' A' ' 74' ' ' VAL . 1.3 m -59.29 165.66 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.555 0 CA-C-N 114.117 -1.401 . . . . 0.0 108.464 167.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.4 m -143.02 -177.68 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 124.293 1.037 . . . . 0.0 108.534 164.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -143.25 164.76 29.32 Favored 'General case' 0 N--CA 1.441 -0.9 0 C-N-CA 125.68 1.592 . . . . 0.0 107.853 164.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.7 mt -73.57 135.82 43.95 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 125.847 1.659 . . . . 0.0 109.471 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 64.9 t -137.92 162.72 31.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 106.073 -1.825 . . . . 0.0 106.073 162.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -139.35 143.61 37.85 Favored 'General case' 0 C--N 1.32 -0.714 0 C-N-CA 125.326 1.45 . . . . 0.0 107.183 170.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -144.09 136.0 26.25 Favored 'General case' 0 CA--C 1.519 -0.248 0 CA-C-N 118.221 0.464 . . . . 0.0 110.511 168.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.7 ttm -58.18 -32.44 68.24 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 127.751 2.42 . . . . 0.0 113.128 -170.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.62 10.81 4.39 Favored 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 124.009 0.924 . . . . 0.0 109.277 -175.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 47.58 53.13 13.38 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 124.683 1.135 . . . . 0.0 111.485 -160.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 1.7 mp -40.96 -46.25 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 C-N-CA 127.263 2.225 . . . . 0.0 110.761 174.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 36.3 mm-40 -135.83 -172.84 3.2 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 128.073 2.549 . . . . 0.0 106.387 176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.549 ' CE1' ' HE3' ' A' ' 61' ' ' LYS . 29.1 m-85 79.16 -73.06 0.07 Allowed 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 127.194 2.197 . . . . 0.0 110.623 170.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -50.62 -44.91 47.62 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 124.124 0.869 . . . . 0.0 112.781 -167.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -90.91 137.38 32.4 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.519 1.128 . . . . 0.0 108.093 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 12.8 t 95.7 176.02 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 129.163 2.985 . . . . 0.0 108.695 -159.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -117.61 13.09 13.44 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 127.238 2.351 . . . . 0.0 112.868 -178.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 6.5 tt -57.52 -43.58 83.28 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.345 0 O-C-N 121.117 -1.225 . . . . 0.0 108.944 155.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 91.4 m -84.4 151.52 24.63 Favored 'General case' 0 N--CA 1.438 -1.029 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 12.2 mt -108.86 -43.86 4.14 Favored 'General case' 0 N--CA 1.462 0.14 0 C-N-CA 123.875 0.87 . . . . 0.0 109.861 179.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -163.96 -170.58 29.08 Favored Glycine 0 C--N 1.335 0.514 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 -176.477 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.532 HG22 ' CD1' ' A' ' 59' ' ' PHE . 47.2 t -123.17 153.25 28.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 125.449 1.5 . . . . 0.0 107.467 171.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 95.3 mt -105.71 153.67 21.52 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 124.912 1.285 . . . . 0.0 110.152 -177.121 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 4.2 m -148.11 156.86 43.51 Favored Pre-proline 0 C--N 1.325 -0.459 0 C-N-CA 125.822 1.649 . . . . 0.0 109.511 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -69.02 115.02 3.78 Favored 'Trans proline' 0 N--CA 1.447 -1.206 0 C-N-CA 121.555 1.503 . . . . 0.0 109.971 175.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.5 t-160 -70.57 128.43 36.1 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 16.5 m -126.48 39.74 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.391 1.876 . . . . 0.0 108.906 -174.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 48.56 55.33 11.12 Favored Glycine 0 C--N 1.338 0.639 0 C-N-CA 124.663 1.125 . . . . 0.0 112.187 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -91.4 -100.81 0.11 Allowed 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 -175.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 47.5 m -162.48 85.48 1.5 Allowed Pre-proline 0 C--O 1.239 0.55 0 O-C-N 120.418 -1.427 . . . . 0.0 108.13 -170.007 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -65.97 151.7 83.32 Favored 'Trans proline' 0 N--CA 1.451 -0.999 0 C-N-CA 121.194 1.263 . . . . 0.0 110.791 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -92.48 -39.21 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.391 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 165.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -144.66 -175.04 4.5 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 125.528 1.531 . . . . 0.0 108.808 -178.355 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -131.36 155.92 46.43 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.114 -1.439 . . . . 0.0 107.114 165.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 7.5 tpt180 -125.44 123.4 39.17 Favored 'General case' 0 CA--C 1.52 -0.189 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 175.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -87.05 148.2 25.37 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 166.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.2 m -148.62 171.04 2.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 127.915 2.486 . . . . 0.0 107.212 179.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -115.32 163.18 16.06 Favored 'General case' 0 CA--C 1.535 0.385 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 169.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -129.33 136.5 50.11 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 127.524 2.33 . . . . 0.0 108.059 -173.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 4.4 ttt-85 -62.94 151.66 38.8 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 118.26 0.482 . . . . 0.0 110.432 177.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.9 tttm -146.34 169.85 17.99 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.624 0.769 . . . . 0.0 111.381 178.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 32.5 m120 -121.35 -17.95 7.47 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 114.865 1.431 . . . . 0.0 114.865 -175.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.826 0 CA-C-O 117.364 -1.798 . . . . 0.0 109.268 -177.166 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.668 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 18.2 m80 -96.5 168.68 10.4 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 107.993 -1.114 . . . . 0.0 107.993 166.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.2 t -99.51 147.85 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 N-CA-C 107.106 -1.442 . . . . 0.0 107.106 164.114 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 16.6 tt0 -98.42 142.69 29.73 Favored 'General case' 0 N--CA 1.432 -1.326 0 C-N-CA 126.171 1.789 . . . . 0.0 107.931 173.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 83.1 mt -131.36 158.65 40.15 Favored 'General case' 0 N--CA 1.442 -0.833 0 C-N-CA 124.677 1.191 . . . . 0.0 108.887 175.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -141.56 112.01 7.0 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 106.364 -1.717 . . . . 0.0 106.364 -167.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 12.9 mt -128.32 146.22 58.81 Favored Pre-proline 0 N--CA 1.466 0.355 0 CA-C-O 118.924 -0.56 . . . . 0.0 110.273 -165.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -71.05 130.62 18.03 Favored 'Trans proline' 0 N--CA 1.457 -0.672 0 C-N-CA 123.459 2.773 . . . . 0.0 110.467 -175.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 24.7 t -80.0 123.24 36.56 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 106.164 -1.791 . . . . 0.0 106.164 169.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 26.4 mt -123.36 148.53 45.95 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 126.32 1.848 . . . . 0.0 107.173 -176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.657 ' O ' HG23 ' A' ' 15' ' ' VAL . 2.7 mm-40 -84.38 135.23 34.37 Favored 'General case' 0 C--N 1.331 -0.196 0 C-N-CA 123.633 0.773 . . . . 0.0 110.284 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 7.4 p -60.49 -21.03 22.12 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 C-N-CA 123.717 0.807 . . . . 0.0 111.428 179.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.58 -22.93 58.72 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 118.831 -0.604 . . . . 0.0 111.611 177.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 28.8 m-20 -103.04 -23.15 13.7 Favored 'General case' 0 C--O 1.232 0.136 0 C-N-CA 125.98 1.712 . . . . 0.0 111.611 -175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 11' ' ' GLN . 2.8 t -69.88 63.89 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.682 0 C-N-CA 126.009 1.724 . . . . 0.0 111.195 175.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 16.2 mt -34.95 -48.38 0.4 Allowed 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 125.795 1.638 . . . . 0.0 113.272 178.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.2 m -119.03 128.67 75.79 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 CA-C-N 119.426 1.012 . . . . 0.0 109.298 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.07 24.18 5.27 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 127.319 2.248 . . . . 0.0 111.18 -168.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -142.33 94.26 0.18 Allowed Glycine 0 N--CA 1.453 -0.23 0 N-CA-C 109.348 -1.501 . . . . 0.0 109.348 -171.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.6 m-85 -60.51 -20.95 61.79 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 117.66 0.73 . . . . 0.0 111.571 176.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -162.59 -177.17 35.39 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 127.422 2.439 . . . . 0.0 107.69 171.413 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -102.25 -8.32 21.38 Favored 'General case' 0 CA--C 1.541 0.63 0 N-CA-C 112.609 0.596 . . . . 0.0 112.609 -178.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.3 m -117.29 158.0 25.11 Favored 'General case' 0 N--CA 1.467 0.4 0 C-N-CA 124.616 1.166 . . . . 0.0 109.836 170.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -63.79 -47.35 91.32 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 CA-C-O 118.438 -0.792 . . . . 0.0 110.794 -176.495 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -69.62 -30.29 67.99 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 119.967 -0.693 . . . . 0.0 110.342 -170.156 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 7.7 mm-40 -55.03 -68.44 0.19 Allowed 'General case' 0 CA--C 1.521 -0.167 0 C-N-CA 125.732 1.613 . . . . 0.0 108.24 169.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -59.5 -36.87 76.89 Favored 'General case' 0 N--CA 1.445 -0.689 0 C-N-CA 123.991 0.916 . . . . 0.0 110.898 -172.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -58.62 -47.11 85.47 Favored 'General case' 0 CA--C 1.538 0.487 0 O-C-N 121.554 -0.716 . . . . 0.0 111.195 173.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.11 -46.19 88.47 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 119.182 0.901 . . . . 0.0 110.218 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -63.31 -38.15 90.03 Favored 'General case' 0 C--N 1.326 -0.413 0 C-N-CA 127.262 2.225 . . . . 0.0 110.897 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -59.03 -46.59 87.83 Favored 'General case' 0 N--CA 1.451 -0.405 0 O-C-N 120.981 -1.074 . . . . 0.0 111.659 -179.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.8 mtt180 -52.82 -39.73 62.7 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 119.198 0.908 . . . . 0.0 110.478 171.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -65.54 -55.54 17.19 Favored 'General case' 0 N--CA 1.433 -1.282 0 C-N-CA 124.804 1.242 . . . . 0.0 112.209 -176.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.6 m80 -71.74 -25.94 62.26 Favored 'General case' 0 C--N 1.339 0.142 0 O-C-N 121.286 -0.884 . . . . 0.0 110.476 -177.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.5 mt -63.47 -36.86 85.16 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.051 0.841 . . . . 0.0 111.142 169.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 3.0 tppt? -67.96 -47.79 67.65 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 119.195 0.907 . . . . 0.0 109.424 -179.782 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 80.0 m-20 -58.86 -46.63 87.3 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 123.174 0.589 . . . . 0.0 110.667 174.101 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.44 -0.19 32.8 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 126.006 1.765 . . . . 0.0 112.712 -173.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -81.58 43.63 0.76 Allowed 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 126.694 1.998 . . . . 0.0 110.232 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -134.74 150.33 50.56 Favored 'General case' 0 N--CA 1.443 -0.787 0 O-C-N 120.699 -1.251 . . . . 0.0 108.053 -179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -127.67 -163.07 11.3 Favored Glycine 0 CA--C 1.52 0.347 0 C-N-CA 124.651 1.119 . . . . 0.0 111.492 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.8 tp -129.32 137.6 51.09 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.551 1.94 . . . . 0.0 106.492 171.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . 0.55 ' CG2' HG21 ' A' ' 15' ' ' VAL . 50.8 t -115.89 130.0 71.31 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 163.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 61.2 mt-10 -59.72 158.45 10.24 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 125.725 1.61 . . . . 0.0 110.465 177.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.9 mt -104.84 126.64 52.12 Favored 'General case' 0 CA--C 1.515 -0.371 0 O-C-N 121.624 -0.673 . . . . 0.0 110.732 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -150.02 170.67 18.32 Favored 'General case' 0 N--CA 1.445 -0.712 0 C-N-CA 127.437 2.295 . . . . 0.0 108.817 -164.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -53.65 -59.96 3.93 Favored 'General case' 0 C--O 1.234 0.267 0 C-N-CA 125.436 1.494 . . . . 0.0 111.204 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.75 22.4 37.3 Favored Glycine 0 CA--C 1.523 0.541 0 C-N-CA 125.68 1.609 . . . . 0.0 111.495 -170.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.2 t -78.87 -64.95 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.188 0 CA-C-N 118.58 1.19 . . . . 0.0 108.987 171.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 1.9 mt -40.17 -54.09 4.77 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 126.855 2.062 . . . . 0.0 111.357 179.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.98 44.13 1.69 Allowed 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.35 2.7 . . . . 0.0 112.699 -177.488 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -148.17 -12.3 0.36 Allowed 'General case' 0 C--N 1.332 -0.163 0 C-N-CA 129.146 2.979 . . . . 0.0 110.709 166.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HB2' ' CE1' ' A' ' 57' ' ' TYR . 77.0 mt -89.0 161.18 16.73 Favored 'General case' 0 CA--C 1.515 -0.401 0 N-CA-C 106.799 -1.556 . . . . 0.0 106.799 -177.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -67.25 -72.25 0.17 Allowed 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.802 -1.094 . . . . 0.0 110.697 -165.522 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 1.9 tp60 -167.64 -50.73 0.0 OUTLIER Pre-proline 0 N--CA 1.435 -1.206 0 CA-C-O 116.906 -1.521 . . . . 0.0 113.179 162.619 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -76.82 92.21 1.12 Allowed 'Trans proline' 0 N--CA 1.439 -1.679 0 N-CA-C 108.137 -1.524 . . . . 0.0 108.137 -179.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.433 ' CE1' ' HB2' ' A' ' 53' ' ' LEU . 8.1 m-85 -78.98 95.47 5.49 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 113.65 -1.613 . . . . 0.0 107.24 -176.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 4.4 t -73.29 92.64 0.59 Allowed 'Isoleucine or valine' 0 C--O 1.232 0.181 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.599 ' CD1' HG22 ' A' ' 95' ' ' VAL . 23.4 m-85 -79.9 162.89 24.73 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-O 123.086 1.422 . . . . 0.0 113.291 -175.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 26.4 pt -116.08 121.73 68.09 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 CA-C-N 111.76 -2.473 . . . . 0.0 107.163 159.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 5.9 ptpt -112.76 147.61 36.52 Favored 'General case' 0 CA--C 1.503 -0.834 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 168.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.609 ' HA ' HG12 ' A' ' 75' ' ' VAL . 0.1 OUTLIER -77.06 110.56 11.81 Favored 'General case' 0 N--CA 1.447 -0.62 0 CA-C-O 119.015 -0.517 . . . . 0.0 109.983 178.25 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 29.5 p -48.39 -68.17 0.21 Allowed 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 124.777 1.231 . . . . 0.0 110.004 172.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 8.1 t0 53.02 23.27 2.84 Favored 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 128.431 2.692 . . . . 0.0 112.625 -178.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -143.18 21.11 1.92 Allowed 'General case' 0 CA--C 1.541 0.621 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 -158.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 4.2 mt -126.51 115.23 19.23 Favored 'General case' 0 N--CA 1.469 0.479 0 N-CA-C 106.387 -1.708 . . . . 0.0 106.387 177.039 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.5 m -70.29 72.32 0.46 Allowed 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 126.818 2.047 . . . . 0.0 111.722 -169.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 89.4 m -134.51 -43.8 0.76 Allowed 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 124.6 1.16 . . . . 0.0 111.842 -176.476 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -116.82 -32.01 5.26 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 120.592 1.542 . . . . 0.0 113.129 -170.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.8 t-160 24.15 69.4 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 128.976 2.91 . . . . 0.0 112.347 -175.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -173.2 -28.25 0.03 OUTLIER Glycine 0 CA--C 1.526 0.719 0 CA-C-O 118.864 -0.965 . . . . 0.0 113.516 -176.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 66.0 m80 -124.09 145.23 49.4 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 118.916 1.358 . . . . 0.0 108.007 178.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -74.74 75.14 2.08 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.469 0.707 . . . . 0.0 109.816 179.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.4 t -52.7 147.97 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 C-N-CA 123.893 0.877 . . . . 0.0 109.626 175.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.609 HG12 ' HA ' ' A' ' 62' ' ' ARG . 35.8 m -121.9 -173.85 0.83 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.449 0 C-N-CA 124.381 1.072 . . . . 0.0 110.25 172.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -143.06 -178.87 6.05 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 170.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.6 mt -105.29 121.29 43.56 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 175.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 61.1 t -123.91 167.92 17.14 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 126.722 2.009 . . . . 0.0 106.958 178.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -142.26 163.69 32.18 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 167.067 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.56 137.32 6.73 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -169.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 3.2 ttm -91.18 -17.55 25.91 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 125.897 1.679 . . . . 0.0 111.99 -168.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -138.66 1.84 2.15 Favored 'General case' 0 N--CA 1.469 0.512 0 O-C-N 120.255 -1.528 . . . . 0.0 110.014 170.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 52.16 33.69 38.39 Favored Glycine 0 N--CA 1.441 -0.98 0 CA-C-O 117.267 -1.852 . . . . 0.0 110.492 -160.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 44.3 mt -25.61 -68.72 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.345 0.371 0 C-N-CA 129.516 3.126 . . . . 0.0 110.054 179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -102.04 -57.27 2.1 Favored 'General case' 0 N--CA 1.462 0.171 0 CA-C-O 121.95 0.881 . . . . 0.0 110.527 -179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -54.77 -34.8 63.07 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 129.334 3.054 . . . . 0.0 111.991 -170.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -73.01 123.71 8.73 Favored Glycine 0 N--CA 1.45 -0.394 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 -179.08 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.446 0.0 OUTLIER 56.16 19.37 3.78 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.519 1.128 . . . . 0.0 113.76 -167.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.45 ' HB3' HG22 ' A' ' 91' ' ' ILE . 58.5 m -73.14 133.82 44.23 Favored 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 107.267 -1.382 . . . . 0.0 107.267 146.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -74.33 -10.96 82.32 Favored Glycine 0 CA--C 1.531 1.05 0 O-C-N 121.625 -0.672 . . . . 0.0 114.455 -172.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.45 HG22 ' HB3' ' A' ' 89' ' ' SER . 12.6 tt -59.45 -36.69 65.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 125.584 1.554 . . . . 0.0 110.655 166.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 5.1 m -78.75 138.18 38.11 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 -174.492 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 10.4 mt -105.6 -30.36 9.54 Favored 'General case' 0 N--CA 1.466 0.363 0 C-N-CA 122.399 0.28 . . . . 0.0 111.319 -173.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 176.27 -168.99 41.42 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.599 HG22 ' CD1' ' A' ' 59' ' ' PHE . 79.7 t -128.36 145.69 35.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 C-N-CA 126.512 1.925 . . . . 0.0 106.936 179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 1.5 mm? -83.92 144.39 29.22 Favored 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 125.126 1.37 . . . . 0.0 109.558 176.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 43' ' ' VAL . 4.2 m -149.22 156.1 39.91 Favored Pre-proline 0 C--N 1.328 -0.355 0 C-N-CA 125.577 1.551 . . . . 0.0 109.198 -176.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -76.74 109.61 2.89 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.186 2.591 . . . . 0.0 110.915 -177.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -80.55 122.62 27.26 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 108.566 -0.901 . . . . 0.0 108.566 176.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.9 m -119.92 38.86 0.86 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.442 0 C-N-CA 124.427 1.091 . . . . 0.0 109.981 177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 58.92 47.56 90.0 Favored Glycine 0 CA--C 1.528 0.849 0 CA-C-O 119.615 -0.547 . . . . 0.0 112.629 178.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -69.85 -101.07 0.0 OUTLIER 'General case' 0 CA--C 1.528 0.128 0 C-N-CA 125.051 1.34 . . . . 0.0 107.49 170.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -166.29 107.89 0.7 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 N-CA-C 106.376 -1.712 . . . . 0.0 106.376 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -72.79 144.87 39.85 Favored 'Trans proline' 0 N--CA 1.445 -1.331 0 C-N-CA 120.864 1.042 . . . . 0.0 111.521 169.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.502 ' H ' HD13 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -81.44 -38.14 16.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.746 168.729 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.77 -168.23 2.98 Favored 'General case' 0 N--CA 1.467 0.385 0 C-N-CA 125.331 1.452 . . . . 0.0 109.866 178.421 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -131.75 138.75 48.74 Favored 'General case' 0 C--O 1.236 0.365 0 C-N-CA 125.104 1.362 . . . . 0.0 109.409 175.81 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 8.2 mmt180 -122.54 114.89 21.28 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 126.452 1.901 . . . . 0.0 107.752 -176.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 37.9 m-20 -79.4 155.84 28.19 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.734 175.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.1 m -144.03 166.31 13.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 126.763 2.025 . . . . 0.0 107.991 171.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -103.64 163.75 12.11 Favored 'General case' 0 N--CA 1.467 0.385 0 O-C-N 121.297 -0.877 . . . . 0.0 109.507 158.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.27 143.48 50.86 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 127.415 2.286 . . . . 0.0 107.93 169.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 1.3 mpt_? -56.61 142.18 40.58 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 171.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.1 mmmt -133.57 70.54 1.46 Allowed 'General case' 0 C--O 1.225 -0.193 0 N-CA-C 107.146 -1.427 . . . . 0.0 107.146 167.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 6.3 m-80 -58.46 -45.68 88.12 Favored 'General case' 0 C--O 1.234 0.241 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 174.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 N-CA-C 103.981 -3.648 . . . . 0.0 103.981 -144.615 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.852 0 N-CA-C 109.892 -1.283 . . . . 0.0 109.892 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 1.4 m80 -78.49 159.12 28.39 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.3 t -88.61 147.27 5.33 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.0 tt0 -100.66 140.55 34.77 Favored 'General case' 0 N--CA 1.447 -0.607 0 CA-C-N 120.772 1.624 . . . . 0.0 110.008 173.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 87.7 mt -136.35 153.4 51.14 Favored 'General case' 0 CA--C 1.516 -0.331 0 C-N-CA 124.791 1.236 . . . . 0.0 108.551 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -118.78 158.22 26.02 Favored 'General case' 0 N--CA 1.445 -0.7 0 C-N-CA 123.905 0.882 . . . . 0.0 108.943 165.73 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 96.2 mt -142.33 146.03 37.64 Favored Pre-proline 0 C--O 1.236 0.352 0 C-N-CA 124.278 1.031 . . . . 0.0 108.705 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_endo -70.6 141.07 40.96 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.164 1.909 . . . . 0.0 108.327 168.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.5 t -92.1 127.51 44.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 105.26 -2.126 . . . . 0.0 105.26 167.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 11.0 mt -123.64 146.02 48.52 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.37 1.868 . . . . 0.0 106.413 -173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -72.75 138.34 46.44 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 121.09 1.768 . . . . 0.0 108.931 176.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 12.2 p -62.11 -25.13 36.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.29 0 O-C-N 121.788 -0.57 . . . . 0.0 110.942 -175.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 12.9 ptt85 -72.97 -37.92 66.9 Favored 'General case' 0 N--CA 1.451 -0.388 0 CA-C-O 118.777 -0.63 . . . . 0.0 111.297 176.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -69.63 -44.84 69.82 Favored 'General case' 0 C--O 1.223 -0.331 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -176.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 14.6 t -56.53 65.82 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.112 0 C-N-CA 131.496 3.918 . . . . 0.0 112.785 170.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 81.5 mt -29.46 -43.51 0.03 OUTLIER 'General case' 0 C--O 1.238 0.465 0 C-N-CA 126.65 1.98 . . . . 0.0 113.366 173.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 5.2 t -123.79 109.13 22.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 125.013 1.325 . . . . 0.0 109.839 -170.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.16 21.27 14.34 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 125.029 1.332 . . . . 0.0 113.019 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.69 98.97 0.5 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 108.785 -1.726 . . . . 0.0 108.785 177.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -52.0 -28.26 16.37 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-N 117.367 0.584 . . . . 0.0 112.369 174.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -163.3 -147.61 5.11 Favored Glycine 0 C--N 1.333 0.388 0 N-CA-C 108.574 -1.811 . . . . 0.0 108.574 179.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 1.8 t70 -121.15 -16.22 8.03 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 113.736 1.013 . . . . 0.0 113.736 -176.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.2 m -130.31 168.92 16.13 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.79 0.836 . . . . 0.0 111.358 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 22.3 t -64.52 -54.04 35.3 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.795 0 O-C-N 121.277 -0.889 . . . . 0.0 109.68 -172.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -67.7 -24.76 65.44 Favored 'General case' 0 N--CA 1.442 -0.837 0 O-C-N 124.329 1.018 . . . . 0.0 110.594 -173.744 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.1 mm-40 -59.89 -66.56 0.5 Allowed 'General case' 0 C--O 1.227 -0.086 0 C-N-CA 124.53 1.132 . . . . 0.0 109.239 170.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -57.39 -41.34 80.07 Favored 'General case' 0 C--O 1.225 -0.204 0 C-N-CA 122.963 0.505 . . . . 0.0 111.312 -174.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.29 -43.43 92.57 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 118.331 0.514 . . . . 0.0 111.261 178.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 t -64.36 -47.08 80.69 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.863 0.865 . . . . 0.0 110.905 177.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.2 mm-40 -66.0 -41.38 91.14 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -178.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -55.7 -52.12 64.98 Favored 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 124.029 0.931 . . . . 0.0 109.835 -178.153 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 7.9 ptt180 -57.59 -39.07 75.98 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 119.071 0.851 . . . . 0.0 112.371 177.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -70.91 -43.56 68.03 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -177.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 52.1 m80 -68.71 -37.61 79.62 Favored 'General case' 0 N--CA 1.454 -0.229 0 O-C-N 120.341 -1.475 . . . . 0.0 109.082 179.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.8 mt -64.9 -29.54 70.49 Favored 'General case' 0 CA--C 1.534 0.363 0 O-C-N 121.057 -1.027 . . . . 0.0 111.191 175.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.5 ttpp -74.26 -46.37 41.91 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.945 1.298 . . . . 0.0 109.69 173.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -64.25 -28.09 69.49 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.153 0.981 . . . . 0.0 112.196 175.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.64 5.43 74.77 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 125.135 1.35 . . . . 0.0 112.758 -169.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.6 p -93.81 39.44 1.07 Allowed 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 126.114 1.766 . . . . 0.0 111.105 -172.72 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 41.9 t -125.27 154.19 42.07 Favored 'General case' 0 N--CA 1.452 -0.336 0 O-C-N 120.769 -1.207 . . . . 0.0 108.35 -179.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.08 178.57 19.74 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 126.417 1.96 . . . . 0.0 109.716 175.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 34.6 tp -125.2 151.19 46.19 Favored 'General case' 0 C--N 1.333 -0.131 0 C-N-CA 125.98 1.712 . . . . 0.0 109.694 -173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 91.7 t -133.82 124.68 47.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 104.559 -2.386 . . . . 0.0 104.559 166.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -73.49 161.08 30.79 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 120.324 1.42 . . . . 0.0 110.414 174.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 HD13 ' H ' ' A' ' 88' ' ' ARG . 17.8 mt -90.15 126.59 35.85 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.75 -1.114 . . . . 0.0 110.58 -175.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 81.6 mt-10 -139.52 167.78 21.31 Favored 'General case' 0 C--O 1.238 0.488 0 N-CA-C 107.032 -1.469 . . . . 0.0 107.032 172.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 35.0 ttpt -43.22 -60.94 1.48 Allowed 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.339 1.456 . . . . 0.0 112.375 -168.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.99 16.85 59.47 Favored Glycine 0 N--CA 1.45 -0.4 0 CA-C-O 118.098 -1.39 . . . . 0.0 114.26 -167.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.464 ' HA ' HE21 ' A' ' 52' ' ' GLN . 91.1 t -75.39 -55.27 12.03 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-N 119.276 1.538 . . . . 0.0 110.961 -172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.497 ' HA ' HD12 ' A' ' 53' ' ' LEU . 6.3 mt -47.81 -52.9 35.71 Favored Pre-proline 0 CA--C 1.536 0.436 0 C-N-CA 127.076 2.15 . . . . 0.0 113.333 -175.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -82.74 43.57 1.51 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 CA-C-N 123.278 2.206 . . . . 0.0 111.978 -171.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . 0.464 HE21 ' HA ' ' A' ' 49' ' ' VAL . 30.8 mt-30 -140.49 -19.91 0.85 Allowed 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 130.099 3.36 . . . . 0.0 109.507 174.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 50' ' ' LEU . 52.8 mt -79.44 179.1 7.64 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 127.945 2.498 . . . . 0.0 107.484 175.066 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 75.0 mm-40 -75.69 -96.11 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.52 -1.289 . . . . 0.0 107.52 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 2.1 mm100 -159.03 -54.56 0.02 OUTLIER Pre-proline 0 N--CA 1.449 -0.505 0 CA-C-O 116.663 -1.637 . . . . 0.0 113.579 -173.633 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_exo -68.54 86.34 0.44 Allowed 'Trans proline' 0 N--CA 1.456 -0.696 0 CA-C-N 122.173 1.812 . . . . 0.0 110.215 172.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 13.0 m-85 -79.45 112.4 16.65 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 -176.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 45.8 t -75.9 91.17 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.224 0 C-N-CA 123.537 0.735 . . . . 0.0 109.397 179.07 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.602 ' CD1' HG22 ' A' ' 95' ' ' VAL . 35.6 m-85 -79.06 168.52 19.54 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 122.485 1.136 . . . . 0.0 111.652 179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 34.1 pt -133.39 123.94 47.73 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 CA-C-N 113.861 -1.518 . . . . 0.0 107.596 171.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.09 150.46 39.95 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.02 176.428 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.4 ptt180 -71.55 66.42 0.5 Allowed 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.476 1.111 . . . . 0.0 113.304 -176.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 31.1 t 46.23 -116.34 0.63 Allowed 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.101 -1.815 . . . . 0.0 106.101 -164.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -150.66 -58.89 0.18 Allowed 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 126.011 1.724 . . . . 0.0 106.373 166.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -85.7 112.72 21.3 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.761 0.824 . . . . 0.0 111.096 177.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 81.8 mt -135.01 172.88 12.38 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 125.681 1.592 . . . . 0.0 107.233 161.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.6 t -132.2 160.69 35.38 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 170.829 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.6 4.44 28.31 Favored 'General case' 0 CA--C 1.538 0.489 0 CA-C-N 119.082 0.855 . . . . 0.0 111.318 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 6.7 t30 -70.51 60.98 0.22 Allowed 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 127.585 2.354 . . . . 0.0 112.536 -174.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 42.5 73.24 0.14 Allowed 'General case' 0 C--O 1.238 0.486 0 C-N-CA 129.013 2.925 . . . . 0.0 110.515 -172.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -133.02 161.28 24.11 Favored Glycine 0 CA--C 1.523 0.585 0 C-N-CA 125.592 1.568 . . . . 0.0 110.575 175.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 55.9 m80 -87.72 156.97 19.19 Favored 'General case' 0 C--O 1.238 0.456 0 C-N-CA 123.254 0.622 . . . . 0.0 111.234 178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 17.9 mtmm -73.21 95.94 2.18 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 161.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -69.81 166.03 2.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 157.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 29.8 m -134.0 -179.38 3.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.347 0 C-N-CA 124.139 0.976 . . . . 0.0 108.667 160.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -127.98 -171.46 2.45 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.416 1.087 . . . . 0.0 108.647 166.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 21.7 mt -97.45 149.35 22.25 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.863 1.665 . . . . 0.0 109.406 164.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.34 169.01 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.633 0 N-CA-C 105.209 -2.145 . . . . 0.0 105.209 165.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -161.66 126.17 3.39 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -177.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -139.51 116.97 11.34 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 118.824 -0.608 . . . . 0.0 110.041 -171.438 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 21.2 ptm -73.66 4.68 4.72 Favored 'General case' 0 N--CA 1.471 0.594 0 N-CA-C 114.56 1.319 . . . . 0.0 114.56 -179.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -142.13 4.79 1.65 Allowed 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.221 1.008 . . . . 0.0 110.822 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 50.72 38.29 36.3 Favored Glycine 0 CA--C 1.536 1.394 0 O-C-N 121.0 -1.062 . . . . 0.0 113.001 -159.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 82.4 mt -38.95 -63.19 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 128.023 2.529 . . . . 0.0 110.702 -174.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 14.3 mm100 -130.61 179.63 5.83 Favored 'General case' 0 N--CA 1.444 -0.769 0 C-N-CA 125.066 1.346 . . . . 0.0 108.39 174.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 15.6 m-85 74.07 -53.81 0.68 Allowed 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 128.209 2.604 . . . . 0.0 110.933 177.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -44.07 136.16 5.48 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 125.338 1.446 . . . . 0.0 110.699 176.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.428 ' H ' HD13 ' A' ' 45' ' ' LEU . 0.8 OUTLIER 62.88 -5.37 0.2 Allowed 'General case' 0 CA--C 1.546 0.821 0 N-CA-C 114.786 1.402 . . . . 0.0 114.786 173.452 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 3.9 t -75.55 175.56 8.42 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.264 1.426 . . . . 0.0 111.922 -178.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -75.17 34.14 1.09 Allowed Glycine 0 CA--C 1.526 0.72 0 C-N-CA 128.114 2.769 . . . . 0.0 113.828 -176.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . . . . . . . . . 21.2 tt -155.33 -32.26 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.424 0 C-N-CA 124.837 1.255 . . . . 0.0 111.642 -171.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.4 m -82.83 148.52 27.71 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -174.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 6.2 mt -109.09 -45.47 3.76 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.245 0.618 . . . . 0.0 109.527 -174.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -168.0 -171.17 33.64 Favored Glycine 0 C--N 1.337 0.603 0 N-CA-C 110.385 -1.086 . . . . 0.0 110.385 -174.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.602 HG22 ' CD1' ' A' ' 59' ' ' PHE . 95.3 t -120.55 143.88 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 126.931 2.093 . . . . 0.0 106.864 171.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 74.2 mt -90.64 150.43 21.69 Favored 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.938 1.295 . . . . 0.0 110.825 179.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 15.9 m -139.85 161.64 55.07 Favored Pre-proline 0 C--N 1.323 -0.574 0 C-N-CA 125.958 1.703 . . . . 0.0 108.694 179.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -61.75 143.03 95.84 Favored 'Trans proline' 0 N--CA 1.447 -1.254 0 C-N-CA 121.179 1.253 . . . . 0.0 109.224 162.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 10.2 t-80 -94.0 121.83 35.88 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 165.207 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 23.3 m -135.82 39.59 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.803 0 C-N-CA 126.001 1.721 . . . . 0.0 111.021 -175.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 75.95 17.18 80.19 Favored Glycine 0 CA--C 1.533 1.214 0 O-C-N 120.722 -1.236 . . . . 0.0 114.893 170.444 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -69.92 0.06 6.53 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 126.347 1.859 . . . . 0.0 113.517 -176.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 104' ' ' PRO 0.274 1.3 m 69.36 116.74 0.03 OUTLIER Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 128.871 2.868 . . . . 0.0 113.58 -174.862 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 103' ' ' THR . 3.8 Cg_exo -69.84 160.39 49.87 Favored 'Trans proline' 0 C--N 1.352 0.722 0 C-N-CA 122.197 1.931 . . . . 0.0 111.415 176.449 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -103.74 -31.74 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 C-N-CA 124.186 0.994 . . . . 0.0 110.029 164.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -152.33 -172.5 4.25 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 125.046 1.338 . . . . 0.0 109.11 179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -136.49 153.43 51.04 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.269 1.428 . . . . 0.0 109.773 173.384 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 18.2 mmt180 -130.55 116.7 18.52 Favored 'General case' 0 CA--C 1.512 -0.503 0 C-N-CA 125.462 1.505 . . . . 0.0 107.884 177.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . . . . . . . . . 4.1 p-10 -96.58 146.04 25.18 Favored 'General case' 0 C--O 1.238 0.452 0 O-C-N 123.747 0.654 . . . . 0.0 109.648 167.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.3 m -148.82 179.03 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 128.211 2.605 . . . . 0.0 106.689 -177.373 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.99 155.13 21.23 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 161.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -100.04 139.02 36.31 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 127.959 2.504 . . . . 0.0 105.736 164.062 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -66.49 30.28 0.02 OUTLIER 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.767 1.627 . . . . 0.0 114.455 175.734 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 12.4 ttmt 60.93 -139.65 0.55 Allowed 'General case' 0 C--O 1.233 0.221 0 C-N-CA 125.229 1.412 . . . . 0.0 107.291 -176.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 14.9 m-80 -93.79 -80.83 0.38 Allowed 'General case' 0 CA--C 1.516 -0.33 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 177.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.974 0 N-CA-C 104.76 -3.336 . . . . 0.0 104.76 -157.478 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.868 0 N-CA-C 110.815 -0.914 . . . . 0.0 110.815 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 32.2 m80 60.47 171.95 0.09 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.676 1.99 . . . . 0.0 110.753 -162.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.1 t -124.48 141.66 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 N-CA-C 106.233 -1.766 . . . . 0.0 106.233 178.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -88.34 139.46 30.47 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 179.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 94.2 mt -136.44 139.92 42.74 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 174.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.436 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 0.8 OUTLIER -107.86 161.29 15.05 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.172 0.989 . . . . 0.0 108.447 175.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 16.1 mt -143.81 131.1 10.59 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 178.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -65.15 129.57 23.3 Favored 'Trans proline' 0 N--CA 1.451 -1.007 0 N-CA-C 107.495 -1.771 . . . . 0.0 107.495 163.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 90.9 t -79.84 118.24 27.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 N-CA-C 104.956 -2.239 . . . . 0.0 104.956 170.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 44.3 mt -119.15 139.03 52.49 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -173.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.414 ' O ' HG23 ' A' ' 15' ' ' VAL . 8.5 mt-30 -65.24 134.08 52.87 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 176.423 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 8.8 p -63.74 -22.2 30.42 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 O-C-N 121.493 -0.754 . . . . 0.0 111.521 -179.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -65.47 -48.33 73.02 Favored 'General case' 0 C--N 1.342 0.248 0 CA-C-N 119.072 0.851 . . . . 0.0 110.031 171.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -66.45 -42.56 87.42 Favored 'General case' 0 C--O 1.235 0.327 0 C-N-CA 124.714 1.205 . . . . 0.0 110.114 -170.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 11' ' ' GLN . 37.2 t -61.9 64.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--O 1.216 -0.677 0 C-N-CA 130.882 3.673 . . . . 0.0 110.192 172.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 53.4 mt -43.24 -43.81 4.98 Favored 'General case' 0 C--N 1.323 -0.563 0 O-C-N 120.427 -1.42 . . . . 0.0 113.333 167.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.8 p -99.71 99.28 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 CA-C-O 122.766 1.27 . . . . 0.0 109.693 -177.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 -103.23 7.31 38.51 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 127.964 2.506 . . . . 0.0 112.234 -174.326 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -127.75 140.26 11.7 Favored Glycine 0 N--CA 1.444 -0.797 0 N-CA-C 108.289 -1.924 . . . . 0.0 108.289 173.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 87.8 m-85 -83.0 -14.91 53.09 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 117.804 0.802 . . . . 0.0 111.502 164.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -166.89 176.68 41.87 Favored Glycine 0 C--O 1.239 0.454 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 174.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -83.1 -23.8 32.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 124.136 0.974 . . . . 0.0 112.471 177.612 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 67.1 m -119.29 158.99 24.95 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.759 0.824 . . . . 0.0 112.624 -176.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -59.2 -50.22 80.59 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.639 0 C-N-CA 124.184 0.994 . . . . 0.0 110.077 -173.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -68.62 -43.1 77.09 Favored 'General case' 0 N--CA 1.434 -1.263 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.289 -171.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -51.2 -59.58 4.04 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.633 1.573 . . . . 0.0 108.588 173.545 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -61.52 -43.3 99.11 Favored 'General case' 0 N--CA 1.444 -0.774 0 C-N-CA 123.805 0.842 . . . . 0.0 111.22 -168.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -61.06 -43.28 99.13 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 118.077 0.399 . . . . 0.0 110.611 177.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 18.2 m -62.36 -53.37 56.07 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 124.276 1.031 . . . . 0.0 110.889 -178.697 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.82 -39.01 87.37 Favored 'General case' 0 N--CA 1.449 -0.477 0 C-N-CA 125.982 1.713 . . . . 0.0 110.387 179.871 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -57.63 -56.98 14.94 Favored 'General case' 0 N--CA 1.445 -0.716 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -49.66 -35.98 23.28 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.473 1.033 . . . . 0.0 111.012 176.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.29 -44.39 71.89 Favored 'General case' 0 N--CA 1.444 -0.753 0 C-N-CA 123.92 0.888 . . . . 0.0 112.656 177.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -72.41 -32.97 66.81 Favored 'General case' 0 C--O 1.224 -0.25 0 O-C-N 120.129 -1.607 . . . . 0.0 108.497 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 3.2 mp -64.65 -32.78 74.59 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.345 1.058 . . . . 0.0 112.209 173.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -61.09 -44.82 96.78 Favored 'General case' 0 CA--C 1.521 -0.173 0 CA-C-N 119.779 1.172 . . . . 0.0 109.944 171.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 26.7 m-80 -80.53 -16.82 53.29 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 123.859 0.864 . . . . 0.0 112.101 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.57 7.05 88.78 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.077 1.323 . . . . 0.0 113.053 -171.775 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 41.3 p -84.51 39.75 0.75 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 126.386 1.874 . . . . 0.0 110.398 -176.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 49.1 t -132.38 134.71 45.48 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 126.44 1.896 . . . . 0.0 106.803 -174.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -125.67 177.8 16.89 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 127.835 2.636 . . . . 0.0 110.449 177.463 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 25.2 tp -131.14 112.21 12.65 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 118.237 1.019 . . . . 0.0 112.668 -171.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 11.1 t -79.94 134.9 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 124.924 1.29 . . . . 0.0 108.616 165.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -67.71 149.94 49.35 Favored 'General case' 0 CA--C 1.523 -0.084 0 O-C-N 121.919 -0.488 . . . . 0.0 109.737 171.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 10.3 mt -81.79 112.63 19.11 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 164.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -118.94 -168.18 1.51 Allowed 'General case' 0 C--O 1.236 0.367 0 C-N-CA 125.06 1.344 . . . . 0.0 108.093 164.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 7.3 tttm -79.67 -42.23 25.21 Favored 'General case' 0 CA--C 1.528 0.121 0 O-C-N 121.525 -0.734 . . . . 0.0 111.506 -176.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.44 3.73 71.74 Favored Glycine 0 C--O 1.221 -0.708 0 CA-C-O 118.928 -0.929 . . . . 0.0 114.17 -177.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.3 t -81.15 -55.87 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-N 120.263 2.032 . . . . 0.0 112.793 -161.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.9 mt -53.54 -46.91 97.96 Favored Pre-proline 0 CA--C 1.538 0.483 0 CA-C-O 116.576 -1.678 . . . . 0.0 113.212 -175.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -83.35 44.16 1.58 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.371 2.048 . . . . 0.0 110.167 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 28.5 mt-30 -140.72 -26.64 0.74 Allowed 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 128.651 2.78 . . . . 0.0 108.665 168.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.08 166.1 23.2 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.223 1.409 . . . . 0.0 109.522 173.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -70.33 -80.0 0.06 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-O 118.6 -0.715 . . . . 0.0 110.092 -169.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . 0.419 ' HB3' ' HD3' ' A' ' 56' ' ' PRO . 24.9 tp60 -162.12 -54.11 0.01 OUTLIER Pre-proline 0 N--CA 1.434 -1.235 0 CA-C-O 116.445 -1.741 . . . . 0.0 111.807 169.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.419 ' HD3' ' HB3' ' A' ' 55' ' ' GLN . 57.9 Cg_endo -76.77 89.62 1.28 Allowed 'Trans proline' 0 N--CA 1.446 -1.311 0 CA-C-N 122.459 1.914 . . . . 0.0 107.578 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -78.03 111.49 13.98 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 113.142 -1.845 . . . . 0.0 107.045 -173.52 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 39.0 t -83.56 87.45 2.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 -178.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.623 ' CD1' HG22 ' A' ' 95' ' ' VAL . 40.8 m-85 -79.1 166.26 22.46 Favored 'General case' 0 CA--C 1.511 -0.549 0 CA-C-O 122.423 1.106 . . . . 0.0 111.654 179.557 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 28.9 pt -126.22 129.27 72.08 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.953 0 CA-C-N 112.455 -2.157 . . . . 0.0 108.693 169.402 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.488 ' HG2' HG21 ' A' ' 78' ' ' VAL . 2.3 pttt -133.46 141.71 47.94 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.109 0.964 . . . . 0.0 109.367 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.3 ptt180 -71.78 77.47 0.86 Allowed 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.249 1.02 . . . . 0.0 111.167 176.826 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 8.1 t 35.64 88.93 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 129.008 2.923 . . . . 0.0 112.787 161.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 57.9 t0 -75.96 68.91 2.52 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.367 0.667 . . . . 0.0 112.032 -173.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -156.26 19.02 0.35 Allowed 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.106 0.962 . . . . 0.0 112.452 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 57.1 mt -124.46 160.99 27.01 Favored 'General case' 0 N--CA 1.464 0.244 0 O-C-N 121.342 -0.849 . . . . 0.0 111.114 -162.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 85.2 p -114.23 -15.01 12.24 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.611 1.165 . . . . 0.0 112.301 -173.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 91.0 m -157.17 146.22 20.01 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -99.24 55.57 1.0 Allowed 'General case' 0 CA--C 1.535 0.375 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 -178.472 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 4.2 m80 -68.23 155.95 38.63 Favored 'General case' 0 C--O 1.233 0.206 0 O-C-N 121.109 -0.994 . . . . 0.0 108.705 172.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 79.22 -173.91 55.27 Favored Glycine 0 CA--C 1.523 0.535 0 N-CA-C 111.623 -0.591 . . . . 0.0 111.623 178.571 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.98 156.24 31.92 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.947 0.899 . . . . 0.0 110.822 -176.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.9 mtmp? -71.96 91.94 1.24 Allowed 'General case' 0 C--O 1.232 0.182 0 CA-C-O 122.281 1.039 . . . . 0.0 110.614 175.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -68.53 149.49 11.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 C-N-CA 125.359 1.464 . . . . 0.0 107.639 161.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 31.3 m -136.39 -179.23 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 164.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -126.26 156.27 40.58 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 171.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.2 mt -77.92 139.02 39.19 Favored 'General case' 0 C--O 1.236 0.349 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 162.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.488 HG21 ' HG2' ' A' ' 61' ' ' LYS . 2.4 t -141.55 157.07 21.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 104.422 -2.436 . . . . 0.0 104.422 177.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -136.59 145.56 45.08 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 120.766 -1.209 . . . . 0.0 108.795 168.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -157.94 125.92 5.34 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 124.197 0.999 . . . . 0.0 108.414 -167.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.9 ptm -79.54 -48.35 14.01 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 118.736 0.698 . . . . 0.0 110.868 -176.838 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -86.53 2.65 47.3 Favored 'General case' 0 N--CA 1.471 0.59 0 O-C-N 120.102 -1.624 . . . . 0.0 110.853 -174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 39.41 50.53 2.99 Favored Glycine 0 CA--C 1.53 1.005 0 CA-C-O 118.741 -1.033 . . . . 0.0 110.686 -146.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 87.2 mt -46.4 -56.08 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.346 0.439 0 C-N-CA 126.109 1.763 . . . . 0.0 108.609 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -110.77 172.88 6.61 Favored 'General case' 0 N--CA 1.437 -1.111 0 N-CA-C 106.059 -1.83 . . . . 0.0 106.059 169.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.459 ' CE1' ' HD3' ' A' ' 61' ' ' LYS . 14.2 m-85 71.57 -47.03 0.65 Allowed 'General case' 0 C--N 1.318 -0.77 0 C-N-CA 128.355 2.662 . . . . 0.0 112.96 169.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -61.87 -19.0 58.19 Favored Glycine 0 N--CA 1.465 0.571 0 CA-C-N 120.156 1.344 . . . . 0.0 114.425 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.75 12.74 12.25 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 125.106 1.362 . . . . 0.0 113.241 172.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.43 ' HB3' HG22 ' A' ' 91' ' ' ILE . 61.5 m -90.76 172.75 8.42 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.065 0.848 . . . . 0.0 109.845 175.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -110.34 -3.91 29.08 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 123.972 0.796 . . . . 0.0 112.566 172.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.43 HG22 ' HB3' ' A' ' 89' ' ' SER . 9.7 tt -61.06 -21.17 23.8 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.591 0 O-C-N 120.759 -1.436 . . . . 0.0 111.491 162.556 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.9 m -93.18 142.43 27.31 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 123.886 0.874 . . . . 0.0 109.353 -165.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 11.0 mt -109.93 -30.81 7.64 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 122.922 0.489 . . . . 0.0 111.739 -174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.35 -171.88 41.32 Favored Glycine 0 C--N 1.337 0.588 0 N-CA-C 110.646 -0.981 . . . . 0.0 110.646 174.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.623 HG22 ' CD1' ' A' ' 59' ' ' PHE . 91.0 t -115.34 133.22 62.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.941 1.696 . . . . 0.0 106.624 170.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 75.3 mt -83.77 145.61 28.61 Favored 'General case' 0 N--CA 1.443 -0.806 0 C-N-CA 125.142 1.377 . . . . 0.0 108.612 179.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 27.9 m -141.89 149.08 51.69 Favored Pre-proline 0 C--N 1.322 -0.604 0 C-N-CA 124.895 1.278 . . . . 0.0 107.97 -175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_endo -66.46 125.51 14.03 Favored 'Trans proline' 0 N--CA 1.45 -1.053 0 CA-C-N 120.71 1.289 . . . . 0.0 108.765 173.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 12.6 t-80 -76.7 127.73 33.32 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 32.8 m -132.85 39.45 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 C-N-CA 125.418 1.487 . . . . 0.0 110.52 -178.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 63.17 48.65 77.87 Favored Glycine 0 C--N 1.336 0.534 0 CA-C-O 118.734 -1.037 . . . . 0.0 112.92 170.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -81.5 -101.18 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.518 0 O-C-N 124.309 0.653 . . . . 0.0 109.46 167.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -159.65 125.92 2.44 Favored Pre-proline 0 CA--C 1.535 0.403 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 174.548 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -74.65 148.54 37.16 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 121.417 1.412 . . . . 0.0 110.502 164.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -102.39 -23.51 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.368 1.067 . . . . 0.0 111.292 168.588 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -159.22 -179.85 8.36 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 127.111 2.164 . . . . 0.0 107.535 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -134.63 139.75 45.54 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 124.243 1.017 . . . . 0.0 108.905 173.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 41.6 mmt-85 -117.43 97.84 6.1 Favored 'General case' 0 CA--C 1.503 -0.839 0 C-N-CA 126.016 1.726 . . . . 0.0 108.001 -177.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.436 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 9.2 m-20 -83.09 140.86 32.41 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 106.414 -1.699 . . . . 0.0 106.414 174.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.0 m -142.78 178.99 1.89 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 C-N-CA 126.988 2.115 . . . . 0.0 107.505 177.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -114.23 167.78 10.4 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.938 0.895 . . . . 0.0 109.252 166.073 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 23.8 tp -131.78 139.69 48.99 Favored 'General case' 0 C--O 1.225 -0.201 0 C-N-CA 129.887 3.275 . . . . 0.0 108.34 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 14.3 ptt85 -51.69 129.53 26.29 Favored 'General case' 0 CA--C 1.535 0.383 0 N-CA-C 114.758 1.392 . . . . 0.0 114.758 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 13.2 mttm -157.81 98.73 1.66 Allowed 'General case' 0 C--O 1.233 0.201 0 C-N-CA 130.089 3.356 . . . . 0.0 106.284 161.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 15.3 p-10 -53.95 -38.98 65.51 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 148.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.401 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 166.035 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.599 0 N-CA-C 109.225 -1.55 . . . . 0.0 109.225 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.545 ' CB ' HD12 ' A' ' 111' ' ' LEU . 33.9 m80 58.05 -176.59 0.07 Allowed 'General case' 0 CA--C 1.545 0.782 0 C-N-CA 123.529 0.732 . . . . 0.0 111.706 -173.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 ' C ' HD13 ' A' ' 111' ' ' LEU . 0.0 OUTLIER -142.27 116.81 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 C-N-CA 127.028 2.131 . . . . 0.0 107.526 -178.024 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.549 ' HG3' HD22 ' A' ' 111' ' ' LEU . 19.7 tt0 -67.12 140.35 57.55 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 90.0 mt -139.03 116.36 11.16 Favored 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 125.956 1.703 . . . . 0.0 107.332 174.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 109' ' ' ASN . 22.2 m -79.28 163.19 25.14 Favored 'General case' 0 N--CA 1.438 -1.047 0 CA-C-N 115.33 -0.85 . . . . 0.0 108.843 160.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 74.9 mt -143.88 151.37 52.72 Favored Pre-proline 0 N--CA 1.452 -0.338 0 C-N-CA 126.697 1.999 . . . . 0.0 107.651 175.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -69.75 160.13 50.86 Favored 'Trans proline' 0 CA--C 1.54 0.813 0 C-N-CA 122.194 1.93 . . . . 0.0 110.089 161.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.1 t -111.71 133.7 56.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.34 -2.096 . . . . 0.0 105.34 169.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.3 mt -126.74 138.48 53.39 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 124.701 1.201 . . . . 0.0 108.56 -171.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -64.17 144.18 57.31 Favored 'General case' 0 CA--C 1.522 -0.122 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -177.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 2.2 p -69.3 0.66 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 O-C-N 120.845 -1.159 . . . . 0.0 110.678 174.251 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 9.0 mtt-85 -108.9 -9.43 15.14 Favored 'General case' 0 C--N 1.34 0.182 0 O-C-N 120.785 -1.197 . . . . 0.0 113.584 170.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.25 -40.23 10.1 Favored 'General case' 0 CA--C 1.515 -0.399 0 O-C-N 121.226 -0.921 . . . . 0.0 110.967 176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . 0.313 21.2 t -57.47 67.09 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 128.775 2.83 . . . . 0.0 115.553 176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 52.9 mt -39.76 -52.82 2.29 Favored 'General case' 0 C--N 1.324 -0.517 0 O-C-N 119.411 -2.056 . . . . 0.0 112.646 163.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.3 t -82.75 82.14 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 CA-C-O 124.288 1.994 . . . . 0.0 109.622 -169.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.645 ' HE ' HD13 ' A' ' 53' ' ' LEU . 3.8 mmp_? -80.24 -1.38 40.42 Favored 'General case' 0 C--N 1.325 -0.497 0 C-N-CA 127.647 2.379 . . . . 0.0 112.659 -171.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -152.69 115.86 0.71 Allowed Glycine 0 N--CA 1.444 -0.817 0 N-CA-C 105.309 -3.116 . . . . 0.0 105.309 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.5 m-85 -62.63 -29.61 70.75 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 119.09 1.445 . . . . 0.0 111.084 172.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -160.21 -175.3 31.04 Favored Glycine 0 N--CA 1.446 -0.66 0 N-CA-C 107.386 -2.286 . . . . 0.0 107.386 179.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 47.9 t0 -120.51 31.69 6.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 122.958 1.361 . . . . 0.0 110.767 -168.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 75.7 m -153.44 162.73 40.98 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 127.949 2.5 . . . . 0.0 106.209 159.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 24.3 m -59.92 -43.83 93.08 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.524 0 CA-C-N 120.139 1.336 . . . . 0.0 109.664 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -68.87 -36.14 77.75 Favored 'General case' 0 N--CA 1.438 -1.047 0 O-C-N 124.13 0.894 . . . . 0.0 109.708 -172.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -58.67 -56.58 20.35 Favored 'General case' 0 CA--C 1.518 -0.279 0 C-N-CA 125.675 1.59 . . . . 0.0 109.482 173.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -62.98 -39.01 93.45 Favored 'General case' 0 N--CA 1.44 -0.974 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.391 -171.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -68.71 -34.88 76.39 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.299 0.64 . . . . 0.0 112.656 177.293 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.4 m -63.67 -58.37 7.12 Favored 'General case' 0 C--O 1.236 0.355 0 CA-C-N 118.682 0.674 . . . . 0.0 109.608 174.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 12.2 mm-40 -55.61 -44.67 77.26 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 125.529 1.532 . . . . 0.0 110.023 -177.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -48.67 -61.55 1.97 Allowed 'General case' 0 N--CA 1.441 -0.879 0 C-N-CA 123.942 0.897 . . . . 0.0 109.704 171.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 82.1 mtp180 -60.21 -12.78 9.6 Favored 'General case' 0 N--CA 1.47 0.537 0 O-C-N 121.069 -1.019 . . . . 0.0 113.489 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.87 -43.18 14.36 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 124.938 1.295 . . . . 0.0 112.583 169.247 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 25.4 m80 -77.35 -27.83 52.81 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 124.641 1.177 . . . . 0.0 108.095 -172.544 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.0 mp -60.62 -46.2 91.16 Favored 'General case' 0 N--CA 1.451 -0.382 0 O-C-N 121.357 -0.839 . . . . 0.0 111.558 168.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 1.3 tmmm? -65.55 -40.07 92.42 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.838 0.855 . . . . 0.0 111.203 -174.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASN . . . . . . . . . . . . . 68.0 m-80 -73.67 -41.68 62.34 Favored 'General case' 0 CA--C 1.521 -0.162 0 C-N-CA 123.317 0.647 . . . . 0.0 110.247 173.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 103.15 27.65 6.46 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 125.471 1.51 . . . . 0.0 112.833 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 11.4 p -103.47 40.0 1.49 Allowed 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 128.909 2.884 . . . . 0.0 109.304 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 42.8 t -120.17 153.09 36.73 Favored 'General case' 0 CA--C 1.54 0.578 0 O-C-N 120.62 -1.3 . . . . 0.0 109.263 175.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.73 178.44 21.12 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 126.849 2.166 . . . . 0.0 110.5 171.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 16.1 tp -116.87 148.61 41.14 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 126.65 1.98 . . . . 0.0 110.13 -171.266 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' VAL . . . . . . . . . . . . . 42.1 t -130.51 116.01 33.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.336 0 C-N-CA 127.964 2.505 . . . . 0.0 105.452 171.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -66.37 151.57 46.85 Favored 'General case' 0 C--O 1.236 0.361 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 95' ' ' VAL . 37.3 mt -88.24 151.35 22.72 Favored 'General case' 0 N--CA 1.465 0.28 0 C-N-CA 122.687 0.395 . . . . 0.0 111.169 178.369 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 4.2 mt-10 -151.25 -175.06 5.01 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.44 1.496 . . . . 0.0 110.427 -170.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 28.7 tptt -67.02 -51.47 54.49 Favored 'General case' 0 N--CA 1.468 0.45 0 O-C-N 120.197 -1.564 . . . . 0.0 110.03 162.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -102.35 11.04 56.78 Favored Glycine 0 CA--C 1.522 0.476 0 CA-C-O 118.534 -1.148 . . . . 0.0 114.026 -163.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 3.7 t -77.12 -55.66 10.09 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 119.88 1.84 . . . . 0.0 109.893 171.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.488 HD22 ' CE2' ' A' ' 57' ' ' TYR . 0.5 OUTLIER -41.55 -53.18 7.59 Favored Pre-proline 0 CA--C 1.542 0.669 0 CA-C-O 117.007 -1.473 . . . . 0.0 113.574 178.415 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -79.56 43.87 1.59 Allowed 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.565 2.843 . . . . 0.0 111.768 178.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLN . . . . . . . . . . . . . 62.3 mt-30 -143.19 -28.19 0.56 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 128.751 2.82 . . . . 0.0 109.725 168.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.645 HD13 ' HE ' ' A' ' 18' ' ' ARG . 0.9 OUTLIER -79.4 161.16 26.33 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-N 119.973 1.261 . . . . 0.0 109.638 -177.698 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -62.19 -86.44 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 126.169 1.788 . . . . 0.0 109.35 -174.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.61 -62.61 0.02 OUTLIER Pre-proline 0 N--CA 1.451 -0.422 0 CA-C-O 116.157 -1.878 . . . . 0.0 111.481 179.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -76.67 87.43 1.47 Allowed 'Trans proline' 0 N--CA 1.451 -1.015 0 CA-C-N 122.089 1.782 . . . . 0.0 108.867 -179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.488 ' CE2' HD22 ' A' ' 50' ' ' LEU . 5.3 m-85 -78.95 108.48 12.46 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 -178.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 47.6 t -73.14 99.89 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' PHE . . . . . 0.552 ' CD1' HG22 ' A' ' 95' ' ' VAL . 25.2 m-85 -87.33 167.64 13.88 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-O 122.448 1.118 . . . . 0.0 112.56 179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 27.8 pt -122.01 117.19 51.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.084 0 CA-C-N 112.813 -1.994 . . . . 0.0 107.5 165.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HE2' HG21 ' A' ' 78' ' ' VAL . 0.0 OUTLIER -119.94 160.65 22.32 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 118.895 -0.574 . . . . 0.0 110.252 173.735 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 5.2 mtm180 -69.64 38.83 0.04 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 115.351 1.612 . . . . 0.0 115.351 -173.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 74.18 -48.13 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 126.506 1.922 . . . . 0.0 110.071 -175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . . . . . . . . . 24.3 t0 68.3 -62.58 0.36 Allowed 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 127.912 2.485 . . . . 0.0 109.888 -168.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -72.6 30.17 0.06 Allowed 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.952 1.701 . . . . 0.0 112.91 174.116 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . 0.34 0.6 OUTLIER 26.77 60.59 0.08 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 130.088 3.355 . . . . 0.0 116.042 164.476 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.6 t -24.83 -61.67 0.06 Allowed 'General case' 0 C--O 1.24 0.59 0 C-N-CA 130.43 3.492 . . . . 0.0 114.09 -178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' THR . . . . . . . . . . . . . 23.8 p -140.62 169.7 17.16 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -31.97 -73.49 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 127.404 2.282 . . . . 0.0 113.556 -174.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' HIS . . . . . . . . . . . . . 34.9 t-80 -166.33 151.83 8.42 Favored 'General case' 0 C--O 1.24 0.57 0 C-N-CA 126.45 1.9 . . . . 0.0 106.517 176.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -168.29 69.33 0.17 Allowed Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' HIS . . . . . . . . . . . . . 25.5 m-70 54.21 -160.8 0.14 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-O 122.137 0.97 . . . . 0.0 110.664 -164.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.4 tppt? -66.43 73.38 0.08 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.158 2.183 . . . . 0.0 110.592 173.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.9 t -62.67 145.62 13.3 Favored 'Isoleucine or valine' 0 C--O 1.235 0.297 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 174.364 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 4.6 m -138.65 178.91 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.759 0 C-N-CA 125.484 1.513 . . . . 0.0 108.684 171.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -146.86 167.07 24.84 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 157.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 3.1 mt -62.85 137.86 58.38 Favored 'General case' 0 C--O 1.242 0.69 0 C-N-CA 125.205 1.402 . . . . 0.0 110.705 164.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.457 HG21 ' HE2' ' A' ' 61' ' ' LYS . 65.0 t -132.83 170.78 19.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 C-N-CA 128.829 2.852 . . . . 0.0 105.275 162.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -138.66 151.58 47.32 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 167.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -153.86 141.69 20.11 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 168.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.1 ptp -78.21 133.54 37.73 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 173.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.3 t0 48.66 13.94 0.06 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 125.192 1.397 . . . . 0.0 114.709 -166.145 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 73.06 14.72 78.74 Favored Glycine 0 N--CA 1.436 -1.353 0 CA-C-O 116.492 -2.282 . . . . 0.0 114.794 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -23.2 -83.5 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.915 0 C-N-CA 127.616 2.366 . . . . 0.0 113.212 -157.436 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -89.41 -53.22 4.64 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 119.839 1.199 . . . . 0.0 112.391 -172.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -54.38 -35.43 62.81 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 126.357 1.863 . . . . 0.0 111.964 -177.495 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLY . . . . . . . . . . . . . . . -62.33 140.94 46.71 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -178.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 17.5 ttp180 56.08 3.52 0.1 Allowed 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.261 1.824 . . . . 0.0 114.49 -179.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.414 ' CB ' HG22 ' A' ' 91' ' ' ILE . 74.6 m -64.39 141.52 58.74 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 120.058 1.299 . . . . 0.0 107.662 160.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -72.87 -8.65 73.68 Favored Glycine 0 CA--C 1.526 0.747 0 O-C-N 121.328 -0.857 . . . . 0.0 113.026 -178.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ILE . . . . . 0.414 HG22 ' CB ' ' A' ' 89' ' ' SER . 11.7 tt -64.75 -28.83 45.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 124.728 1.211 . . . . 0.0 110.943 165.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 28.5 m -95.65 121.53 37.45 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 -170.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 22.5 mt -85.13 -52.17 6.13 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 -172.7 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -153.24 -176.23 25.5 Favored Glycine 0 C--N 1.336 0.552 0 N-CA-C 110.413 -1.075 . . . . 0.0 110.413 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 59' ' ' PHE . 58.2 t -100.94 160.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 C-N-CA 126.763 2.025 . . . . 0.0 106.604 163.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 89.8 mt -117.22 151.95 35.83 Favored 'General case' 0 N--CA 1.44 -0.931 0 C-N-CA 125.32 1.448 . . . . 0.0 108.472 177.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 23.8 m -142.45 153.79 62.78 Favored Pre-proline 0 C--N 1.323 -0.576 0 C-N-CA 125.243 1.417 . . . . 0.0 108.195 -174.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_endo -70.44 120.25 6.98 Favored 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 121.45 1.434 . . . . 0.0 108.621 173.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 5.7 t-160 -74.33 105.04 5.31 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 174.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 35.0 m -118.16 52.46 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 124.819 1.247 . . . . 0.0 110.657 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 77.49 5.0 85.53 Favored Glycine 0 CA--C 1.534 1.225 0 O-C-N 120.496 -1.377 . . . . 0.0 116.337 171.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 77.6 mt-10 -61.42 1.62 0.2 Allowed 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 129.696 3.198 . . . . 0.0 116.847 -169.528 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' THR . . . . . . . . . . . . . 52.1 m 65.62 97.97 0.04 OUTLIER Pre-proline 0 CA--C 1.537 0.448 0 C-N-CA 127.121 2.168 . . . . 0.0 112.112 178.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -74.94 168.27 25.21 Favored 'Trans proline' 0 N--CA 1.448 -1.186 0 C-N-CA 121.84 1.693 . . . . 0.0 112.834 -179.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -111.51 -26.9 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.707 0 CA-C-N 112.207 -2.27 . . . . 0.0 109.696 177.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -154.55 179.41 9.06 Favored 'General case' 0 C--N 1.339 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 110.335 178.658 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -128.2 157.64 40.28 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 125.108 1.363 . . . . 0.0 108.973 169.383 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ARG . . . . . . . . . . . . . 9.6 tpt85 -133.04 141.23 48.13 Favored 'General case' 0 N--CA 1.463 0.223 0 C-N-CA 125.577 1.551 . . . . 0.0 108.729 176.139 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 6' ' ' SER . 4.6 t-20 -109.36 135.2 50.8 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.938 0.895 . . . . 0.0 112.204 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -139.86 174.43 8.76 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 C-N-CA 126.574 1.949 . . . . 0.0 108.649 178.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.549 HD22 ' HG3' ' A' ' 4' ' ' GLN . 3.2 mm? -114.28 152.2 31.72 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 169.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.87 153.58 32.27 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 126.519 1.928 . . . . 0.0 107.16 171.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.38 138.76 58.26 Favored 'General case' 0 N--CA 1.452 -0.334 0 O-C-N 121.097 -1.002 . . . . 0.0 111.74 175.681 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.408 ' H ' ' HA ' ' A' ' 2' ' ' HIS . 30.5 mttt -141.19 133.85 28.66 Favored 'General case' 0 N--CA 1.445 -0.721 0 N-CA-C 104.944 -2.243 . . . . 0.0 104.944 146.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -120.3 -52.36 2.17 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 104.264 -2.495 . . . . 0.0 104.264 167.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.498 -0.989 0 N-CA-C 105.589 -3.004 . . . . 0.0 105.589 170.705 . . . . . . . . 0 0 . 1 stop_ save_